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 Abstract 
SNARE proteins are essential components of the machinery that facilitates membrane 
fusion in eukaryotic cells.  SNARE proteins are subject to multiple levels of regulation, 
one of which is imbedded in the syntaxin (Qa-SNARE) molecule.  It has been 
demonstrated that some syntaxins adopt a closed conformation, whereby an autonomously 
folded N terminal domain (the Habc domain) forms intramolecular contacts with the 
SNARE domain; this conformation precludes complex assembly.  The Sec1p / Munc18 
(SM) family are a conserved group of proteins that regulate membrane fusion through 
interactions with their cognate syntaxins.  Formulation of unifying hypotheses describing 
how SM proteins function has been problematic, primarily due to the multiple modes of 
interaction that have been characterised for different members of this family binding to 
their cognate SNARE proteins.  
The yeast SM protein Vps45p regulates membrane fusion through the trans-Golgi / late 
endosomal system, and interacts directly with the syntaxin (Tlg2p) and the v-SNARE 
(Snc2p) proteins.  Vps45p also binds to the assembled SNARE complex of Tlg2p, Vti1p, 
Tlg1p and Snc2p.  In this thesis I demonstrate that the Habc domain of Tlg2p has an 
inhibitory effect on SNARE complex formation.  This is an important finding, as whether 
or not Tlg2p adopts a closed conformation has hitherto been controversial.  Furthermore, I 
have demonstrated that the inhibitory effect of the Habc domain on complex formation can 
be alleviated by Vps45p in vitro.   
In addition to investigating the functional significance of Vps45p’s interaction(s) with 
Tlg2p, I have also investigated binding of the SM protein to the v-SNARE Snc2p.  I have 
demonstrated that the affinity of Vps45p for Snc2p is weaker than either of the modes of 
interaction characterised between Vps45p and Tlg2p.  Finally, I have developed an in vitro 
fusion assay to enable us to dissect the functional significance of the various interactions 
that Vps45p displays with its cognate SNARE proteins.    
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1.1 Cellular trafficking in eukaryotic cells 
Eukaryotic cells are compartmentalised into distinct organelles, contained within the 
plasma membrane.  Each organelle has a particular environment, which is circumscribed 
by an intracellular membrane boundary.  Groundbreaking work, using the pancreatic 
exocrine cell as a model, demonstrated that newly synthesised proteins destined to be 
secreted, pass through a series of organelles en route to the plasma membrane (Palade, 
1975).  Protein containing vesicles at the periphery of each compartment were observed, 
leading to the hypothesis that protein was “shuttled” between compartments in membrane 
bound vesicles (Palade, 1975).  The non-disruptive transportation of essential molecules 
between these isolated organelles is extremely important, and each trafficking event has to 
be tightly regulated both temporally and spatially to ensure specificity (Bonifacino and 
Glick, 2004).  Transport vesicles containing cargo bud from the donor membrane, travel 
through the cell to a target membrane where they initially tether, then dock, before fusion 
of the opposing phospholipid bilayers allows release of the cargo (Pfeffer, 1999).  This 
allows trafficking of molecules into and out of the cell, as well as between intracellular 
compartments.  In addition to cellular transport, the regulated movement of lipid 
membranes maintains organelle integrity.  The myriad biological transport steps found in 
eukaryotes vary dramatically in the manners by which they are controlled and regulated.  
Despite this, the basic machinery underpinning these trafficking events is thought to be 
conserved in all systems (Chen and Scheller, 2001).   
 
1.2 Membrane fusion 
The fusion of biological membranes in close apposition does not happen spontaneously, 
energy is required to overcome the natural physical barriers of the fusion event.  At long 
range the membranes are subject to electrostatic and Van der Waals forces; more 
importantly, at closer ranges (1 - 2.5 nm), membranes experience a strong repulsive 
“hydration” force, resulting from the energy required to dehydrate the lipid polar heads 
(Rand, 1981).  A wide range of scientific approaches have been used to understand how 
fusion of opposing lipid bilayers is actually achieved.  Studies of enveloped viruses proved 
to be an excellent model for membrane fusion (Patzer et al., 1979, White et al., 1983).  
Investigations into various viral mechanisms have greatly enhanced our understanding of 
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membrane fusion (White et al., 1983).  One such example is the involvement of the 
influenza virus protein hemagglutinin (HA), which is anchored to the viral membrane and 
facilitates fusion with the host cell membrane (White et al., 1982a, White et al., 1982b).  
The crystal structure of HA revealed it has a coiled-coil region extending from the 
membrane (Wilson et al., 1981).  The membrane fusion potential of HA is activated by low 
pH, which results in a conformational change from this native structure, which involves the 
extrusion of an N terminal fusion peptide and the alignment of a much extended α-helical 
region (Bullough et al., 1994, Chen et al., 1995).  Structural similarities between the low-
pH (fusion competent) form of HA and equivalent regions of other viral membrane fusion 
proteins suggests that they may share a common mechanism (Harrison, 2008).  The protein 
machinery responsible for membrane fusion of trafficking intermediates and organelles in 
the cell also contain domains which adopt an energy favourable conformation (an increase 
in α-helical content), before fusion (Bentz and Mittal, 2000).  This suggests that the protein 
folding events in the domains involved with membrane fusion, in these different systems, 
provide the energy to overcome the repulsive forces of the opposing membranes (Sollner, 
2004).   
These viral studies were the basis for a fusion pore model which allows direct fusion of 
two membranes (Chernomordik and Kozlov, 2005).  A more defined model, termed hemi-
fusion, better explains the energy requirements of the fusion event (Chernomordik and 
Kozlov, 2003, Chernomordik and Kozlov, 2005).  In this model, the initially contacting 
outer membrane leaflets merge to form a fusion intermediate (hemifusion), this first bilayer 
fusion stalk relieves the hydration force (Zimmerberg et al., 1993), before expanding into a 
diaphragm, which then breaks to form a fusion pore and allows the inner membrane 
leaflets to mix (Chernomordik and Kozlov, 2008).  The hemifusion model is outlined in 
Figure 1.1.  There are still many unanswered questions as to how fusion is triggered and 
executed, and this ultimately depends on complex involvement of both the proteins and 
lipids responsible. 
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Figure 1.1 Schematic model of membrane fusion via hemifusion intermediate 
(A) Membranes of two opposing phospholipid bilayers are shown in close apposition.  (B) The proximal 
leaflets (red) from each membrane merge to form a stalk.   (C) The stalk expands, (D) and then ruptures to 
allow the distal membrane leaflets (orange) to merge.  This allows content mixing of the two, previously 
distinct, aqueous compartments (blue and green).  (E) Fusion is complete and a single, continuous 
phospholipid bilayer encloses the mixed contents.  Adapted from (McNew, 2008). 
 
1.3 SNARE proteins 
The cytosolic proteins N-ethylmaleimide sensitive factor (NSF) and soluble NSF 
attachment protein (SNAP) were originally identified by Rothman and colleagues as 
essential components of the cellular transport machinery (Clary et al., 1990, Glick and 
Rothman, 1987).  They proposed NSF and SNAP to be part of a membrane bound 
multisubunit complex required to promote fusion.  Subsequently, using recombinant NSF 
and SNAP on an affinity column, SNAP receptor (SNARE) proteins were isolated from a 
bovine brain detergent (Sollner et al., 1993b).  The isolated SNARE proteins were further 
analysed and micro-sequenced, each protein sequence was identified by sequence 
homology with known proteins associated with the synapse (Sollner et al., 1993b).  
Syntaxin 1a (Sx1a) was identified as a homologue of the 35 kDa synaptotagmin interacting 
protein from rat brain homogenates (Bennett et al., 1992).  Synaptosome associated protein 
of 25 kDa (SNAP-25), was identified by homology to murine SNAP-25 (Oyler et al., 
1989).  Finally, synaptobrevin-2 was identified by homology to the previously 
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characterised bovine brain synaptic vesicle protein, synaptobrevin (Sudhof et al., 1989).  
Sx1a (containing one SNARE motif) and SNAP-25 (containing 2 SNARE motifs) on the 
target membrane were thought to form a stable complex with synaptobrevin (containing 
one SNARE motif) on the vesicle membrane.  The association of these proteins was 
presumed to facilitate membrane fusion (Sollner et al., 1993a).  A schematic diagram of 
the neuronal SNAREs is shown in Figure 1.2. 
 
 
Figure 1.2 The neuronal SNARE proteins 
Schematic representation of the neuronal SNARE proteins localised to their respective membranes, SNARE 
domains are shown in black.  Sx1a (red) is anchored to the target membrane by a C terminal transmembrane 
domain and also contains an autonomously folded N terminal domain.  SNAP-25 (green) contains two 
SNARE motifs, and is anchored to the target membrane by palmitoylation of cysteine residues in the linker 
region between the two motifs.  Synaptobrevin (blue) is anchored to the vesicle membrane by a C terminal 
transmembrane domain. 
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1.4 The SNARE hypothesis 
The isolation of SNARE proteins from bovine neuronal tissue (Sollner et al., 1993b) led to 
lucrative avenues of investigation in the membrane fusion field.  The SNARE hypothesis 
was then proposed, in which specific target (t-SNARE) and vesicle (v-SNARE) proteins 
exist on opposing membranes and form an energy favourable complex which facilitates 
fusion of the membranes (Rothman, 1994, Sollner et al., 1993b).  The yeast homologues of 
Sx1a, Sed5p and Pep12p, known to be important for vesicle trafficking at the ER-Golgi 
(Hardwick and Pelham, 1992) and the Golgi-vacuole (Preston et al., 1991) steps 
respectively, led Rothman and colleagues to propose that a family of SNARE proteins 
confer specificity to these trafficking events based on their intracellular location (Rothman, 
1994, Sollner et al., 1993b).  Figure 1.3 outlines the SNARE hypothesis.  Homologues of 
the originally identified neuronal SNARE proteins have subsequently been identified in a 
range or organisms (Bock et al., 2001, Weimbs et al., 1997).  All members of the SNARE 
protein family have a defining SNARE motif, which is highly conserved throughout 
evolution (Bennett and Scheller, 1993), and is involved in forming a complex with cognate 
SNARE partners to facilitate membrane fusion. 
The SNARE hypothesis was an appealing concept as it encompassed the two main 
difficulties experienced in proposing a theory to explain membrane fusion: 1) the 
specificity required to allow these events to occur in a controlled and regulated manner, 
which could be conferred through specific SNARE protein family members at each cellular 
location;  2) the energy requirements of merging opposing phospholipid bilayers, which 
can be obtained through the formation of a stable complex between SNARE proteins on 
opposing membranes. 
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Figure 1.3 The SNARE hypothesis 
The SNARE hypothesis predicts that the specificity of membrane fusion is conferred by the SNARE proteins 
localised to particular membranes.  For example, vesicles trafficking from the ER to the Golgi (red arrow) 
will contain a v-SNARE (red) that will interact specifically with a t-SNARE complex at the cis-Golgi.  This 
energy favourable complex will facilitate the fusion of the ER derived vesicle with the membrane of the cis-
Golgi.  The red v-SNARE will not be able to interact with other t-SNARE complexes associated with other 
transport steps.  Three trafficking pathways of vesicles derived from the trans-Golgi membrane are also 
represented: to the plasma membrane (turquoise); to the late endosome (orange); and to the vacuole (pink).  
Each pathway has its own complement of specific SNARE proteins that facilitate fusion at each target 
membrane. 
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1.4.1 SNARE-SNARE protein interactions 
The observation that Sx1a can bind directly with the v-SNARE synaptobrevin was in 
agreement with the SNARE hypothesis (Rothman, 1994, Sollner et al., 1993b).  However, 
the affinity of the interaction is relatively weak (Calakos et al., 1994).  Further 
investigations were pursued to better understand the interactions between individual 
SNAREs and the complex they form.  Glutathione S transferase (GST) pull down 
experiments using recombinant proteins demonstrated that Sx1a binds to SNAP-25, and 
this binary complex has a greater affinity for synaptobrevin than either of the individual 
proteins (Hayashi et al., 1994).  This study also revealed that Sx1a, SNAP-25 and 
synaptobrevin form a stochiometric complex that is resistant to the denaturing agent 
sodium dodecyl sulphate (SDS) (Hayashi et al., 1994).  This detergent resistance indicates 
that the interactions are extremely stable, a contention that was later supported by studies 
showing that the Sx1a-SNAP-25 complex and the ternary complex involving 
synaptobrevin protect the SNARE proteins from protease digestion by trypsin, in contrast 
to the individual SNARE proteins which are susceptible to digestion (Poirier et al., 1998a).   
Studies using circular dichroism spectrophotometry were subsequently used to gain further 
insight into the SNARE complex.  This technique was used to ascertain the α-helical 
content of monomeric SNAREs, which are largely unstructured with the exception of Sx1a 
(Fasshauer et al., 1997a, Fasshauer et al., 1997b; discussed in more detail in section 1.3.4).  
It was later shown that formation of the complex between Sx1a and SNAP-25 precedes 
binding to synaptobrevin (Fasshauer and Margittai, 2004).  The binding of Sx1a to SNAP-
25 results in a modest increase in α-helical content (Fasshauer et al., 1997a), but the 
formation of a stochiometric 1:1:1 complex with synaptobrevin results in greatly enhanced 
α-helicity, beyond the theoretical sum of the individual components alone (Canaves and 
Montal, 1998, Fasshauer et al., 1997b), corresponding to major conformational changes in 
the SNARE proteins.  Collectively, these data suggested that the energy requirements for 
membrane fusion may be attained when these largely unstructured SNARE proteins form a 
stable complex.  Biophysical investigations of the homologous SNARE proteins 
responsible for exocytosis in yeast, Sso1p, Sec9p and Snc2p, have shown that these 
structural and energetic properties are conserved throughout evolution (Rice et al., 1997). 
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1.4.2 SNARE complex structure 
The crystal structure at 2.4 Å of the neuronal SNARE complex showed that the 4 
individual alpha helical SNARE motifs contributed by Sx1a, SNAP-25 and synaptobrevin 
align in parallel to form a bundle of ~12 nm in length (Sutton et al., 1998).  These 
structural observations were confirmed by spin labelling electron paramagnetic resonance 
(EPR) spectroscopy, which showed that the individual SNARE domains of the neuronal t-
SNAREs align in parallel (Poirier et al., 1998b).  The coiled-coil structure of the SNARE 
complex is generated from the heptad repeat pattern of hydrophobic residues within the 
SNARE domain of each protein, in layers of interacting amino acid residue side-chains 
(Sutton et al., 1998).  A schematic representation of the layered structure of the neuronal 
SNARE complex is depicted in Figure 1.4.  The crystal structure at 1.9 Å of the 
mammalian endosomal SNARE complex, comprised of Sx7, Sx8, Vti1b and VAMP8, 
revealed a helix alignment and layered structure comparable to the neuronal complex 
(Antonin et al., 2002b).  There is limited sequence homology between the SNARE proteins 
of these two complexes, but their similar structure suggests the superhelical bundle 
structure is conserved throughout SNARE complexes (Antonin et al., 2002b).  This has 
been corroborated by crystallography studies of the SNAREs responsible for exocytosis in 
yeast (Protein data bank (PDB) accession number: 3B5N; Strop et al., 2008) and squid 
(PDB accession number: 1L4A; Bracher et al., 2002), and the complex responsible for 
homotypic fusion of mammalian early endosomes (PDB accession number: 2NPS; 
Zwilling et al., 2007); all of which have similar overall structures to that of the neuronal 
complex. 
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Figure 1.4 Orientation and organisation of the core SNARE complex 
(A) Ribbon backbone representation of neuronal SNARE protein core complex.  α-helical SNARE domains 
from Sx1a (green), SNAP-25 N terminus (turquoise), SNAP-25 C terminus (light blue) and VAMP2 (dark 
blue) align in parallel.  Crystal structure data (Sutton et al., 1998) was obtained from the PDB; accession 
code: 1SFC.and modelled using RasMol software. 
 
Interestingly, analysis of recombinant Sx1a and synaptobrevin containing their distal C 
terminal regions, including the transmembrane domains, revealed that these residues 
increased the stability of the complex, and like the SNARE motifs, were resistant to 
protease digestion (Poirier et al., 1998a).  More recently, X-ray crystallography studies 
have been carried out on the neuronal SNARE complex using versions of Sx1a and 
synaptobrevin that contain these carboxy-terminal linker and transmembrane domain 
residues, and have shown that these additional regions are also structured (PDB accession 
number: 3HD7; Stein et al., 2009).  In addition to this, it has been shown that increasing 
the length of the carboxy-terminal linker regions results in a reduced rate of fusion, 
suggesting the distance between the membranes and the SNARE proteins is important for 
fusion (McNew et al., 1999).  These data taken together support a model whereby the 
structured organisation of SNARE proteins in complex extends into the membranes, 
increasing the energy produced upon complex formation, to overcome the repulsive forces 
of the opposing phospholipid bilayers.   
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1.4.3 SNARE classification 
SNARE proteins were originally classified as either v- or t- SNAREs depending on 
whether they were localised to the trafficking vesicle or target membrane respectively.  
This proved inappropriate under circumstances such as homotypic fusion where vesicle 
and target membranes are functionally and structurally the same (Wickner, 2002).  
Sequence alignment and modelling techniques were used to demonstrate that the structure 
of the neuronal SNARE complex is conserved throughout evolution (Fasshauer et al., 
1998).  A reclassification of SNARE proteins based on the amino acid contributed by each 
SNARE motif at the central ionic layer was devised.  Q-SNAREs, such as Sx1a and 
SNAP-25, contribute a glutamine residue (Fasshauer et al., 1998).  These SNARE proteins 
were further classified based on sequence homology into Qa-SNAREs (homologues of 
Sx1a), Qb-SNAREs
 
(homologues of the
 
N terminal SNAP-25 domain) and Qc-SNARES 
(homologues of the C terminal SNAP-25 domain) (Bock et al., 2001).  R-SNAREs, such as 
synaptobrevin, contribute an arginine residue (Fasshauer et al., 1998).  The importance of 
this ionic zero layer is highlighted by sequence analysis data from a wide range of 
homologues, that revealed this residue is the most highly conserved in SNARE proteins 
(Weimbs et al., 1998).  This reassigned nomenclature appears to be the rule of thumb for 
SNARE proteins, but sequence alignment studies also revealed that 2 yeast proteins: the 
yeast v-SNARE Sft1p involved with retrograde Golgi traffic (Banfield et al., 1995) and the 
yeast t-SNARE Bet1p involved with ER to Golgi traffic (Newman et al., 1992) contain an 
aspartic acid (D) and a serine (S) respectively in this central ionic location (Weimbs et al., 
1997).  Another exception was revealed from the crystal structure of the mammalian 
endosomal t-SNARE Vti1p in complex with its cognate partners, which also contributes an 
aspartic acid (D) to this position instead of a glutamine (Q) (Zwilling et al., 2007).  Further 
investigation of SNARE complexes may reveal whether the replacement of these general 
components of the ionic layer has any functional relevance.  
 
1.4.4 Syntaxin (Qa-SNARE) family 
Sx1a was initially identified as a plasma membrane associated protein in neuronal rat 
tissue (Inoue et al., 1992).  Sx1a was subsequently identified as a SNAP binding protein 
(Bennett et al., 1992), and a component of the neuronal SNARE complex (Sollner et al., 
1993b).  There are 15 genes in mammals that encode syntaxins localised to various 
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compartments within the cell, with some additional alternatively spliced isoforms existing 
for several syntaxin proteins (Teng et al., 2001).  There are only 7 syntaxins encoded in the 
yeast genome, which are also localised to specific membranes within the cell (Pelham, 
2001).  Aside from the SNARE domain common to all syntaxins, almost all have a region 
of hydrophobic residues at the C terminus (Bock et al., 2001, Weimbs et al., 1997); this 
transmembrane domain allows the protein to anchor to the membrane.  Sx11, identified as 
a Sx1a homologue by sequence alignment analysis (Advani et al., 1998, Tang et al., 1998), 
appears to be the only exception to this rule so far; it contains a cysteine rich region instead 
of a typical C terminal transmembrane domain (Tang et al., 1998), and is incorporated into 
the membrane after posttranslational palmitoylation of this cysteine rich domain (Prekeris 
et al., 2000).   
Another characteristic of some syntaxin family members is that they contain an additional 
N terminal structured domain, which was originally identified, and has subsequently been 
characterised, using NMR studies on Sx1a (Chen et al., 2008, Fernandez et al., 1998, 
Lerman et al., 2000).  The discovery of this structured N terminal domain explained 
previous circular dichroism spectrophotometry findings that although the monomeric non-
syntaxin neuronal SNARE proteins have very little α-helical content, monomeric Sx1a 
contains approximately 43% α-helical content, indicative of a structured domain not 
present in the other SNARE proteins (Fasshauer et al., 1997a, Fasshauer et al., 1997b; also 
discussed in section 1.3.1).  The N terminal domain of Sx1a is composed of three 
individual α-helices, domains Ha, Hb and Hc, that align in an up and down bundle, 
collectively termed the Habc domain (Fernandez et al., 1998).  Figure 1.5 (A) & (B) shows 
a ribbon representation of the N terminal Habc domain of Sx1a.   
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Figure 1.5 Structure of the N terminal Habc domain of Sx1a 
(A) The three alpha helices of the Habc domain are shown: Ha domain, residues 28 - 62 (blue); Hb domain, 
residues 71 - 104 (green); Hc domain, residues 111 - 144 (orange / red).  Residues 69 (between Ha and Hb 
helices) and 108 (between Hb and Hc helices) are also indicated.  Crystal structure data (Fernandez et al., 
1998) was obtained from the PDB; accession code: 1BRO and modelled using RasMol software. (C) 
Schematic representation of Sx1a in a closed conformation, (D) and in an open conformation.  In each case 
the SNARE and Habc domains are indicated by cylinders. 
 
Studies on the linker region of ~40 residues connecting the Habc domain and the SNARE 
domain revealed it to be largely unstructured (Fernandez et al., 1998).  However, the linker 
region appears to be flexible, in that it cycles between randomly coiled (when Sx1a is 
interacting with its cognate SNARE partners) and having a defined secondary structure 
(when Sx1a is in complex with a regulatory Sec1p / Munc18 (SM) protein, Munc18a) 
(Margittai et al., 2003; discussed in more detail in section 1.5.4.1).  This observation was 
followed by the demonstration that Sx1a adopts two distinct conformations when bound to 
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either the regulatory SM protein Munc18a, or its cognate SNARE partners (Dulubova et 
al., 1999).  A schematic diagram outlining these two distinct conformations is shown in 
Figure 1.5 (C) & (D).  The distinct Sx1a conformation involved with binding to the SM 
protein was identified in the X-ray crystal structure of Sx1a in complex with Munc18a 
(Misura et al., 2000).  This revealed that the N terminal Habc domain of Sx1a is capable of 
folding back upon this flexible linker and forming an intramolecular interaction with the 
SNARE motif, in what is termed a closed conformation (Misura et al., 2000; mode-1 
binding, discussed in section 1.5.4.1).  As this precludes entry into SNARE complexes it 
was presumed that the closed conformation of syntaxins acts as a negative regulator on 
complex assembly and fusion (Dulubova et al., 1999, Misura et al., 2000, Yang et al., 
2000).  The crystal structures of other syntaxins have been shown to also form a closed 
conformation that is unfavourable for membrane fusion: the squid Sx1a (Bracher and 
Weissenhorn, 2004) and the yeast cell-surface Sso1p (Munson et al., 2000).  Functional 
and biochemical studies on other plasma membrane syntaxins (the mammalian Sx4, and 
the worm UNC-64) have demonstrated that they too regulate complex formation through a 
conformational switch between these two distinct (open and closed) conformations (Aran 
et al., 2009, D'Andrea-Merrins et al., 2007, Johnson et al., 2009, Richmond et al., 2001).  It 
was originally presumed that only SNARE proteins localised to the plasma membrane 
contained Habc domains (Fernandez et al., 1998).  More recently it has been shown that, 
despite poor sequence homology to Sx1a at these N terminal residues, other syntaxins do 
contain an autonomously folded Habc domain (Antonin et al., 2002a, Dulubova et al., 
2001, Dulubova et al., 2002, Misura et al., 2002). 
 
1.4.5 SNAP-25 (Qb & Qc) SNARE family 
SNAP-25 is a protein composed of 206 amino acids and differs from the other two SNARE 
proteins originally identified from the neuronal system, Sx1a and synaptobrevin (Sollner et 
al., 1993b), as it does not contain a stretch of residues that form a transmembrane domain 
(Oyler et al., 1989).  SNAP-25 contains four closely positioned cysteine residues (Bark and 
Wilson, 1994), which allow its membrane association through palmitoylation (Hess et al., 
1992, Lane and Liu, 1997, Vogel and Roche, 1999).  SNAP-25 can bind directly to Sx1a 
and synaptobrevin (Chapman et al., 1994) in a functional SNARE complex (Weber et al., 
1998).  SNAP-25 also differs from the other neuronal SNAREs as it contains two 
conserved SNARE motifs, one at the N terminus and one at the C terminus (Wilson et al., 
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1996).  SNAP-25 homologues, such as SNAP-23 which is expressed ubiquitously in cells 
(Ravichandran et al., 1996), and the yeast plasma membrane Sec9p (Brennwald et al., 
1994) have been identified.  Further sequence alignment analysis on intracellular SNARE 
proteins revealed that complexes at these locations involved two individual proteins, in 
addition to the syntaxin and v-SNARE homologues, each protein contributing one motif 
each (Bock et al., 2001, Weimbs et al., 1997).  Based on the homology these proteins have 
to either the N or C terminal motifs of SNAP-25, they were classified as Qb- and Qc-
SNAREs respectively (Bock et al., 2001). 
 
1.4.6 Synaptobrevin (R) SNARE family 
The final component of a four helix core SNARE complex bundle containing three Q 
SNARE motifs is an R-SNARE (Jahn et al., 2003, Pelham, 2001).  Before synaptobrevin 
was isolated as a component of the neuronal SNARE complex (Sollner et al., 1993b), it 
had been identified as a 120 amino acid protein containing a C terminal transmembrane 
domain, associated with synaptic vesicles (Trimble et al., 1988).  Homologues of 
synaptobrevin have been identified in various other species (Bock et al., 2001, Hong, 
2005).  Most R-SNAREs have a C terminal transmembrane domain, one notable exception 
is the yeast SNARE associated with multiple vacuolar trafficking steps, Ykt6p (Kweon et 
al., 2003); membrane localization of Ykt6p is mediated by isoprenylation (McNew et al., 
1997).  The fact Ykt6p has been associated with multiple trafficking routes (Alkaline 
phosphatase (ALP), cytoplasm-to-vacuole (CVT), and carboxypeptidase Y (CPY) 
pathways; depicted in Figure 1.11 as grey block arrows), demonstrates that specificity is 
not reliant on the v- / R-SNARE family alone (Kweon et al., 2003), and that other 
regulatory factors are involved (discussed in section 1.6).  
 
1.5 SNARE mediated membrane fusion 
The SNARE hypothesis proposed that specificity of membrane fusion events could be 
conferred through various SNARE partners interacting at specific membrane boundaries 
throughout the cell (Rothman, 1994, Sollner et al., 1993b).  A schematic representation of 
SNARE mediated membrane fusion is shown in Figure 1.6.   
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Figure 1.6 Schematic representation of SNARE mediated membrane fusion 
(A) A synaptic vesicle (turquoise), containing the v-SNARE synaptobrevin (dark blue) embedded in the 
vesicle membrane by a C terminal TMD, approaches the target membrane, (in this case, the plasma 
membrane of a neuronal cell).  The target membrane harbours syntaxin molecules (red), anchored to the 
plasma membrane via a C terminal TMD.  The N terminal Habc domain of Sx1a interacts directly with the 
SNARE motif, in a closed conformation that is incompatible with complex assembly.  SNAP-25 (green) is 
also associated with the target membrane; it is anchored by covalent attachment of palmitate groups to a 
cysteine rich linker region between the two SNARE motifs of the protein.  (B) The syntaxin molecules 
undergo a conformational change which releases the N terminal inhibitory domain and allows the SNARE 
motif to form a core complex with the two SNAP-25 domains and the synaptobrevin domain.  The vesicle is 
now said to be docked at the membrane via a trans-SNARE complex.  (C) The docked vesicle undergoes 
membrane fusion, which allows the vesicle cargo to be released.  The cis-SNARE complex containing Sx1a, 
SNAP-25 and synaptobrevin on the same membrane then requires ATP driven disassembly to recycle the 
SNAREs for subsequent fusion events.  Taken from (Barrick and Hughson, 2002).  
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Whilst this was in theory an excellent model to explain the necessary specificity of 
individual membrane fusion events, further work revealed that specificity is not encoded 
solely through the SNARE proteins; in fact, many SNARE proteins associated with various 
transport steps interact promiscuously (Fasshauer et al., 1999, Tsui and Banfield, 2000, 
Yang et al., 1999).  It is especially unsurprising that promiscuous SNARE pairings occur, 
as the SNARE motifs are so highly conserved (Rizo and Sudhof, 2002).  On the other 
hand, some promiscuous SNARE pairings have been shown to be ineffective at promoting 
exocytosis in PC12 cells; suggesting that SNAREs do confer some level of specificity to 
membrane fusion (Scales et al., 2000). 
An in vitro assay was developed and used to demonstrate that SNARE proteins 
incorporated into synthetic vesicle membranes were sufficient to drive fusion of the two 
vesicle populations, one harbouring the v-SNARE and the other the t-SNARE complex 
(Weber et al., 1998; discussed in detail in Chapter V).  This suggests that formation of the 
energy favourable conformation of the SNARE complex (discussed in section 1.3.2) is 
sufficient to drive fusion of opposing phospholipid membranes (Weber et al., 1998).  This 
assay was further used to test the ability of various v-SNAREs to promote fusion in vitro 
with known t-SNARE complexes that exist at the Golgi, vacuole or plasma membrane 
(McNew et al., 2000).  This study demonstrated that generally a specific v-SNARE is 
responsible for promoting fusion with t-SNARE complexes at the various cellular locations 
(McNew et al., 2000).  A more extensive examination of possible t-SNARE complexes 
with all v-SNAREs in yeast corroborated this report, demonstrating that very few SNARE 
combinations resulted in fusion; suggesting that cognate SNARE partners localised to 
specific compartments predominantly facilitate fusion of synthetic membranes (Parlati et 
al., 2002).  A report identifying the yeast SNARE Vti1p used in vivo techniques to 
demonstrate that it could functionally act as a v-SNARE; Vti1p interacts with complexes 
containing different syntaxin homologues (Sed5p and Pep12p) for two distinct cellular 
locations: the cis-Golgi and the pre-vacuolar compartment, respectively (von Mollard et 
al., 1997).  The discrepancy in specificity observed in various systems may be due to levels 
of in vivo regulation peculiar to any given step; there also may be more attuned regulatory 
requirements for yeast SNARE proteins, which carry out the various cellular fusion events 
with fewer homologues of fusion machinery components than are found in higher 
eukaryotes (Pelham, 2001, Pelham, 1999).  The regulatory family of Rab proteins, and 
their effectors, have been successfully incorporated into liposomes with SNARE proteins 
(Ohya et al., 2009).  This study reported that both machineries work in concert to increase 
both the specificity and efficiency of membrane fusion (Ohya et al., 2009). 
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1.6 Regulation of membrane fusion 
Although SNARE proteins have been identified as key components of the fusion 
machinery, it remains clear that there are other essential factors involved in the process of 
membrane fusion (Ungar and Hughson, 2003).  Various proteins have been associated with 
the regulation of membrane fusion, but their precise roles remain unknown.  The following 
sections will discuss some of the factors that have been implicated in the regulation of 
SNARE mediated membrane fusion. 
 
1.6.1 Sec1p / Munc18 (SM) proteins 
Genetic screening of the nematode worm Caenorhabditis elegans revealed a large number 
of mutations that affected the normal movement behaviour of the animals, termed 
uncoordinated (Brenner, 1974); one of these genes encodes the canonical SM protein 
UNC-18.  The uncoordinated phenotype observed from deletion of unc-18 in C. elegans 
was shown to be caused by a block in neuronal vesicular transport (Gengyo-Ando et al., 
1993).  The first discovered homologue of UNC-18, named Sec1p, was identified in a 
genetic screen of S. cerevisiae isolating secretory mutants that fail to export synthesised 
protein due to a block in the transport and fusion of secretory vesicles to / with the plasma 
membrane (Novick et al., 1980).  Two functionally related yeast Sec1p homologues 
involved with intracellular transport, Sly1p and Slp1p, were subsequently identified by 
sequence alignment techniques (Aalto et al., 1992).  Sly1p is involved with ER to Golgi 
trafficking (Ossig et al., 1991).  Genetic and biochemical analysis of Slp1p revealed it to be 
the same as Vps33p (Robinson et al., 1988); responsible for trafficking from the Golgi to 
the vacuole (Wada et al., 1990).  The final yeast SM protein was identified from a screen 
of mutants responsible for vacuolar protein sorting defects, named Vps45p (Raymond et 
al., 1992); which is associated with trafficking at the late Golgi and early endosome system 
(Cowles et al., 1994, Piper et al., 1994).  SM protein family members have been identified 
in higher eukaryotes also, including ROP in Drosophila melanogaster (Harrison et al., 
1994) and the mammalian UNC-18 neuronal homologue in rat brain, Munc18 (Hata et al., 
1993).  Three isoforms of Munc18 have been identified: the original, neuronal specific, 
Munc18a (Hata et al., 1993); Munc18b, which is predominately expressed in epithelial 
cells (Riento et al., 1996) and Munc18c, which is ubiquitously expressed in mammalian 
cells (Katagiri et al., 1995, Tellam et al., 1995). 
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1.6.2 SM protein structure 
All SM proteins are ~600 amino acids in length, and are presumed to form similar 
structures due to sequence conservation distributed throughout their entire sequences 
(Halachmi and Lev, 1996, Toonen and Verhage, 2003).  This contention is supported by  
X-ray crystallography studies that set out to characterise the interaction between SM 
proteins and syntaxins.  The first example of this was the crystal structure of Munc18a in 
complex with Sx1a, which revealed Munc18a forms an arch shape structure with a central 
cavity (Misura et al., 2000).  This structure was confirmed by the crystal structure of 
Munc18a homologue in the squid Loligo pealei, sSec1p (Bracher et al., 2000).  Ribbon 
diagrams generated from the two crystal structures of Munc18a and nSec1p are shown in 
Figure 1.7.  To date, the crystal structures of four SM proteins have been solved: Munc18a 
(Misura et al., 2000; Figure 1.7 (A)); sSec1p (Bracher et al., 2000; Figure 1.7 (B)); the 
yeast protein Sly1p (PBD accession code: 1MQS; Bracher and Weissenhorn, 2002); and 
Munc18c (PBD accession code: 2PJX; Hu et al., 2007); all of which share this similar arch 
shaped structure containing a central cavity. 
 
Figure 1.7 X-ray crystal structures of Munc18a and nSec1p 
Comparison of the X-ray crystallography structural data generated for two SM protein homologues, α-helices 
are denoted by spirals, β-sheets by arrows.  (A) Ribbon representation of Munc18a from rat: domain 1 shown 
in blue, domain 2 in green and domain 3 in yellow.  Approximate dimensions of the protein included with 
arrows.  PDB accession code: 1DN1.  Adapted from (Misura et al., 2000).  (B) Ribbon representation of 
sSec1 from squid: domain 1 shown in yellow, domain 2 in blue and domain 3 in grey.  The approximate 
distance of the cleft formed between domains 1 and 3 is indicated.  PDB accession code: 1FVH.  Adapted 
from (Bracher et al., 2000). 
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1.6.3 Role of SM proteins 
The role of SM proteins is not well understood, but their importance in fusion has been 
established through various in vivo studies.  Null mutation of Munc18a and ROP, SM 
proteins in Mus musculus and D. melanogaster respectively, both result in a fatal 
phenotype characterised by severe blockage in neurotransmitter release (Harrison et al., 
1994, Verhage et al., 2000).  Similarly, severe trafficking phenotypes are observed when 
SM proteins are mutated or deleted in S. cerevisiae (Banta et al., 1990, Cowles et al., 1994, 
Novick et al., 1980, Ossig et al., 1991, Piper et al., 1994) and C. elegans (Gengyo-Ando et 
al., 1993, Hosono et al., 1992, Weimer et al., 2003).  Many of these mutations were 
responsible for the original identification of individual SM proteins, through the genetic 
screens mentioned above (section 1.5.1).  The SM protein requirement in numerous 
transport pathways from various species suggests a conserved, fundamental role in 
membrane fusion. 
Despite relatively low sequence identity between this family of proteins, homology is 
distributed throughout the entire length of the proteins (Halachmi and Lev, 1996, Toonen 
and Verhage, 2003), suggesting that they share a common function.  However, it is unclear 
whether a universal function can be applied to SM proteins due to seemingly inconsistent 
data gathered from the various systems studied (Toonen and Verhage, 2003).  One 
recurrent characteristic of SM proteins is their association with members of the syntaxin 
family, which was first observed when Munc18a was identified as a Sx1a binding partner 
(Hata et al., 1993), but has since been reported in various other systems (Toonen and 
Verhage, 2003).  It has been suggested that the role of SM proteins is carried out through 
specific interaction with a syntaxin family member (Jahn, 2000).  However, there is not a 
strict 1:1 relationship between SM proteins and syntaxins, highlighted by the fact the yeast 
genome has only four SM genes but seven syntaxin genes (Hayashi et al., 1994, Jahn and 
Sudhof, 1999, Pelham, 2001).  Further investigations into SM protein interactions with the 
syntaxin family has not clarified their role, largely because they have been shown to bind 
syntaxins via distinct mechanisms and also to interact with non-syntaxin SNARE family 
members (Toonen and Verhage, 2003; discussed in section 1.6.4.5). 
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1.6.4 SM protein binding 
A wealth of biochemical and structural data have shown SM proteins to interact with 
SNARE proteins by distinct mechanisms, but the significance of these binding modes 
remains unclear (Burgoyne and Morgan, 2007).  These binding modes have been loosely 
categorised as mode-1, mode-2 and mode-3 (Burgoyne and Morgan, 2007).  However, not 
all SM-SNARE protein interactions fall neatly into these categories, and there appears to 
be no obvious reason why different SM proteins should bind their cognate SNAREs by 
such strikingly different mechanisms, especially considering their apparent conserved 
structure and function (Jahn, 2000). 
 
1.6.4.1 Mode-1 binding 
The first SM binding mode was discovered when the crystal structure of the neuronal SM 
protein Munc18a in complex with its cognate syntaxin, Sx1a, was solved (Misura et al., 
2000; Figure 1.8(A)).  This study revealed Munc18a forms an arch shaped molecule 
(discussed in section 1.5.2), and the central cavity interacts with Sx1a in a closed 
conformation (Misura et al., 2000); this conformation is known to be incompatible with 
core complex assembly (Dulubova et al., 1999; discussed in section 1.3.4).  A cartoon of 
mode-1 binding is shown in Figure 1.8 (B).  The fact that Sx1a interacting with Munc18a 
via this mode-1 binding precludes its ability to form SNARE complexes (Yang et al., 
2000), suggested that SM proteins may act as negative regulators of membrane fusion.  
However, evidence showing the absolute requirement for Munc18a in neuronal exocytosis 
(Verhage et al., 2000), alongside the requirement of SM protein family members at other 
transport steps (Sudhof and Rothman, 2009), supports a model where the interaction 
between Munc18a and Sx1a destabilises the closed conformation of the syntaxin, thus 
priming it for entry into SNARE complexes. 
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Figure 1.8 Mode-1 binding of SM proteins 
(A) Topology diagram indicating the domain structure of Munc18a in complex with Sx1a: Sx1a SNARE 
domain and Habc domain are shown in green; Munc18a is shown in blue, domains I, II, IIIA and IIIB are 
indictaed.  α-helices are denoted by spirals, β-sheets by arrows.  Crystal structure data (Misura et al., 2000) 
was obtained from the PDB; accession code: 1DN1 and modelled using RasMol software.  (B) Schematic 
diagram of mode-1 binding; syntaxin (red), SNARE motif (black), SM protein (purple) and membrane (dark 
grey) are depicted.  The N terminal Habc domain of the syntaxin interacts with the SNARE motif in a closed 
conformation.  The SM protein interacts with the syntaxin by clasping the closed conformation in its central 
cavity.   
 
1.6.4.2 Mode-2 binding 
NMR analysis of the Golgi syntaxin Sed5p revealed that, like Sx1a (discussed in section 
1.3.4), Sed5p contains an N terminal Habc domain, with the three α-helices spanning from 
residues 53 and 168 (Yamaguchi et al., 2002).  This study also demonstrated that the distal 
N terminus of Sed5p preceding the Habc domain (residues 1 - 40) was sufficient to capture 
its cognate SM protein, Sly1p (Yamaguchi et al., 2002).  This was supported by limited 
proteolysis experiments of the Sed5p-Sly1p complex that showed a 5 kDa N terminal 
fragment of Sed5p was protected from digestion through its interaction with Sly1p 
(Bracher and Weissenhorn, 2002).  This study resolved the crystal structure of the N 
terminal fragment (residues 1 - 45) of Sed5p in complex with Sly1p (Bracher and 
Weissenhorn, 2002; shown in Figure 1.9 (A)).  This study revealed that SM proteins Sly1p 
and Munc18a do, in fact, have a very similar arch shaped structure; but the manner by 
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which Sly1p binds its cognate syntaxin is remarkably different to the binding of Sx1a with 
Munc18a (Bracher and Weissenhorn, 2002, Misura et al., 2000).  The short N terminal 
peptide of Sed5p forms a point of contact with a hydrophobic pocket (composed of 
residues Leu137, Leu140, Ala141, Ile153 and Val156) located on the exterior of domain I 
of Sly1p (Bracher and Weissenhorn, 2002).  A cartoon representation of mode-2 binding is 
shown in Figure 1.9 (B).  Mutation of one of the highly conserved hydrophobic residues in 
the pocket region (L137R, L140K or A141K) results in Sed5p binding being completely 
abolished; binding is also abolished if a residue in the N terminal peptide of Sed5p is 
mutated (L10A) (Peng and Gallwitz, 2004).   
 
Figure 1.9 Mode-2 binding of SM proteins 
(A) Topology diagram indicating the domain structure of Sly1p in complex with the N terminus of Sed5p: 
Sed5p is shown in green and the three domains of Sly1p are shown in blue.  α-helices are denoted by 
cylinders, β-sheets by arrows.  Crystal structure data (Bracher and Weissenhorn, 2002) was obtained from the 
PDB; accession code: 1DN1 and modelled using RasMol software.  (B) Schematic diagram of mode-2 
binding; syntaxin (red), SNARE motif (black), SM protein (purple) and membrane (dark grey) are depicted.  
Only the N terminal peptides are included in current crystal structures of a syntaxin molecule interacting with 
an SM protein via mode-2 binding, therefore the orientation of the proteins in this schematic representation is 
presumed.  The distal N terminal peptide of the syntaxin interacts with a hydrophobic pocket in the exterior 
of domain I of the SM protein (lightest shade of purple). 
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Another striking difference between this interaction and mode-1 binding was demonstrated 
by the ability of Sly1p to interact with Sed5p either as a monomer or when it is in complex 
with its cognate SNARE partners, with no apparent effect on Sed5p’s ability to form 
SNARE complexes (Peng and Gallwitz, 2002).  Sly1p binding to Sed5p was demonstrated 
to enhance its ability to form trans-SNARE complexes (Kosodo et al., 2002).  In addition 
to this, Sly1p bound to Sed5p in the resulting cis complexes after fusion has been 
implicated in the SNARE complex disassembly process, working in conjunction with the 
ATPase Sec18p (Kosodo et al., 2003).  The binding of Sly1p to Sed5p has shown that SM 
proteins can confer a level of specificity on SNARE complex assembly, as Sed5p in 
complex with Sly1p precludes formation of complexes with non-cognate v-SNARE 
partners (Peng and Gallwitz, 2002).  Intriguingly, a yeast strain expressing a mutant 
version of Sly1p abrogated for mode-2 binding (L140K) was found still to localise to Golgi 
membranes and correctly function in the trafficking of both CPY and invertase (Peng and 
Gallwitz, 2004).  Somewhat surprisingly, in vitro binding of the mutant Sly1pL140K to 
assembled SNARE complexes was greatly reduced, and no Sly1p could be co-
immunoprecipitated with Sed5p from yeast cell lysates, suggesting Sly1p function is not 
directly coupled to assembled SNARE complexes (Peng and Gallwitz, 2004).  Mode-2 
binding has also been documented for the yeast SM protein Vps45p binding its cognate 
syntaxin, Tlg2p (Dulubova et al., 2002); and the mammalian SM protein Munc18c binding 
to Sx4 (Latham et al., 2006), which was further supported by the crystal structure of this 
complex being solved and found to resemble that of Sed5p-Sly1p (Hu et al., 2007). 
 
1.6.4.3 Mode-3 binding 
The crystal structure of the yeast syntaxin responsible for exocytosis, Sso1p, revealed that 
it adopts a closed conformation, akin to that of Sx1a (Munson et al., 2000).  Mutant 
versions of Sso1p unable to form a closed conformation were used to demonstrate that the 
Habc domain has a striking inhibitory effect on complex assembly both in vitro and in vivo 
(Munson et al., 2000, Munson and Hughson, 2002, Nicholson et al., 1998).  It is surprising 
that the Habc domain of Sso1p has this capacity to inhibit SNARE complex assembly, like 
that of Sx1a, but does not interact with its cognate SM protein via mode-1 binding (Carr et 
al., 1999), as characterised for Sx1a binding Munc18a (Dulubova et al., 1999, Misura et 
al., 2000).  It had been previously shown that the Sso1p cognate SM protein, Sec1p, could 
not bind to monomeric Sso1p (Carr et al., 1999).   Both in vivo and in vitro experiments in 
Chris MacDonald, 2009  Chapter I, 40 
yeast were used to demonstrate that Sec1p binds to preassembled SNARE complexes (Carr 
et al., 1999, Grote et al., 2000).  A cartoon representation of mode-3 binding is shown in 
Figure 1.10.  A small amount of Sec1p-Sso1p binding was documented in vitro in another 
report (Scott et al., 2004), but more extensive in vivo searches for an interaction proved 
fruitless, as did searches for Sec1p binding to any monomeric components of the core 
complex (Togneri et al., 2006).  This has led to the proposal that Sec1p has a direct 
function related to fusion facilitated by the core complex (Togneri et al., 2006).  This is 
supported by functional studies utilising an in vitro liposome fusion assay (discussed in 
Chapter V), where the binary t-SNARE complex between Sso1p and Sec9p was 
reconstituted into one population of vesicles, and the cognate v-SNARE Snc2p into 
another population; the reconstituted SNAREs facilitate fusion of the two liposome 
populations (Scott et al., 2004).  When the cognate SM protein, Sly1p, is reconstituted with 
the binary t-SNARE complex, the rate of fusion is enhanced almost three fold above the 
standard fusion reaction, demonstrating that the SM protein is having a direct effect 
enhancing the rate of fusion (Scott et al., 2004). 
 
Figure 1.10 Mode-3 binding of SM proteins 
There is no crystal structure of a SNARE complex interacting with an SM protein via mode-3 binding; the 
schematic representation is based on biochemical analysis of the proteins involved, and so the orientation of 
proteins is again presumed.  Syntaxin (red), light chain t-SNARE proteins (green), v-SNARE protein (blue), 
SNARE domains (black) and SM protein (purple) are depicted.  It is not known if Sec1p preferentially binds 
to complexes on opposing membranes (trans-SNARE complexes) or to complexes on the same membrane 
(cis-SNARE complexes), as depicted here. 
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1.6.4.4 Indirect mode of SM protein binding 
Vam3p, the syntaxin that localises to, and regulates traffic into, the yeast vacuole (Sato et 
al., 1998, Srivastava and Jones, 1998, Wada et al., 1997), differs again in its mode of 
binding to cognate SM protein Vps33p, in that it does not do so directly (Sato et al., 2000).  
Sato and colleagues demonstrated that Vps33p is part of a complex (the homotypic fusion 
and vacuole protein sorting (HOPS) complex; composed of Vps11p, Vps16p, Vps18p, in 
addition to Vps33p), when it interacts with monomeric Vam3p (Sato et al., 2000).  The 
interaction between this SM protein containing HOPS complex and Vam3p is required for 
homotypic fusion of vacuolar membranes (Seals et al., 2000).  Investigations into Vps33p 
binding have shown no direct interaction with Vam3p (Dulubova et al., 2001, Price et al., 
2000).  Functional studies on D. melanogaster revealed that a Vps33p homologue also 
interacts with a complex (Sevrioukov et al., 1999).  In silico analysis of yeast Vps33p 
revealed two homologues (Vps33a and Vps33b) in higher eukaryotes: D. melanogaster; 
Homo sapiens; Mus musculus; Rattus norvegicus; Danio rerio; C. elegans (Gissen et al., 
2005).  A low affinity interaction has also been demonstrated between Vps33p and the late 
endosomal syntaxin Pep12p (Subramanian et al., 2004), which is thought to mediate 
trafficking to the vacuole (Becherer et al., 1996).  This is the only documented example of 
a syntaxin interacting with two SM proteins, as Pep12p has also been shown to interact 
with Vps45p (Burd et al., 1997, Webb et al., 1997).  However, the main binding site of 
Vps45p has been shown to be Tlg2p, the syntaxin responsible for trans-Golgi network 
(TGN) / early endosome trafficking (Abeliovich et al., 1999, Abeliovich et al., 1998, 
Bryant and James, 2001, Nichols et al., 1998). 
 
1.6.4.5 SM proteins binding non-syntaxin SNAREs 
SM proteins, despite having varied binding modes to their cognate syntaxins were 
presumed to carry out their function via this interaction; the discovery that SM proteins 
could also bind to non-syntaxin SNAREs further complicates the proposal of a hypothesis 
to explain conserved SM protein function(s) (Peng, 2005).  The syntaxin Sed5p, which can 
interact with different cognate SNARE partners to facilitate membrane fusion at the ER-
Golgi and intra-Golgi trafficking steps (Parlati et al., 2000, Parlati et al., 2002), is known to 
bind with a high affinity to SM protein Sly1p (Grabowski and Gallwitz, 1997).  As 
discussed in section 1.5.4.2, Sed5p interacts with Sly1p through mode-2 binding (Bracher 
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and Weissenhorn, 2002, Yamaguchi et al., 2002).  Further investigation of this system, 
using mutant versions of Sed5p and Sly1p that abolish mode-2 binding, demonstrated that 
this mode of interaction is not essential for in vivo function (Peng and Gallwitz, 2004).  
The fact that a large fraction of mutant Sly1p unable to interact with Sed5p via mode-2 was 
still found localised to Golgi membranes, led Peng and Gallwitz to test if Sly1p could 
interact with non-syntaxin SNAREs (Peng and Gallwitz, 2004).  These experiments 
revealed that Sly1p could directly interact with four non-syntaxin SNARE proteins: two 
involved in ER-Golgi traffic (Bet1p and Bos1p) and two involved with intra-Golgi traffic 
(Gos1p and Sft1p) (Peng and Gallwitz, 2004).  Furthermore, Sly1p interaction with non-
syntaxin SNAREs is not promiscuous, as it does not bind the non-syntaxin SNARE 
molecules Tlg1p, Vti1p and Nyv1p, which are not associated with these Sed5p related 
trafficking steps (Peng and Gallwitz, 2004).  Another example of an SM protein binding to 
a non-syntaxin SNARE protein was identified in the yeast TGN / early endosomal system: 
Vps45p interacts with its cognate v-SNARE Snc2p (Carpp et al., 2006; this interaction is 
discussed in more detail in Chapter IV), in addition to its better characterised mode-2 
interaction with Tlg2p (Abeliovich et al., 1999, Bryant and James, 2001, Dulubova et al., 
2002, Nichols et al., 1998).  
 
1.6.4.6 Other SM protein binding 
Rab proteins and their effectors have been shown to coordinate various aspects of 
membrane trafficking, and have also been implicated in conferring a level of specificity to 
membrane fusion events (Zerial and McBride, 2001; discussed in more detail in section 
1.5.5).  Rab5 is associated with transport into and through the mammalian early endosome 
and carries out its function through various effectors recruited to the endosomes 
(Christoforidis et al., 1999, McBride et al., 1999).  The SM protein Vps45 has been shown 
to indirectly associate with Rab5 through an interaction with one of these effectors, 
Rabenosyn-5 (Nielsen et al., 2000).  A more recent in vivo study in D. melanogaster 
demonstrated that the Rabenosyn-Vps45 complex on early endosomes links Rab5 to the 
syntaxin Avalanche (Avl), and that all four proteins are necessary for vesicle fusion in the 
early endosome (Morrison et al., 2008).   
Another novel interaction, involving the Golgi associated SM protein Sly1 binding directly 
to a tethering factor, was recently identified (Laufman et al., 2009).  Tethering factors are a 
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family of loosely related proteins that have been implicated in membrane fusion as being 
the first point of vesicle contact, and also conferring a level of specificity (reviewed in 
Whyte and Munro, 2002; discussed in section 1.5.6).  The conserved oligomeric Golgi 
(COG) complex is a large multisubunit complex composed of eight individual proteins 
(Kim et al., 1999, VanRheenen et al., 1999, Whyte and Munro, 2001), which are now 
labelled Cog1 – Cog8 (or Cog1p - Cog8p in yeast) (Ungar et al., 2002).  The COG 
complex has been shown to interact directly with Golgi syntaxin Sed5p, and its 
mammalian homologue, Sx5 (Shestakova et al., 2007).  More recently, a direct interaction 
between the Golgi SM protein Sly1 and the N terminal portion of Cog4 has been identified 
(Laufman et al., 2009).  This study further documented that the N terminal portion of Cog4 
is also responsible for the Sx5 interaction, although it appears different residues of the 
Cog4 N terminus are involved in each interaction (Laufman et al., 2009).  There are also 
some documented cases of the neuronal SM protein Munc18a interacting with additional 
proteins, such as Munc18 interacting proteins (Mints) that are predominantly expressed in 
the brain (Okamoto and Sudhof, 1997).  These proteins / interactions are thought to be 
specific to neuronal exocytosis (reviewed in Latham and Meunier, 2007).  
 
1.6.4.7 SM proteins binding via multiple modes 
The crystal structure of the mode-1 interaction between Munc18a and Sx1a is one of the 
best characterised examples of an SM protein binding to a syntaxin (Misura et al., 2000).  
A series of reports have since been published characterising additional modes of Munc18a 
binding (Verhage and Toonen, 2007), which has helped to reconcile discrepancies between 
Munc18a apparently only binding an inactive conformation of Sx1a (Dulubova et al., 
1999, Yang et al., 2000), whilst being required for neuronal exocytosis (Verhage et al., 
2000).  Gel filtration and NMR techniques have been used to demonstrate that Munc18a 
interacts with the assembled core complex (Dulubova et al., 2007).  In addition to this, in 
vitro binding studies and in vivo co-localisation analysis techniques were used to 
demonstrate that Munc18a can interact with Sx1a by a mode that is functionally, and 
spatially, distinct from the closed conformation (Rickman et al., 2007).  Similarly, 
investigations on the effects of arachidonic acid in stimulation of SNARE complex 
formation showed that Munc18a was in association with the assembled SNARE complex 
(Connell et al., 2007, Latham et al., 2007).  The functional significance of Munc18a 
association to the SNARE complex was supported in a report that demonstrated that 
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Munc18a binds to assembled complexes anchored to liposomes in vitro, and that this 
association accelerates the rate of liposome fusion (Shen et al., 2007).  It was suggested by 
Rickman and colleagues that the association of Munc18a to the assembled complex may be 
facilitated through the N terminus of Sx1a (Rickman et al., 2007).  This was confirmed by 
FRET and NMR analysis, in a study that also demonstrated the functional importance of 
the N terminal peptide in exocytosis (Khvotchev et al., 2007).  This N terminal interaction 
was suggested to be a link between the Munc18a interactions of the closed conformation 
and the assembled complex (Khvotchev et al., 2007).  Isothermal titration calorimetry 
(ITC) measurements were used to show that the Sx1a N terminal peptide contributes to its 
affinity for Munc18a; this led to a refinement to the crystal structure of the Sx1a-Munc18a 
complex, showing that Munc18a interaction with the closed conformation of Sx1a could 
occur concurrently with binding to the N terminal peptide (Burkhardt et al., 2008).  The 
authors proposed a model whereby this Munc18a interaction controls accessibility of Sx1a 
to its cognate partners, a feature that could be common to all SM proteins (Burkhardt et al., 
2008). 
ITC experiments have also been used to investigate the affinity of mammalian (m)Vps45 
for its cognate syntaxin, Sx16; the N terminal peptide of Sx16 binds to mVps45, but longer 
cytosolic versions have a marked increase in affinity (Burkhardt et al., 2008).  This is 
suggestive of an additional binding mode in the C terminal part of the protein, which 
additively contributes to the affinity of the N terminal peptide alone.  The authors speculate 
this additional binding mode may be a closed conformation (Burkhardt et al., 2008).  Other 
SM-syntaxin partners have been shown to interact by both mode-1 and mode-2 binding 
modes, such as the mammalian Sx4 binding to Munc18c (Aran et al., 2009, D'Andrea-
Merrins et al., 2007) and UNC-64 binding to UNC-18 in C. elegans (Johnson et al., 2009).  
In addition to this, yeast Vps45p known to interact with Tlg2p via a mode-2 interaction 
(Dulubova et al., 2002), has been shown to also bind to SNARE complexes by a distinct 
mechanism (Carpp et al., 2006). 
 
1.6.5 Rab family of proteins 
The Rab GTPases are the largest family of small GTPases, homologues of which have 
been identified in a wide variety of species (Bock et al., 2001, Pereira-Leal and Seabra, 
2001).  Rab proteins act as molecular switches, alternating between an active GTP bound 
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form and an inactive GDP bound form, this cycle in activity can impose temporal and 
spatial regulation on fusion; for this reason Rab proteins have been implicated in a number 
of roles associated with membrane trafficking (Stenmark, 2009).  To achieve their 
function, activated Rab proteins bind to soluble factors known as effectors (examples listed 
in Zerial and McBride, 2001).  Interestingly, Rabs have been shown to localise to distinct 
intracellular membranes, the first indication that they may confer specificity to membrane 
fusion (Chavrier et al., 1990).  Mutation of the yeast Rab GTPase Sec4p results in 
accumulation of vesicles destined for the plasma membrane, indicating that one role of Rab 
proteins is involved with vesicle docking (Salminen and Novick, 1987).  Sec4p has been 
shown to interact with Sec15p, a component of the exocyst complex (Guo et al., 1999), 
which acts as a tethering factor that forms long distance contact between secretory vesicles 
and the plasma membrane (Lipschutz and Mostov, 2002; discussed in section 1.5.6).  Rabs 
have been associated with other aspects of membrane fusion besides being directly 
involved with vesicle fusion, one such example is at the earlier stage of vesicle budding.  
Rab5 is an important factor in endocytosis, as a version of Rab5 defective in its ability to 
bind GTP was shown to drastically reduce the rate of endocytosis, in contrast, over-
expression of wild-type Rab5 accelerates uptake of endocytic markers (Bucci et al., 1992).  
An in vitro study later demonstrated that Rab5 is required for formation of clathrin coated 
vesicles (McLauchlan et al., 1998).  Another role Rab proteins have been implicated in is 
vesicle motility: in S. cerevisiae, organelles are delivered to the emerging bud during cell 
division (Yaffe, 1991).  The trafficking of late Golgi compartments along actin cables is 
mediated by the type V myosin motor Myo2p (Rossanese et al., 2001), the attachment of 
which is facilitated by the Rab GTPase Ypt11p (Arai et al., 2008).  There is an ever 
increasing volume of data illustrating the essential roles Rab proteins play in fusion related 
processes.  Furthermore, multiple Rab proteins have been shown to coordinate roles at the 
same location (Stenmark, 2009).  The multiple regulatory roles of Rab proteins have led to 
them being regarded as universal coordinators of membrane fusion. 
 
1.6.6 Tethering factors 
The first physical contact between a target membrane and an incoming vesicle is thought to 
be mediated through a family of poorly understood tethering factors (Pfeffer, 1999).  
Tethering factors have been grouped into long coiled-coil proteins and large multisubunit 
complexes (Whyte and Munro, 2002).  An example of a long coiled-coil tethering factor is 
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the yeast Uso1p, which is a parallel homodimer with two globular heads (Yamakawa et al., 
1996) and has been shown to mediate binding of ER-derived vesicles (Barlowe, 1997).  
Electron microscopy has been used to image Uso1p, and revealed that it is a substantial 
~160 nm in length (Yamakawa et al., 1996).  Furthermore, it has been shown that Uso1p is 
necessary for formation of functional SNARE complexes to facilitate fusion of ER-Golgi 
vesicles (Sapperstein et al., 1996).  Various other long coiled-coil protein tethering factors 
have been identified, but they do not all share similar sequence, or even structure 
(Gillingham and Munro, 2003).   
Some multisubunit tethering factors are also diverse from one another; however, several 
conserved tethering complexes have been identified (Whyte and Munro, 2002).  One of the 
best characterised tethering complexes is the exocyst, which was originally identified in S. 
cerevisiae, where it localizes to sites of exocytosis (Guo et al., 1999, TerBush and Novick, 
1995).  The exocyst is composed of eight individual subunits (TerBush et al., 1996); 
homologues of each have been identified and shown to be conserved from yeast to 
mammals (Guo et al., 2000).  The exocyst is included in a subcategory of tethering 
complexes, termed quatrefoil, which are made up of multiples of four; other members 
include the COG complex (mentioned in section 1.5.4.6) and the Golgi associated 
retrograde protein (GARP) complex, associated with intra-Golgi and Golgi-endosomal 
trafficking respectively (Whyte and Munro, 2002).  Comparison of the N termini of all Cog 
proteins, and indeed components of other quatrefoil tethering factors (exocyst and GARP 
complexes), revealed a conserved coiled-coil domain (Whyte and Munro, 2001).  This is 
suggestive of a possible common function, which may be facilitated through interactions 
with other proteins (Whyte and Munro, 2002).  Interestingly, protein associations thus far 
reported include the direct interaction of Cog4 with the fusion machinery (Sed5 and Sly1; 
section 1.5.4.6; Laufman et al., 2009).  Also, the GARP complex has been shown to bind 
directly to the N terminus of the Qb-SNARE, Tlg1p (Siniossoglou and Pelham, 2002).  
Other tethering complexes out with the quatrefoil family include: transport protein particle 
(TRAPP) I complex associated with ER-Golgi traffic, and TRAPP II which has a less well 
understood association to later Golgi traffic (Sacher et al., 2008); the HOPS complex 
associated with vacuolar trafficking (Ostrowicz et al., 2008), one component of which is 
the SM protein Vps33p (mentioned in section 1.5.4.4).  Finally, the less well characterised 
Dsl1p complex (Munson, 2009), that is associated with retrograde traffic from the Golgi to 
the ER (Andag et al., 2001).  Recent structural analysis of Dsl1p components revealed that 
they resemble subunits of the exocyst complex, suggesting these vastly different tethering 
complexes may have evolved from a common precursor (Tripathi et al., 2009). 
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1.7 Membrane trafficking in S. cerevisiae 
S. cerevisiae has proved an excellent model for studying membrane traffic.  Genetic 
mutational analysis has allowed the identification of key proteins essential in trafficking 
pathways.  One such example is proteins involved in the secretory pathway (Bonifacino 
and Glick, 2004; Figure 1.11, blue arrows).  The use of temperature sensitive sec mutants 
unable to secrete proteins from the cell identified 23 proteins essential for the process, 
including the SM protein Sec1p (Novick et al., 1980; discussed in section 1.5.1).  Electron 
microscopy (EM) analysis of mutants revealed an accumulation of vesicles unable to dock 
with the plasma membrane (Novick et al., 1980).  The endosomal trafficking pathway 
(Figure 1.11, red arrows) involves the formation of vesicles at the plasma membrane that 
are subsequently internalised.  There are multiple and distinct endocytic pathways 
following internalisation (Figure 1.11), with sorting through the early and late endosomes 
(Wendland et al., 1998).  There are various other trafficking pathways in yeast, outlined in 
Figure 1.11.   
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Figure 1.11 Schematic representation of trafficking pathways in yeast. 
Compartments of yeast cell are labelled: endoplasmic reticulum (ER); secretory vesicle (SV); plasma 
membrane (PM); early endosome (EE); late endosome (LE).  Trafficking pathways labelled with arrows: 
secretory pathway (blue); endocytotic pathway (red); other trafficking pathways within the cell (green).  The 
SNARE complexes responsible for each trafficking step are also represented (localisation data taken from 
Pelham, 2001, Pelham, 1999).  t-SNAREs are labelled in pink, the syntaxin molecule in bold; v-SNAREs are 
labelled in orange.  The three trafficking pathways to the vacuole, (ALP, CVT and CYP), are labelled with 
partially transparent grey arrows. 
 
1.7.1 vps mutants 
Protein trafficking from the late Golgi to the vacuole has been intensely investigated and 
large scale genetic screens have revealed more than 70 proteins involved (Bowers and 
Stevens, 2005).  A precursor of the vacuolar hydroylase CPY is transported through the 
ER, Golgi and endosome to the vacuole where it is cleaved to its mature form (Figure 1.11; 
discussed in more detail in Chapter III, section 3.33).  Genetic screens based on the 
perturbation of this pathway, which isolates mutants that secrete a precursor of CPY before 
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it reaches the vacuole, have been used to identify a large number of vacuolar protein 
sorting (vps) mutants, many of which correspond to gene products (Bankaitis et al., 1986, 
Bonangelino et al., 2002, Raymond et al., 1992, Robinson et al., 1988, Rothman et al., 
1989, Rothman and Stevens, 1986).  Some of these proteins were also identified in 
different genetic screens searching for mutants defective in other aspects of Golgi to 
vacuole trafficking (Bowers and Stevens, 2005).  Such as the pep mutants defective for 
vacuolar protease activity (reduced peptidases) (Jones, 1977); the vam mutants, that have 
abnormal vacuole morphology (Wada et al., 1992); vac mutants defective for vacuolar 
segregation (Weisman et al., 1990); and the grd mutants which are Golgi retention 
defective (Nothwehr et al., 1996).  The vps mutants have been classified, primarily on 
vacuolar morphology, into 6 groups (A - F) (Raymond et al., 1992).  A 7th class has been 
proposed, characterised by fragmented vacuoles that appear as clusters of interconnecting 
tubules (Conibear and Stevens, 2000).  These morphological studies have helped identify 
proteins that function at the same step in the process, and have given better understanding 
of the multiple processes involved with trafficking to the vacuole (Hedman et al., 2007). 
 
1.7.2 Vps45p 
The class D vps mutants are characterised by large central vacuoles, defects in vacuole 
inheritance during cell division, acidification defects and ALP dispersed in membranes of 
multiple vesicular bodies (Raymond et al., 1992).  The gene products of class D vps 
mutants are generally associated with the trafficking step between the late Golgi and the 
endosomal system (Bryant and Stevens, 1998).  One of these genes, VPS45, was cloned 
and the protein Vps45p was characterised by two separate groups (Cowles et al., 1994, 
Piper et al., 1994).  Vps45p was predicted to be a hydrophilic protein of ~67 kDa, and a 
member of the SM protein family (Cowles et al., 1994, Piper et al., 1994).  As mentioned 
in section 1.6.1, the classification of vps mutants groups protein members likely to be 
involved with the same transport step (Hedman et al., 2007).  Other class D vps genes 
encoding proteins proposed to interact at this step are VPS21 and VPS6, which encode a 
Rab homologue (Rab5; Horazdovsky et al., 1994) and a syntaxin homologue (Pep12p; 
Becherer et al., 1996, Rothman et al., 1989), respectively; further demonstrating the 
importance of these three protein families in membrane trafficking events.  Both studies 
that set out to characterise Vps45p reported that some of the hydrophilic protein associates 
to membranes of the Golgi, the endosome and trafficking vesicles (Cowles et al., 1994, 
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Piper et al., 1994).  Genetic studies suggested that membrane association of Vps45p was 
mediated through interaction with the syntaxin homologue Pep12p (Burd et al., 1997), but 
the main binding site was later shown to be through a physical interaction with the 
syntaxin homologue Tlg2p (Bryant and James, 2001, Dulubova et al., 2002, Nichols et al., 
1998).  Yeast cells lacking Vps45p were shown to secrete CPY, as expected for vps 
mutants; approximately 70 - 85% CPY was secreted as the precursor to the enzyme 
(Cowles et al., 1994, Piper et al., 1994).  Furthermore, electron microscopy was used to 
image mutant yeast cells unable to produce Vps45p, which accumulate large numbers of 
vesicles 40 - 60 nm in diameter (Cowles et al., 1994, Piper et al., 1994).  All of this data 
implicate Vps45p in the targeting and / or fusion pathway between the Golgi and the 
vacuole (Cowles et al., 1994, Piper et al., 1994). 
 
1.7.3 Tlg2p 
Blast searches of the yeast genome based on homology to known syntaxins, the SNARE 
motif and a C terminal transmembrane domain (Weimbs et al., 1997), identified two 
possible syntaxin homologues, Tlg1p and Tlg2p (t-SNAREs affecting a late Golgi 
compartment; Holthuis et al., 1998).  Tlg2p has strongest homology to the endosomal and 
vacuolar syntaxins, Pep12p and Vam3p respectively, but differs from all previously 
documented syntaxins as it contains a 63 residue luminal domain following its 
transmembrane domain (Holthuis et al., 1998).  This luminal domain was shown not to be 
essential for its membrane trafficking function, in a study that demonstrated deletion of 
TLG2 in yeast results in a CPY trafficking defect, with ~20% being secreted in the 
precursor form (Abeliovich et al., 1998).  In addition to this, studies using internalisation 
markers showed that Tlg2p is essential for endocytosis (Abeliovich et al., 1998, Seron et 
al., 1998).  Initial localisation of Tlg2p was reported to be at the Golgi (Holthuis et al., 
1998), confirmed by fractionation studies showing that it localised with Golgi and 
endosomal membranes (Abeliovich et al., 1998).  Tlg2p and Tlg1p were shown to co-
precipitate with Vti1p (Holthuis et al., 1998), and an interaction was found between Tlg2p 
and the v-SNAREs Snc1p and Snc2p (Abeliovich et al., 1998, Holthuis et al., 1998).  
Snc1p and Snc2p are functionally redundant v-SNAREs associated with Golgi, endosome 
and plasma membrane trafficking (Protopopov et al., 1993). 
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1.7.4 Vps45p interactions 
The PEP12 gene encoding the syntaxin homologue Pep12p (associated with trafficking to 
the vacuole; Becherer et al., 1996), has been shown to interact genetically with Vps45p 
(Burd et al., 1997, Webb et al., 1997).  However, over-expression of vacuolar syntaxin 
Vam3p can suppress the CPY trafficking defects of pep12 delete cells but not those of 
VPS45 deletion, suggesting that the sole function of Vps45p is not in regulating Pep12p 
(Darsow et al., 1997).  Soon after this observation was made, binding between Vps45p and 
Tlg2p was documented (Nichols et al., 1998); it is not surprising that an SM protein can 
regulate more than one syntaxin, as there are more syntaxins encoded in the yeast genome 
than there are SM proteins (Pelham, 2001).  The Vps45p interaction with Tlg2p was shown 
to be the main binding site, as Vps45p relies on this interaction, and not that of Pep12p, for 
its membrane association (Bryant and James, 2001, Nichols et al., 1998).  In further 
support of this, Vps45p co-precipitates with Tlg2p and Tlg1p, and the presence of Vps45p 
in vivo is required to maintain endogenous levels of Tlg2p, but not levels of Pep12p 
(Bryant and James, 2001, Coe et al., 1999, Nichols et al., 1998).  The levels of Tlg2p in 
vps45 delete yeast cells can be stabilised in mutant cells lacking proteasomal degradation, 
indicating that in the absence of Vps45p, Tlg2p is rapidly degraded by the proteasome 
(Bryant and James, 2001).  Mutational analysis of the proteins demonstrated that Vps45p 
binds to Tlg2p by a mode-2 interaction (Dulubova et al., 2002), which was later shown to 
be essential for regulation of cellular Tlg2p levels (Carpp et al., 2007).  The finding that 
stabilised Tlg2p levels in the absence of Vps45p can not form SNARE complexes 
suggested that Vps45p has a role in complex assembly (Bryant and James, 2001).  Analysis 
of a vps45 delete strain demonstrated that in the absence of Vps45p, Tlg2p is degraded by 
the proteasome; this degradation can be abolished by using a mutant strain also lacking the 
activity of two catalytic proteasome subunits (vps45∆, pre1-1, pre2-2) (Bryant and James, 
2001).  Co-immunoprecipitation experiments in this strain failed to find Tlg2p bound to its 
cognate SNARE partners, Vti1p and Tlg1p, unless a version of Tlg2p lacking the Habc 
domain was used (Bryant and James, 2001).  Furthermore, this truncated version of Tlg2p 
allows trafficking of CPY when the full length version does not, suggesting the complexes 
formed are functional (Bryant and James, 2001).  These data suggest that Vps45p 
stimulates SNARE complex assembly through an interaction with the N terminus of Tlg2p 
(Bryant and James, 2001).   
Interestingly, a mutant version of Vps45p, analogous to the pocket filled mutant of Sly1p 
with abrogated mode-2 binding (Peng and Gallwitz, 2004), fails to interact with Tlg2p, but 
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can still function to correctly traffic CPY (Carpp et al., 2006).  This study also reported 
that Vps45p could bind directly to the v-SNARE Snc2p, and demonstrated that Vps45p 
could bind to SNARE complexes by a mechanism distinct from mode-2 binding (Carpp et 
al., 2006).  In addition to this, Vps45p has been shown to dissociate from Tlg2p prior to 
complex assembly, but is later found to bind cis-complexes after fusion (Bryant and James, 
2003).  These distinct binding modes could indicate that Vps45p has more than one role in 
membrane fusion. 
The SNARE domain of Snc2p is responsible for its binding to Vps45p (Carpp et al., 2006).  
Similarly, the SNARE domains of non-syntaxin proteins Bet1p and Bos1p facilitate their 
binding to SM protein Sly1p (Peng and Gallwitz, 2004).  It has been proposed that the 
weaker affinity interaction with non-syntaxin SNAREs is a precursor to SM-syntaxin 
interaction, and that the SM protein may act as a physical bridge between these two phases 
(Peng and Gallwitz, 2004).  Support for this has not been observed with Vps45p in vitro, as 
it cannot bind Tlg2p and Snc2p simultaneously, but it is possible that regulatory factors are 
required to facilitate the transition of SM protein binding (Carpp et al., 2006).  The exact 
role(s) of Vps45p in complex assembly and membrane fusion has yet to be elucidated. 
 
1.8 Aims of this project 
The regulatory factors orchestrating membrane fusion events are extremely complex, and 
interplay between factors serves to further complicate the issue.  My aim was to use the 
yeast endosomal system to further our understanding of the regulation of SNARE mediated 
membrane fusion.  We consider trafficking at the late Golgi / early endosome of yeast an 
excellent paradigm to enhance understanding of the SNARE and SM protein families.  
Vps45p has been heavily implicated in this fusion step; appreciating the significance of its 
multiple, distinct SNARE interactions could help the formulation of a unifying hypothesis 
for SM protein family function.  The objectives of my investigations presented in this 
thesis are detailed below. 
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1.8.1 Aims of Chapter III 
The N terminal domain of Tlg2p has been implicated in regulating complex assembly 
(Bryant and James, 2001), in a manner similar to the exocytotic SNAREs: Sx1a (Dulubova 
et al., 1999, Misura et al., 2000) and Sso1p (Carr et al., 1999).  I wanted to test directly if 
the Habc domain of Tlg2p has an inhibitory effect on complex assembly.  As proof of this, 
I wanted to test whether Tlg2p can adopt a closed conformation.   
Vps45p has been shown to interact with monomeric Tlg2p (Bryant and James, 2001, 
Nichols et al., 1998), and has been implicated in facilitating a change in Tlg2p which 
allows it to form SNARE complexes (Bryant and James, 2001).  It has been contested that 
additional in vivo factors may be responsible for these observations (Dulubova et al., 
2002).  Building on the observation that the Habc domain of Tlg2p has a negative role on 
complex assembly (Bryant and James, 2001; section 1.7.1), we wanted to address this 
issue, and directly test if Vps45p can alleviate the inhibition on complex assembly imposed 
by the Tlg2p Habc domain. 
 
1.8.2 Aims of Chapter IV 
The significance of the interaction between Vps45p and its cognate v-SNARE Snc2p has 
yet to be understood.  By further characterising this interaction I hoped to reveal any 
functional relevance it may have.   
 
1.8.3 Aims of Chapter V 
Vps45p can bind to assembled complexes by a mechanism distinct from mode-2 (Carpp et 
al., 2006).  We wanted to test if this interaction, or either interaction of Vps45p with Tlg2p 
or Snc2p, had any functional effect on membrane fusion; as has been demonstrated for SM 
proteins Sec1p (Scott et al., 2004) and Munc18a (Shen et al., 2007). 
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2.1 Materials 
2.1.1 Reagents 
General chemicals and reagents were supplied by: 
Avanti polar lipids, Alabaster, USA 
BioRad Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK 
Clontech Laboratories Inc, California, USA 
Fisher Scientific Ltd, Loughborough, Leicestershire, UK 
GE Healthcare Bio-Sciences Ltd, Buckinghamshire, UK 
Invitrogen Ltd, Paisley, UK 
Melford Labs Ltd, Ipswich, Suffolk, UK 
Qiagen Ltd, Crawley, West Sussex, UK 
Roche Diagnostics Ltd, Burgess Hill, UK 
Sigma-Aldrich Ltd, Dorset, UK 
Spectrum Laboratories Inc, California, USA 
Molecular biology enzymes and reagents were supplied by: 
Merck Chemicals Ltd, Nottingham, UK 
New England Biolabs Ltd, Hertfordshire, UK 
Promega Ltd, Southampton, UK 
Stratagene Technologies, California, USA 
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Media used for bacteria and yeast studies were supplied by: 
FormediumTM, Norfolk, UK 
Melford Labs Ltd, Ipswich, Suffolk, UK 
Antibodies were supplied by: 
Clontech-Takara Bio, Saint-Germain-en-Laye, France 
Millipore Ltd, Livingston, UK 
Molecular Probes Inc, Oregon, USA. 
Roche Diagnostics Ltd, Burgess Hill, UK 
Sigma-Aldrich Company Ltd, Dorset, UK 
 
2.1.2 Computer software 
Dynamics (DynaPro) V2 - Wyatt Technology Corporation  
Image Gauge V4.22 - Fugi Film 
Image J: V1.41 - U. S. National Institutes of Health 
SIS iTEM Imaging - Olympus 
Kaleidagraph V4.0 - Synergy software 
Vector NTI V10.3 - Invitrogen Ltd 
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2.1.3 Primary antibodies 
α-cMyc (Clone 9E10) IgG1 monoclonal antibodies raised in mice.  Recognises amino acid 
sequence EQKLISEEDL.  Purchased from Sigma-Aldrich Company Ltd (catalogue # 
C6594).  Used at a 1 in 200 dilution from stock solution provided. 
α-HA (Clone 3F10) IgG1 monoclonal antibodies raised in rats. Recognises influenza viral 
protein hemagglutinin (HA) peptide sequence YPYDVPDYA.  Purchased from Roche 
Diagnostics Ltd (catalogue # 11815016001).  Used at a 1 in 2,000 dilution from a 100 µg / 
ml stock. 
α-Pgk1p polyclonal antibodies (antisera) raised in rabbits were used as previously 
described (Piper et al., 1994).  Used at a 1 in 20,000 dilution from a ~820 µg / ml stock. 
α-Tlg2p polyclonal antibodies generated by Eurogentec were affinity purified from rabbit 
antiserum to yield antibodies that specifically recognise peptide residues 272 - 287 and 381 
- 396 of Tlg2p.  Affinity purification performed by Marion Struthers.  Used at a 1 in 200 
dilution from a ~390 µg / ml stock. 
α-Vph1p (Clone 10D7) IgG2 monoclonal antibodies raised in mice.  Purchased from 
Molecular Probes Inc (catalogue # A6426).  Used at a 1 in 1,000 dilution from a 250 µg / 
ml stock. 
α-Vps45p polyclonal antibodies generated by Eurogentec were affinity purified from 
rabbit antiserum to yield antibodies that specifically recognise residues 563-577 of 
Vps45p.  Affinity purification performed by Marion Struthers.  Used at a 1 in 1,000 
dilution from a ~600 µg / ml stock. 
α-Snc2p polyclonal antibodies were raised in rabbits immunised with peptides 
corresponding to residues 11 - 25 and 72 - 86 of Snc2p (generated by Eurogentec).  
Antibodies specific to residues 11 - 25 were affinity purified from the rabbit antiserum by 
Eurogentec.  Used at 1 in 1,000 dilution from a ~0.7 mg / ml stock. 
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2.1.4 Secondary antibodies 
All secondary antibodies were purchased from GE Healthcare Bio-Sciences Ltd, 
Buckinghamshire, UK. 
ECL Anti-mouse IgG Horseradish peroxidise-linked species specific whole antibody (from 
sheep); code NA931.  Used at 1: 2,000 dilution from stock solution provided. 
ECL Anti-rabbit IgG Horseradish peroxidise-Linked species specific whole antibody (from 
donkey); code NA934.  Used at 1: 5,000 dilution from stock solution provided. 
ECL Anti-rat IgG Horseradish peroxidise-Linked species specific whole antibody (from 
goat); code NA935.  Used at 1: 2,000 dilution from stock solution provided. 
 
2.1.5 Bacterial and yeast strains 
Strains of E. coli and S. cerevisiae used are listed in Tables 2.1 and 2.2 respectively.  
Plasmids were routinely propagated in either E. coli host strains XL-1 Blue (Stratagene 
Technologies) or Top10 (Invitrogen Ltd).  Recombinant proteins were generally produced 
in the E. coli host strain BL-21(DE3) (Invitrogen Ltd), and occasionally in strain RosettaTM 
2 (DE3) (Merck Chemicals Ltd). 
 
2.1.6 Bacterial growth media 
2YT   1.6% (w / v) tryptone, 1% (w / v) yeast extract, 0.5% (w / v) NaCl 
Terrific broth 1.2% (w / v) tryptone, 2.4% (w / v) yeast extract, 0.4% (v / v) 
glycerol, 0.017 M KH2PO4, 0.072 M K2HPO4.  Purchased from 
Melford Labs Ltd 
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SOC 2% (w / v) tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4, 20 mM glucose 
If plated media was required, 2% (w / v) micro agar was added to selective media prior to 
autoclave sterilisation.  Plates were poured in a sterile environment and routinely stored at 
4oC. 
Antibiotics were routinely used at a 1 in 1,000 dilution from the stock solutions.  Stocks 
prepared: 100 mg / ml ampicillin sodium salt in water; 36 mg / ml chloramphenicol in 
100% ethanol; and 50 mg / ml kanamycin sulphate in water.   
 
2.1.7 Yeast growth media 
Yeast was routinely grown on rich media (YPD) or selective minimal synthetic defined 
(SD) media lacking a particular amino acid.   
YPD   1% (w / v) yeast extract, 2% (w / v) peptone, 2% (w / v) glucose  
SD -leu 2% (w / v) peptone, 0.7% (w / v) yeast nitrogen base, 0.16% (w / v) 
leucine dropout supplement 
SD -leu,-trp 2% (w / v) peptone, 0.7% (w / v) yeast nitrogen base, 0.16% (w / v) 
leucine and tryptophan dropout supplement 
SD -leu,-trp,-his 2% (w / v) peptone, 0.7% (w / v) yeast nitrogen base, 0.15% (w / v) 
leucine, tryptophan and histidine dropout supplement 
If plated media was required, 2% (w / v) micro agar was added to selective media prior to 
autoclave sterilisation.  Plates were poured in a sterile environment and routinely stored at 
4oC. 
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2.2 General molecular biology methods 
2.2.1 Agarose gel electrophoresis 
Agarose powder (0.8 - 2.0% (w / v)) was dissolved in TAE buffer (40 mM Tris Acetate, 1 
mM EDTA, pH 8.0) by boiling in a microwave.  The solution was allowed to cool to 
approximately 50oC before Ethidium Bromide (EtBr) was added to a final concentration of 
0.5 µg / ml.  The solution was left to polymerize in a cassette and then transferred in to a 
gel tank containing TAE buffer.  DNA samples were prepared by addition of 6x DNA 
loading buffer (40% (w / v), ficoll 0.25% (w / v), bromophenol blue).  Samples were 
loaded onto the gel, alongside a 100 bp or 1kb DNA marker (New England Biolabs Ltd).  
The gel was then run at 110 volts and DNA samples were visualised with an ultraviolet 
transilluminator.  
 
2.2.2 Mini DNA preparations 
A single colony from fresh bacterial transformation (section 2.3.1) was used to inoculate 5 
ml 2YT media containing appropriate antibiotic.  Culture was grown overnight at 37oC 
with shaking.  Plasmid DNA was extracted from overnight culture using the Promega Ltd 
Wizard® Plus SV Mini-prep kit following the manufacturer’s instructions.  100 µl of 
sterile water was generally used to elute DNA from the column.  DNA was routinely stored 
at -20oC. 
 
2.2.3 Gel extraction / purification 
Agarose gel electrophoresis (section 2.2.1) was used to separate DNA by size.  Specific 
bands of correct size were identified on a transilluminator, excised from the gel with a 
scalpel, and then placed in a sterile eppendorf tube.  DNA was then extracted and purified 
from sample using the Qiagen QiaQuick Gel Extraction Kit following the manufacturer’s 
instructions.  Depending on subsequent application, between 30 µl and 50 µl sterile water 
was used to elute DNA from the column. 
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2.2.4 DNA amplification by Polymerase Chain Reaction (PCR) 
Appropriate forward and reverse oligonucleotide primers were designed to amplify the 
required DNA sequence.  Primers were synthesised by York BioScience Ltd, and routinely 
diluted to 50 pmol with sterile water then stored at -20oC.  PCR reactions were set up in 
thin walled PCR tubes on ice.  Genomic or existing plasmid DNA was used as a template.  
An equal ratio mixture of dATP, dCTP, dGTP and dTTP were used, each at 10 mM 
concentration.  High fidelity proof-reading DNA polymerase, normally Pfu (Promega Ltd), 
was used with the provided buffer.  Total volume of reaction mix was made up to 50 µl 
with nuclease free water.  Example of standard reaction: 
 Template DNA (~1 µg / µl)     1 µl 
10 x Pfu polymerase buffer     5 µl 
 Forward primer (5 pmol)     1.5 µl 
 Reverse primer (5pmol)     1.5 µl 
 dNTPs (10 mM)      1 µl 
 Nuclease-free water      39 µl 
 Pfu DNA polymerase      1 µl 
PCR reactions were carried out in a thermocycler.  Example of standard conditions: 
1. Initial incubation to denature  95oC   2 min 
 2.  Denature     94oC   1 min 
 3.  Annealing of primers  variable (~ 55oC)  1 min 
 4.  Elongation     72oC   2 min / kb 
 5.  Final elongation    72oC    10 min 
 6.  Chill / End     4oC   Hold 
Steps 2, 3 and 4 were cycled 30 times before step 5.  Size and relative concentration of 
PCR products were checked by agarose gel electrophoresis (section 2.2.1). 
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2.2.5 Site directed mutagenesis (SDM) 
Desired mutations were incorporated into the designed forward and reverse primers.  PCR 
was then used essentially as described in section 2.2.4, to synthesise mutant DNA, with 
several alterations: Pfu polymerase was used at a reduced temperature of 68oC, for a 
reduced time of 1 min / kb, and steps 2, 3 and 4 were only cycled 18 times.  After the 
reaction was complete, 1 µl of DpnI was added to each SDM reaction mix and incubated at 
37oC for 1 hour to digest the methylated parental DNA.  10 µl of reaction mix was then 
transformed into Top10 or XL-1 blue E. coli cells (section 2.3.1).  Successful mutants were 
selected on antibiotic plates and DNA isolated by mini DNA preparations (section 2.2.2).  
Mutants were confirmed by sequencing (section 2.2.10). 
 
2.2.6 Restriction endonuclease digestion 
Normally DNA / plasmids were digested by 2 restriction endonucleases simultaneously in 
the same buffer.  Reactions were set up in an eppendorf tube, for example: 
 
DNA / plasmid (~1 µg / µl)     5 µl 
10 x buffer       1 µl 
Restriction enzyme #1     1 µl (20 units) 
Restriction enzyme #2     1 µl (20 units) 
Sterile water       2 µl 
 
If a double digest could not be completed simultaneously due to incompatibility of buffer 
requirements, sequential digestions were performed.  After the first reaction was completed 
as above, the DNA was isolated from first buffer using the Qiagen QiaQuick PCR 
Purification kit.  DNA was eluted from the column in 30 µl sterile water, and used in 
second reaction: 
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Eluted DNA       30 µl 
10 x buffer #2       4 µl 
Restriction enzyme #2     1 µl (20 units) 
Sterile water       5 µl 
Restriction digests were carried out at 37oC for 4 hours.  Successful digestion was verified 
by agarose gel electrophoresis (section 2.2.1). 
 
2.2.7 Ligation reactions 
Restriction digests of parent vector and plasmid containing desired fragment were carried 
out (section 2.2.6).  Fragment and vector DNA was then isolated by gel extraction (section 
2.2.3).  Vector DNA was eluted from the column then incubated with shrimp alkaline 
phosphatase (SAP) at 37oC for 15 minutes to catalyse the dephosphorylation of 5’ 
phosphates and prevent re-ligation.  SAP was deactivated by 15 minute incubation at 65oC 
before the ligation reaction of the gel purified vector and fragment was set up in PCR tubes 
on ice.  Example of standard reaction: 
 Vector DNA (~0.5 µg / µl)     2 µl 
Fragment DNA (~0.5 µg / µl)     6µl 
10 x T4 DNA Ligase buffer     1 µl 
T4 DNA Ligase      1 µl 
Ligation controls containing only vector DNA, only fragment DNA or no DNA were also 
prepared.  Ligation reactions were carried out at 16oC overnight.  10 µl of each reaction 
mixture was then transformed into Top10 cells and selected for on antibiotic plates. 
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2.2.8 Topo® cloning 
High fidelity proof-reading PCR was used to amplify DNA (section 2.2.4) which was 
subsequently gel purified (2.2.6).  Taq polymerase was used to generate polyadenosine 
overhangs to the PCR product in the following reaction: 
 Gel purified DNA (0.5 µg / µl)    20 µl 
10 x Mg free buffer      2 µl 
MgCl2 (25mM)      1.2 µl 
Taq polymerase      0.4 µl (5 units) 
dNTPs (10 mM)      0.4 µl 
The reaction was set up in PCR tubes and incubated at 72oC for 20 minutes.  2 µl of this 
Taq treated DNA was cloned into the pCR®2.1-TOPO® vector using the Invitrogen pCRII-
TOPO® kit.  The entire ligation reaction mix was transformed into Top10 cells (section 
2.3.1) and selected for on 2YT plates containing appropriate antibiotic and X-gal at a 
concentration of 0.04 µg / ml.  The DNA from white colonies was isolated by mini 
preparation (section 2.2.2) and sequenced (section 2.2.10) to ensure correct DNA had been 
cloned. 
 
2.2.9 Estimation of DNA concentration 
The concentration of DNA in mini preparations was assessed by ultraviolet absorbance 
measurements.  Absorbance of diluted DNA was measured in a spectrophotometer at 260 
nm.  Concentration in mg / ml was calculated by multiplying the optical density reading by 
the dilution factor (normally 100) then by 50, which is the extinction coefficient for double 
stranded DNA. 
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2.2.10 Sequencing 
Sequencing of DNA was carried out by the University of Dundee Sequencing Service.  
The correct sequence was confirmed routinely after any molecular cloning techniques 
involving generation of new DNA. 
 
2.3 General protein methods 
2.3.1 Bacterial transformation 
Chemically competent bacterial cells (either commercially purchased or prepared in the 
laboratory, section 2.3.2) were thawed on ice for 15 minutes.  4 µl of plasmid DNA, 
concentration ~1 µg / µl, was then added to the cells and left on ice for 15 minutes.  The 
cells were then heat shocked at 42oC in a heat block for 45 seconds, before being returned 
to ice.  250 µl of SOC media was then added to the cells, which were incubated for 1 hour 
at 37oC with shaking before being spread onto plates containing appropriate antibiotic, 
allowed to dry for 30 minutes, and then incubated overnight at 37oC. 
 
2.3.2 Preparation of competent bacterial cells 
The appropriate bacterial strain was grown in 5 ml 2YT overnight at 37oC in presence of 
antibiotic if appropriate.  3 ml of culture was then added to 300 ml 2YT and grown at 37oC 
with shaking to an optical density at 600 nm (OD600) of ~0.6.  Cells were then harvested at 
1,000 g and placed on ice before being gently resuspended in 150 ml of ice cold 50 mM 
CaCl2 and left on ice for 1 hour.  Centrifugation was used to collect cells as before, which 
were resuspended in 40 ml of 25% (v / v) glycerol, 50 mM CaCl2 and stored in aliquots of 
200 µl at -80oC. 
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2.3.3 Expression of recombinant proteins 
A single colony from a fresh transformation was used to inoculate 500 ml 2YT media 
which was incubated overnight at 37oC with shaking, in the presence of appropriate 
antibiotic.  Cells were then collected by centrifugation at 1,000 g for 20 minutes then 
resuspended in 0.5 - 12 litres of Terrific Broth.  Typically cells from 40 ml overnight 
culture were resuspended in one litre.  Cells were incubated at 37oC with shaking in 
presence of suitable antibiotic to an OD600 of 0.6 - 0.8.  Expression of recombinant proteins 
was then induced with 0.2 - 1 mM Isopropyl-β-D-thiogalactopyranoside (IPTG) for 4 hrs 
at 37oC.  In some cases, cells were transferred to lower temperatures (15 - 25oC) at an 
OD600 of 0.4, allowed to grow until the OD600 reached 0.6 - 0.8, before being induced with 
0.2 - 0.5 mM IPTG overnight at the reduced temperature.  Induced cells were harvested at 
3,000 g for 30 minutes. 
 
2.3.4 General purification of tagged recombinant proteins 
Cell pellets (as prepared in 2.3.3) were resuspended in 150 ml cold lysis buffer using a 
blender before lysis by passage through a Microfluidizer M-110P cell disrupter set to 
10,000 psi.  DNA was then digested by the addition of DNase I (10 µg / ml) for 30 minutes 
at 4oC.  Cell lysates were then clarified by centrifugation in a Beckman JA-20 rotor for 45 
minutes at 20,000 rpm at 4°C.  During this spin, appropriate beads were washed and 
equilibrated, then stored at 4°C.  Lysates were then added to beads and incubated on a 
roller at 4°C to allow tagged proteins to bind.  5 - 10 bead volumes of wash buffer were 
then added to remove any unspecifically bound proteins.  Beads were harvested at 500 g 
for 1 minute, and then the supernatant fluid was discarded.  This wash step was repeated as 
necessary, normally between 5 and 10 repetitions, to obtain as pure a protein sample as 
possible.  If protein of interest was co-expressed with GroEL and GroES chaperone 
proteins, the final two washes were performed with wash buffer containing 20 mM MgCl2 
and 5 mM ATP Na-salt to remove contaminating GroEL and GroES proteins (Rohman and 
Harrison-Lavoie, 2000, Thain et al., 1996).  Protein was then either cleaved from the 
affinity tag (sections 2.3.4.2 & 2.3.4.3) or eluted from the beads (section 2.3.4.1, 2.3.4.2 & 
2.3.4.3) in an appropriate cleavage / elution buffer.  The purification of SNARE proteins 
for use in the in vitro fusion assay (Chapter V) was carried out as described in section 2.9.1 
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2.3.4.1 Purification of His6 tagged proteins 
E. coli cells producing His6 tagged proteins were resuspended in His6 lysis buffer (25mM 
HEPES.KOH pH 7.4, 400 mM KCl, 10% glycerol, 2.5 mM imidazole, 1 mM PMSF, 5 
mM β-mercaptoethanol and CompleteTM protease inhibitor cocktail (Roche Diagnostics 
Ltd) before lysis (section 2.3.4).  Ni2+-NTA agarose beads were washed 5 times with His6 
wash buffer (lysis buffer containing 20 mM imidazole).  Clarified lysates were incubated 
with washed Ni2+-NTA beads on a roller for ~2 hours at 4°C to allow His6 tagged proteins 
to bind.  Beads were harvested at 500 g for 1 minute and then washed 5 - 10 times with 
His6 wash buffer.  The His6 tagged proteins were eluted by incubation for 20 minutes with 
1 ml of elution buffer (lysis buffer containing 250 mM imidazole).  This process was 
normally repeated three times and the elutions were pooled.  Eluted protein was separated 
from beads by centrifugation at 500 g for 1 minute; supernatant fluid was then removed 
and stored at -80oC in 200 µl aliquots. 
 
2.3.4.2 Purification of GST tagged proteins 
E. coli cells producing GST tagged proteins were resuspended in phosphate buffered saline 
(PBS; 2.7 mM KCl, 1.8 mM KH2PO4, 137 mM NaCl, 10.1 mM Na2HPO4) containing 5 
mM β-mercaptoethanol and CompleteTM protease inhibitor cocktail (Roche Diagnostics 
Ltd).  Cell lysis was then carried out (section 1.3.4) before lysates were clarified by 
centrifugation at 20,000 rpm in a JA-20 rotor.  3 ml of settled Glutathione Sepharose 4B 
beads (GE Healthcare Bio-Sciences Ltd) were washed 3x with PBS.  Clarified lysates were 
incubated on a roller overnight at 4°C with washed Glutathione Sepharose beads to allow 
GST tagged protein to bind.  Beads were harvested at 500 g for 1 minute then washed 3x 
with PBS + 1% Triton X-100, 3x with PBS + 0.5 M NaCl and finally 3x with PBS alone.  
If protein removal from beads was necessary, it was either eluted from the beads using 
PBS containing 25 mM reduced glutathione or cleaved from the GST affinity tag using 
thrombin (Chang, 1985; Sigma-Aldrich Ltd) or PreScission protease (Walker et al., 1994; 
GE Healthcare Bio-Sciences Ltd).  Thrombin cleavage was performed by incubating beads 
with thrombin cleavage buffer (50 mM Tris.HCl pH 8.0, 150 mM NaCl, 2.5 mM CaCl2) 
containing 0.04 units of thrombin per µl sample at room temperature for 2 hours.  
PreScission protease cleavage was performed by incubating beads with protease cleavage 
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buffer (50 mM Tris.HCl pH 7.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT) containing 
0.05 units of PreScission protease per µl sample at 4oC overnight. 
 
2.3.4.3 Purification of Protein A tagged proteins 
E. coli cells producing recombinant proteins containing a Protein A tag were resuspended 
in 150 ml TST buffer (50 mM Tris.HCl pH 7.6, 150 mM NaCl, 0.05% Tween 20) for lysis.  
Proteins were then purified following the IgG Sepharose™ 6 Fast Flow manufacturer’s 
instructions (GE Healthcare Bio-Sciences Ltd).  Protein was either eluted using 0.5 M 
acetic acid, pH 3.4 or cleaved from the beads using thrombin as described in section 
2.3.4.2. 
 
2.3.5 Ion exchange chromatography 
Anion exchange separations were carried out on a Mono Q HR (5 / 5) column (GE 
Healthcare Bio-Sciences Ltd) using Mono Q buffer A (20 mM Tris.HCl pH 8.5, 10% 
glycerol, 1 mM DTT) and buffer B (20 mM Tris.HCl pH 8.5, 1 M NaCl, 10% glycerol, 1 
mM DTT).  Cation exchange separations were carried out on a Mono S HR (5 / 5) column 
(GE Healthcare Bio-Sciences Ltd) using Mono S buffer A (20 mM HEPES.KOH pH 7.0, 1 
mM DTT) and Mono S buffer B (20 mM HEPES.KOH pH 7.0, 1 M NaCl, 1 mM DTT).  
Columns were connected to a fast protein liquid chromatography (FPLC) ACTA system 
(GE Healthcare Bio-Sciences Ltd) following the manufacturer’s instructions. 
Protein fractions eluted from affinity purification containing highest concentrations of 
protein were determined by SDS-PAGE analysis followed by Coomassie staining (sections 
2.3.8 & 2.3.9) these fractions were then pooled.  Before pooled samples were loaded onto 
the ion exchange column, the protein in its elution buffer was diluted to 50 mM NaCl2 
concentration with buffer A before being filtered through a 0.45 µM syringe filter.  The 
columns were first washed with buffer A, followed by buffer B, and then equilibrated with 
5% buffer B (i.e. 50 mM NaCl).  Samples were loaded onto the column via a superloop.  
To elute protein, a gradient from 5% to 50% buffer B (50 mM to 500 mM NaCl) over 20 
column volumes was passed through the column.  4 ml fractions were collected and any 
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displaying absorbance peaks at A280 from the chromatograph were analysed by SDS-PAGE 
and Coomassie staining (sections 2.3.8 & 2.3.9).  Fractions containing protein of interest 
were pooled, concentrated (section 2.3.7) and either stored at -80oC or prepared for further 
purification (section 2.3.6). 
 
2.3.6 Gel filtration chromatography 
Depending on the resolution required, proteins were separated by size on either a Superdex 
200 HR (10 / 30) or a Superdex 75 HR (10 / 30) column (GE Healthcare Bio-Sciences 
Ltd).  Columns were connected to an FPLC system as described in the manufacturer’s 
instructions. 
The columns were routinely equilibrated overnight with filtered 1x potassium phosphate 
buffer (170 mM KH2PO4, 720 mM K2HPO4, 10% (w / v) glycerol, 1 mM DTT).  Protein 
was loaded onto the column 3 ml at a time using a syringe and tubing straight into the 
FPLC.  1x potassium phosphate buffer was then run through the column at a flow rate of 
0.6 ml / min, and 0.5 ml fractions were collected.  Fractions with absorbance at A280 peaks 
were analysed by SDS-PAGE and Coomassie staining (sections 2.3.8 & 2.3.9).  Fractions 
containing the protein of interest at highest purity were concentrated (section 2.3.6), and 
subsequently stored at -80oC after snap freezing in liquid nitrogen.  
 
2.3.7 Concentration of purified protein 
Proteins were routinely concentrated using Microcon centrifugation filtration devices 
(Millipore Ltd, Livingston, UK) following the manufacturer’s instructions.  Suitable 
molecular weight cut-off (MWCO) filters were used for each particular protein being 
concentrated. 
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2.3.8 SDS PAGE 
Discontinuous polyacyrlamide gel electrophoresis was used to resolve proteins as 
described (Laemmli, 1970).  A 30% acrylamide / bisacrylamide mixture (Anachem Ltd, 
Luton, Bedfordshire, UK) was used to form a stacking mixture of 5% in stacking buffer 
(25 mM Tris.HCl pH 6.8, 0.2% (w / v) SDS) and a separating mixture of between 7.5 and 
15% (v / v) in separating buffer (75 mM Tris.HCl pH 8.8, 0.2% (w / v) SDS).  Gels were 
polymerised by addition of ammonium persulfate (APS) and N, N, N’, N’ - 
tetramethylenediamine (TEMED).  Gels were then set up in Bio-Rad mini-PROTEAN III 
apparatus and immersed in running buffer (25 mM Tris base, 190 mM glycine, 0.1% (w / 
v) SDS).  Protein samples were prepared for electrophoresis by incubating at 95oC for 5 
minutes in an equal volume of 2x Laemmli sample buffer (LSB; 100 mM Tris.HCl pH 6.8, 
4% (w / v) SDS, 20% (v / v) glycerol, 0.2% (w / v) bromophenol blue, 10% (v / v) β-
mercaptoethanol).  Samples were loaded onto the gel, a BioRad Broadrange Protein 
Marker was also loaded, and a constant electric potential of 80 volts was applied as 
proteins migrated through the stack gel. This was increased to 160 volts once the samples 
had entered the separating gel.  
 
2.3.9 Coomassie staining 
Coomassie blue stain was prepared by mixing 0.25% (w / v) Brilliant Blue R-250 (Sigma-
Aldrich Ltd) with a solution of 45% methanol, 10% acetic acid (v / v).  This solution was 
thoroughly stirred then filtered through Whatman No 2 filter paper.  Resolved SDS-PAGE 
gels (section 2.3.8) were immersed in staining solution with gentle shaking for a minimum 
of 1 hour.  Gels were de-stained with a solution of 5% methanol, 10% acetic acid (v / v) for 
as long as necessary.  
 
2.3.10 Western blotting 
Proteins to be transferred to a nitrocellulose membrane were first resolved by SDS-PAGE 
(section 2.3.8).  The gels were removed from glass plates and immersed in semi-dry 
transfer buffer (24 mM Tris base, 20 mM glycine, 0.1% (w / v) SDS) for 30 minutes.  
Whatman 3 mm filter paper and nitrocellulose membrane (pore size 45 µm) were also 
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immersed in transfer buffer.  Three pieces of filter paper were layered onto the semi dry 
transfer apparatus, followed by the nitrocellulose membrane.  The gel was then carefully 
placed onto the surface of the membrane, and another 3 pieces of filter paper placed on top.  
Air bubbles were removed before applying a constant current of 180 mA for 30 minutes at 
room temperature.  Efficiency of transfer was determined by staining the nitrocellulose 
membrane with Ponceau S solution (0.1% (w / v) Ponceau S, 5% (v / v) acetic acid). 
 
2.3.11 Immunodetection of proteins 
Proteins transferred onto a membrane by Western blotting were detected by probing with 
specific antibodies and visualised using enhanced chemiluminescence (ECL).  The 
nitrocellulose membrane was removed from semi-dry transfer apparatus and washed in 
PBS-T (2.7 mM KCl, 1.8 mM KH2PO4, 137 mM NaCl, 10.1 mM Na2HPO4, 0.1% (v / v) 
tween-20).  Non-specific binding to the membrane was reduced by incubating in 5% (w / 
v) dried milk or BSA in PBS-T for 1 hour.  Primary antibodies were diluted to appropriate 
concentration in 1% (w / v) dried milk in PBS-T and incubated with the membrane for ~2 
hours on a roller at room temperature.  Unbound antibody was washed off with 6x PBS-T 
washes over a 30 minute period, before incubation with an appropriate horseradish 
peroxidise (HRP) linked secondary antibody for 1 hour at room temperature.  The excess 
secondary antibody was washed off as before and labelled proteins were visualised using 
ECL plus Western Blotting Detection System (GE Healthcare Bio-Sciences Ltd) following 
the manufacturer’s instructions.  The membrane was exposed to X-ray film in a light proof 
cassette before being developed through a Kodak x-omat 2000.  Membranes were routinely 
stripped for re-probing by incubation with 40 ml strip buffer (100 mM glycine.HCl pH 2.2, 
150 mM NaCl) for 30 minutes, washing 6x with PBS-T in 30 minutes, then transferring 
back into blocking solution and following procedure again as described, using a different 
antibody. 
 
Chris MacDonald, 2009  Chapter II, 72 
2.3.12 Estimation of protein concentration 
2.3.12.1 Absorbance assay at 280 nm 
Protein concentrations were estimated by following the manufacturer’s instructions of the 
Bio-Rad protein assay, based on the method of Bradford (Bradford, 1976).  All 
measurements were made on a spectrophotometer at 595 nm.  A standard curve was 
produced by measuring the optical density of a concentration gradient of BSA.  Proteins 
were then measured and relative concentration was calculated from the equation derived 
from the standard curve. 
 
2.3.12.2 Ninhydrine assay 
Protein concentrations were also estimated using ninhydrin colorimetric analysis (Rosen, 
1957).  6 point concentration gradients, from 0 - 20 µl, of protein sample and of a 10 mM 
leucine standard were set up in polypropylene tubes.  150 µl 13 N sodium hydroxide was 
then added to each tube before they were covered with aluminium foil and autoclaved at 
116oC for 30 minutes to hydrolyze proteins.  Tubes were then cooled to room temperature 
and each reaction was neutralized by the addition of 250 µl glacial acetic acid.  400 µl CN 
ninhydrine solution (1.5% (w / v) ninhydrine in 2-methoxyethanol, 50% (v / v) 2-
methyoxyethanol, 100 µM sodium cyanide) was then added to each reaction.  Tubes were 
capped and centrifuged at 3,000 g for 4 minutes before boiling in water bath for 15 
minutes.  Immediately after boiling 2 ml 50% isopropanol was added and all tubes were 
vortexed vigorously then left to cool.  Absorbance of all samples was measured at 570 nm 
in a spectrophotometer.  Data was plotted using a linear fit graph.  The concentration of 
amino acids was calculated using a ratio of the 10 mM leucine standard slope and that of 
the protein samples. 
 
2.3.12.3 Amido black assay 
Protein concentration of proteoliposomes was calculated using a modified version of the 
amido black method (Schaffner and Weissmann, 1973).  20 µl of both proteoliposomes and 
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BSA standards were prepared for colorimetric analysis.  30 µl 1M Tris.HCl pH 7.5, 2% (w 
/ v) SDS and 50 µl 90% (w / v) trichloroacetic acid (TCA) was added to each sample and 
vortexed gently prior to incubation at room temperature for 5 minutes.  A single 0.45 µm 
24 mm filter of mixed cellulose esters (Millipore Ltd) for each sample was pre-wet in 6% 
(w / v) TCA before samples were applied to filters.  Samples were then dried down onto 
the filters using a vacuum manifold, before the filters were washed with an excess (~500 
µl) of 6% (w / v) TCA.  Filters of each sample were then incubated for 15 minutes with an 
excess of 2x amido black staining solution (Sigma-Aldrich Ltd) diluted to 1x with 25% (v / 
v) isopropanol, 10% acetic acid.  Excess stain was then washed off the filters with 3x 30 
second washes with 20 ml 25% (v / v) isopropanol, 10% acetic acid, followed by 3x 30 
second washes with water.  Filters were then dried, chopped up into small pieces and 
incubated with 1 ml 25 mM NaOH, 0.05 mM EDTA, 50% (v / v) ethanol in a glass test 
tube.  Samples were periodically vortexed during a ten minute incubation at room 
temperature.  The solution in each sample was then removed from the test tube and 
transferred to a cuvette to measuring absorbance at A630 in a spectrophotometer.  A 
standard curve was produced from the BSA samples; the concentration of proteins in each 
proteoliposome sample was then calculated from the equation derived from the curve. 
 
2.4 General yeast methods 
2.4.1 Yeast transformation 
100 µl of competent cells per transformation were thawed on ice before addition of ~10 µg 
of mini prepped plasmid DNA was added.  An equivalent volume of 70% (w / v) 
polyethylene glycol-3350 was added to tubes and mixed gently by inversion.  The cells 
were then incubated on a shaker at 30oC for 45 minutes, followed by a 20 minute heat-
shock incubation at 42oC.  Cells were pelleted at 3,000 g on a bench top centrifuge for 2 
minutes and then resuspended in 200 µl sterile water.  Cells were then spread under sterile 
conditions on an agar plate of minimal media lacking appropriate amino acids for 
selection, allowed to dry, and then placed in a 30oC incubator to allow colonies to form. 
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2.4.2 Preparation of competent yeast cells 
A single colony was used to inoculate a 50 ml culture of YPD media.  Cells were incubated 
at 30oC and grown to an OD600 of ~0.8, and then harvested by centrifugation at 1,000 g for 
2 minutes.  Cells were then washed by resuspension in 10 ml LiTE-Sorb (10 mM Tris.HCl 
pH 7.6, 0.1 M Lithium acetate, 1 mM EDTA, 1.2 M sorbitol) before pelleting again.  1 ml 
of LiTE-Sorb was then used to resuspend the cells, followed by incubation at 30oC with 
shaking for 1 hour.  Cells were then incubated on ice for at least 20 minutes, and could be 
used directly for transformation (section 2.4.1).  Alternatively, an equivalent volume of ice 
cold storage buffer (40% (v / v) glycerol, 0.5% (w / v) NaCl) was added to the cells, before 
aliquoting and snap freezing in liquid nitrogen.  Frozen competent cells were stored at        
-80oC.  
 
2.4.3 Yeast-2-Hybrid assay 
2.4.3.1 Expression of proteins in reporter strains 
All constructs for the yeast-2-hybrid assays were transformed into an appropriate yeast 
strain (section 2.4.1).   Expression of bait and prey fusion proteins in the host strain was 
checked by immunoblot analysis of whole cell lysates.  Whole cell lysates were prepared 
by resuspending 10x OD600 equivalents of cells in 100 µl TWIRL buffer (5% (w / v) SDS, 
8M urea, 10% (v / v) glycerol, 50 mM Tris pH 6.8, 0.2% (w / v) bromophenol blue, 10% 
(v / v) β-mercaptoethanol), then incubating at 65oC for 10 minutes.  A volume equivalent 
to 1x OD600 (10µl) of cell lysates were then resolved on an SDS-PAGE gel (section 2.3.8) 
followed by immunoblot analysis with appropriate antibodies (sections 2.3.10 & 2.3.11).  
The vectors containing the Gal4p activation and binding domains also contain N terminal 
HA and cMyc epitope tags respectively, to allow multiple fusion proteins to be detected 
simultaneously. 
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2.4.3.2 Detection of GFPS65T fluorescence expressed in yeast 
A C terminal GFPS65T tag was added to constructs containing VPS45 to allow confirmation 
of full length translated protein.  To detect GFP fluorescence, an overnight culture in 
selective media was treated with a final volume of 3% (v / v) formaldehyde, and left at 
room temperature for 10 minutes to fix the cells.  Cells from 1 ml of this culture were then 
collected by centrifugation at 500 g for 2 minutes; the pellet was then washed twice with 
PBS before being resuspended in 1 ml PBS.  A glass coverslip was washed in 100% 
ethanol and left to air dry.  To this, 50 µl of washed yeast cells were added and allowed to 
dry.  The coverslip was attached to a glass slide with Immuno-mount (Thermo Shandon 
Inc, Pittsburgh, PA, USA).  Cells were imaged through a 100x oil immersion objective on 
a Zeiss Axiomat fluorescence microscope (Carl Zeiss, Germany).  Images were captured 
using an Axiocam MRm camera (Carl Zeiss, Germany). 
 
2.5 GST pull down / complex assembly assay 
0.36 µg of either GST or the GST fusion proteins bound to Glutathione Sepharose 4B 
beads were incubated in the presence or absence of a ~10 fold molar excess of His6-Vti1p, 
His6-Snc2p and untagged Sx8 / Tlg1p chimera.  The reaction volume was made up to 1400 
µl with binding buffer (25 mM HEPES.KOH pH 7.4, 400 mM KCl, 10 (v / v) glycerol, 1% 
(v / v) Triton X-100, 1 mM DTT, 0.5 mg / ml BSA).  Binding reactions were carried out at 
4oC on a 360o rotator for 20 minutes.  Beads were then harvested by centrifugation at 500 g 
at 4oC for 1 minute.  Unbound protein was removed by washing 5 times with 750 µl of 
binding buffer.  The beads were then resuspended in 50 µl of 1x LSB and boiled for 5 
minutes.  Eluted protein was analysed by running on a 15% SDS-PAGE gel (section 2.3.8) 
followed by Coomassie staining (section 2.3.9) or immunoblot analysis (sections 2.3.10 & 
2.3.11). 
 
2.6 CPY-Invertase secretion assay 
Wild-type (BHY10) and tlg2∆ (SGSY2) S. cerevisiae strains expressing a fusion protein 
containing the first 50 amino acids of CPY and residues 3 - 512 of mature invertase were 
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used in this assay.  Wild-type and mutant versions of HA-Tlg2p were expressed in yeast; 
protein expression was checked by SDS-PAGE analysis (section 2.3.8) of yeast cell lysates 
followed by immunoblot analysis using an α-Tlg2p antibody (sections 2.3.10 & 2.3.11).  
An equal number of cells from each transformant was then added to a test tube, and made 
up to 400 µl with 1 M sodium acetate buffer at pH 4.9.  Each sample was split into two 
aliquots, one of which was treated with 5 µl Triton X-100 to lyse the cells, the other was 
left untreated.  50 µl 0.5 M sucrose solution was then added to each sample and incubated 
at 30oC for 30 minutes.  300 µl 0.2 M K2PO4 pH 10.0 was added to each sample before 
boiling for 3 minutes in a water bath.  Tubes were then chilled on ice before addition of 
Glucostat reagent (3.5 mM K2HPO4, 80 units / ml glucose oxidase, 100 µg / ml Horse 
radish Peroxidase, 4 mM NEM, 6 mg / ml o-dianisidine), and a further incubation at 30oC 
for 30 minutes.  Reactions were then stopped by addition of 2 ml 6 N HCl.  The absorbance 
at A540 was then measured and lysed samples used to represent total cellular invertase 
activity, and unlysed samples to show secreted invertase activity. 
 
2.7 Electrophoretic mobility shift assay 
2.7.1 Alexa 488 labelling  
Prior to binding of the Alexa Fluor® 488 C5 maleimide (Invitrogen Ltd), Snc2p1-94 
containing a single C terminal cysteine residue was first purified by affinity, ion exchange 
and gel filtration chromatography, in order to obtain as pure a sample as possible.  The 
sample was then diluted to 50 µM in 1x potassium phosphate buffer containing 1 M Tris 
(2-carboxyethyl) phosphine (TCEP).  The reaction mix was left for 1 hour at room 
temperature to allow reduction of cysteine residues.  To favour the binding reaction to 
Snc2p1-94, a 15 fold excess of dried Alexa 488 was resuspended in phosphate buffer, then 
added to the sample, bringing the total volume to 200 µl.  The reaction was covered in tin-
foil to exclude light and left at room temperature for 3 hours.  Any precipitate formed was 
removed by centrifugation at 15,000 g at 4oC for 15 minutes, and the supernatant fluid was 
transferred to a new tube.  To this final mix 25 µl of phosphate buffer was added, then the 
entire sample was loaded onto an FPLC system with 200 µl tubing.  The tubing was 
covered with aluminium foil.  The sample was then run through a Superdex 75 HR (10 / 
30) gel filtration column (GE Healthcare Bio-Sciences Ltd) to separate the labelled protein.  
Chris MacDonald, 2009  Chapter II, 77 
Mass spectrometry analysis was used to ensure only labelled protein species existed in the 
sample.  Labelled protein was stored at -80oC. 
 
2.7.2 Binding reaction  
Binding reactions of Vps45p and Alexa 488 labelled Snc2p1-94 were set up in a 96 well 
plate.  10 µl Alexa 488 labelled Snc2p1-94 at a concentration of 10 µM in binding buffer 
(170 mM KH2PO4, 720 mM K2HPO4, 10% (w / v) glycerol, 1mM TCEP, 0.1% (v / v) NP-
40) was added to 10 wells.   A concentration gradient of Vps45p was produced by a 3/5 
serial dilution of 16 µM stock, shown in Table 2.1.  40 µl of undiluted Vps45p was added 
to first well, then each of the serial dilutions were added to successive wells and no 
Vps45p added to the last well, to form the decreasing gradient.  The reactions were 
covered in aluminium foil and left to bind in the dark for 3 hours. 
 
Table 2.1 Protein concentrations for Vps45p-Snc2p1-88 binding reaction 
Reaction / Well 1 2 3 4 5 
[Snc2p1-94-Alexa 488] (µM) 10 10 10 10 10 
[Vps45p] (µM) 16 9.6 5.76 3.456 2.073 
 
Reaction / Well 6 7 8 9 10 
[Snc2p1-94-Alexa 488] (µM) 10 10 10 10 10 
[Vps45p] (µM) 1.244 0.746 0.448 0.269 0.161 
 
 
2.7.3 Gel retardation assay 
A 6% native gel (7 mM HEPES.KOH pH 7.4, 8.6 mM imidazole, 6% (v / v) acrylamide / 
bisacrylamide mixture, 2.5% (v / v) glycerol) was polymerised using TEMED and APS. 
The gel was then chilled in running buffer at 4oC for 1 hour.  6 µl of 30% (v / v) glycerol 
containing 0.01% (w / v) bromocresol green dye was added to each binding reaction and 
mixed thoroughly.   50 µl of each reaction was loaded onto the chilled native gel, which 
was then run at 125 volts for 4 hours at 4oC.  Native gels were carefully transferred to a 
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glass plate with excess water, and then all air bubbles were removed.  Gels were 
subsequently scanned in an FLA-5000 Phosphorimager (Fuji Film), set with a single laser 
at 433 nm.  Gels were visualised using Image Gauge V4.22 software. 
 
2.8 Competition binding experiments with recombinantly 
produced proteins 
All proteins used for in vitro binding experiments were recombinatly produced in E. coli 
then dialysed against 4 L of 1x PBS before storage at 4oC. A His6 tagged version Vps45p 
was bound to Ni2+-NTA beads, before incubation on a rotator with a Snc2p1-88-PrA fusion 
protein overnight at 4oC.  A sample of the washed beads, alongside the individual inputs 
was analysed by SDS-PAGE (section 2.3.8) followed by immunoblot analysis (sections 
2.3.10 & 2.3.11) using an α-Vps45p antibody to ensure complex had formed.  50 µl settled 
beads containing ~90µg His6-Vps45p bound to Snc2p1-88-PrA were then added to separate 
tubes, to which competing proteins or controls were added, before the reaction volume was 
made up to 1400 µl with PBS.  Binding reactions were allowed to proceed for 16 hours at 
4ºC on a rotating wheel, after which time non-specifically bound proteins were removed 
from the beads with 3x 1 ml washes with 1x PBS.  An equal volume of 1x LSB was added 
to the washed beads before boiling at 95oC for 5 minutes, and protein on beads was 
analysed by SDS-PAGE (section 2.3.8) followed by immunoblot analysis (sections 2.3.10 
& 2.3.11). 
 
2.9 Fusion assay 
2.9.1 Expression and purification of recombinant SNARE proteins 
To purify heterologously expressed SNARE proteins containing their native 
transmembrane domains, individual overnight cultures were set up in 2YT containing 
appropriate antibiotic.  This was used to inoculate 6 - 12 litres of terrific broth media.  
Proteins were expressed and harvested as discussed above; after the pellet was resuspended 
in A200 lysis buffer (25 mM HEPES.KOH pH 7.4, 200 mM KCl, 4% (w / v) Triton X-100, 
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10% (w / v) glycerol, 5 mM β-mercaptoethanol, 1 mM PMSF).  Cell lysis was achieved by 
passage through a Microfluidizer M-110P cell disrupter set at 10,000 psi.  Lysates were 
clarified as discussed previously, and the tagged protein was routinely bound to 3 ml of 
appropriate beads.  The Triton X-100 in the lysis buffer was exchanged for 1% Octyl-β-D-
glucopyranoside (OG) in the wash buffer, which was used to wash the beads 10 times.  
Proteins were eluted from beads in buffer containing 1% (w / v) OG.  The eluate was then 
aliquoted, snap frozen in liquid nitrogen and stored at -80oC. 
 
2.9.2 Lipid stocks 
A 15 mM lipid stock of t-SNARE liposomes was made up in chloroform containing 85 
mol% POPC and 15 mol% DOPS.  For v-SNARE liposomes, a 3 mM lipid stock was 
made up in chloroform containing 82 mol% POPC, 15 mol% DOPS, 1.5 mol% NBD-
DPPE and 1.5 mol% rhodamine-DPPE.  Lipid stocks were stored under nitrogen at -80oC. 
 
2.9.3 Formation of proteoliposomes 
100 µl of 15mM unlabelled lipid stock, for t-SNARE liposomes, and 500 µl of 3 mM 
labelled lipid stock, for v-SNARE liposomes were added to separate 12 x 75 mm glass 
tubes.  A gentle stream of compressed nitrogen was then used to evaporate the chloroform 
from each tube for 15 minutes.  Lipid films were then placed in a vacuum desiccator for 30 
minutes to completely remove traces of chloroform.  500 µl purified t- or v-SNAREs 
containing 1% OG were then added to the appropriate tube containing the lipid films.  The 
lipid film was then completely resuspended, by vortexing for 15 minutes.  After the lipid 
film was resuspended, the detergent was diluted below its critical micelle concentration 
(CMC) level by the addition of 1 ml of buffer A200 containing 1 mM DTT; buffer was 
added drop-wise while the sample was continuously vortexed.  The samples were then 
dialysed against 4 litres A200 buffer containing 1 mM DTT overnight at 4oC using 3 ml 
Float-a-Lyzers (Spectrum Laboratories Inc ) with appropriate molecular weight cut offs.  4 
g of Bio-Beads (BioRad Laboratories Ltd) were added to dialysis buffer to capture the 
detergent.  Samples were recovered the following day, and each placed in an SW60 tube 
on ice for subsequent separation using gradient centrifugation. 
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2.9.4 Proteoliposome recovery 
Proteoliposomes were recovered by floatation on a nycodenz ((5-[N-(2,3-
dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N’-bis(2,3-dihydroxypropyl) isophthalamide)) 
(Sigma-Aldrich Ltd) gradient.  1.5 ml of dialysed liposome sample was added to an equal 
volume of 80% (w / v) nycodenz (Sigma-Aldrich Ltd) in A200 buffer containing 1 mM 
DTT and mixed extensively.  This 40% mixture was carefully overlaid with 1.5 ml 30% (w 
/ v) nycodenz in A200 buffer containing 1 mM DTT.  Finally, a third layer containing 250 
µl of glycerol free A200 buffer was carefully overlaid on the top.  These gradients were then 
centrifuged for 4 hours at 46,000 rpm in an SW60 rotor at 4oC.  Proteoliposomes float to 
the interface between the glycerol free A200 and the 30% nycodenz layers, due to their lipid 
content, and free protein remains in the 40% layer.  Proteoliposomes were recovered from 
the top of the gradient by collecting the top 400 µl of sample with a pipette.  If necessary, 
proteoliposomes were snap frozen in liquid nitrogen and stored at -80oC. 
 
2.9.5 Proteoliposome characterisation 
2.9.5.1 Lipid recovery 
The percentage lipid recovered in proteoliposomes was calculated by scintillation counting 
tritium added to the stock solutions.  5 µl of recovered proteoliposome sample was added 
to 4 ml scintillation fluid and counted in a Beckman Coulter LS 6500 scintillation counter 
set to automatically count using the tritium detection filter for 3 minutes per sample.  A 5 
µl sample of the stock solution was also measured.  The percentage lipid recovery was 
calculated by comparing the [3H] DPPC counts per minute from recovered material and 
stock solution. 
 
2.9.5.2 Protein orientation 
In order to analyse the percentage of reconstituted SNARE proteins externally orientated in 
the proteoliposomes, trypsin digests were carried out.  To digest externally orientated 
proteins, 10 µl of recovered liposomes were incubated at 37oC for 3 hours in presence of   
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2 µl 0.05% trypsin-EDTA (Invitrogen Ltd).  To digest the total protein content, including 
those internally orientated, 10 µl of liposomes were disrupted by addition of 1.5 µl 0.1% (v 
/ v) Triton X-100 and incubated with 2 µl trypsin.  As a control, 10 µl of liposomes were 
incubated at 37oC for 3 hours in the absence of trypsin.  The total protein content of each 
digestion was analysed by SDS-PAGE and Coomassie staining (sections 2.3.8 & 2.3.9).  
Densitometry analysis of the resultant gel was performed using Image J software, this data 
was then used to estimate the percentage of externally facing SNAREs. 
 
2.9.5.3 Dynamic light scattering size analysis 
Dynamic light scattering (DLS) was used to estimate the average size of donor and 
acceptor proteoliposomes.  200 µl of recovered samples were diluted 1/10 in A200 buffer 
then added to a DynaPro 801 Dynamic light scattering instrument (Wyatt Technology 
Corp.), through a 200 nm filter.  All measurements were made at ~37oC, and the laser 
power was adjusted to keep the intensity between 500,000 counts and 2,000,000 counts.  
The results were then processed with the programme Dynamics V2 (Wyatt Technology 
Corporation).  The hydrodynamic radii of each population were calculated with the 
regularisation algorithm provided by this software. 
 
2.9.5.4 Electron microscope size analysis 
Samples of recovered proteoliposomes at a 1/10 dilution were applied to a glow discharged 
Formvar / Carbon-coated 200 mesh copper grid then dried down with filter paper to a thin 
layer onto the hydrophilic support film.  20 µl of 1% aqueous methylamine vanadate 
(Nanovan; Nanoprobes, Stony Brook, NY, USA) stain was applied and the mixture dried 
down immediately with filter paper to remove excess stain.  The samples were then imaged 
with a LEO 912 energy filtering transmission electron microscope at 120 kV.  The size of 
individual proteoliposomes was measured from images using SIS iTEM soft imaging 
software (Olympus). 
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2.9.6 FRET fusion assay 
Typically fusion assays were set up on ice by mixing 5 µl of v-SNARE liposome with 45 
µl of t-SNARE liposome directly in a well of a chilled 96 well microtitre plate.  For assays 
requiring the addition of soluble v-SNARE, 5 µl of purified protein in buffer A200 was 
added to the t-SNARE liposomes on ice for 10 minutes prior to the addition of v-SNARE 
liposomes.  To correct for the resulting difference in volume 5 µl of A200 buffer was added 
to all other wells in that run.  The microtitre plate was warmed to 37oC and then 
fluorescence was monitored in a FLUOstar Optima plate reader. The fluorescence was 
measured for 2 hours with the excitation set to 460 nm and the emission recorded at 538 
nm at 2 minute intervals.  After this period, the plate was removed and 10 µl of 2.5% (w / 
v) n-dodecylmaltoside was added to each well in order to achieve a maximal fluorescence 
reading.  The plate was then replaced in plate reader, and fluorescence was recorded as 
before for 40 minutes at 2 minute intervals. 
 
2.9.7 Analysis of raw fluorescence data 
Raw fluorescence data was analysed with KaleidaGraph Software.  Raw fluorescence was 
plotted against time.  This was then normalised to percentage maximal detergent signal by 
using the highest fluorescence reading after addition of n-dodecylmaltoside.  Percentage 
maximal detergent signal was then plotted against time. 
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Table 2.2 E. coli strains used in this study 
E. coli strains used in this study 
Strain Genotype Source 
BL21(DE3) F- ompT hsdSB(rB-mB-) gal dcm (DE3) Invitrogen Ltd 
RosettaTM 
2(DE3) 
F- ompT hsdSB(rB-mB-) gal dcm (DE3) pRARE2 Merck Chemicals 
Ltd 
Top10 F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 
nupG recA1 araD139 ∆(ara-leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ- 
Invitrogen Ltd 
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZ∆M15 Tn10 (Tetr)] 
Stratagene 
Technologies 
 
 
 
Table 2.3 Saccharomyces cerevisiae strains used in this study 
S. cerevisiae strains used in this study 
Strain  
(Stock #) 
Genotype Reference 
AH109 
(75) 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, 
gal4∆, gal80∆, LYS2::GAL1UAS-GAL1 TATA-
HIS3, 
GAL2UAS-GAL2TATA-ADE2, 
URA3::MEL1UAS-MEL1 TATA-lacZ, MEL1 
Clontech 
Laboratories Inc 
(James et al., 
1996) 
BHY10 
(98) 
MATα, leu2-3,112 ura3-52 his3-A200 trpl-A901 
lys2-801 suc2-A9 leu2-3,112::pBHYl 1(CPY-Inv 
LEU2) 
(Horazdovsky et 
al., 1994) 
MaV103 
(81) 
MATa, leu2-3, 112 trp-901 his3D200 ade2-1  
gal4D gal80D SPAL10::URA3 GAL1::lacZ 
GAL1::HIS3-LYS2 can1R cyh2R 
(Vidal et al., 
1996a) 
MaV203 
(82) 
MATα, leu2-3, 112 trp-901 his3D200 ade2-1  
gal4D gal80D SPAL10::URA3 GAL1::lacZ 
GAL1::HIS3-LYS2 can1R cyh2R  
(Vidal et al., 
1996a) 
SGSY2 
(100) 
MATα, leu2-3,112 ura3-52 his3-A200 trpl-A901 
lys2-801 suc2-A9 leu2-3,112p::BHYl 1(CPY-Inv 
LEU2), tlg2::KanMX 
Constructed by 
Dr. Scott Shanks 
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Table 2.4 Table of oligonucleotides used in this study 
Oligo Key Sequence (5'  3') 
3 EcoRIinframeSNC2 GAATTCGATGTCGTCATCAGTGCCATA
GC 
4 HindIIIstopstopSNC2 AAGCTTTTATTAATCTTTCCACCACAT
TTGCT 
210 BamHIstartSXN8 GGATCCTTGGGTTTCGATGAGATCCG 
211 SXN8 TLG1 GTCCATACCCTCGTCCATATTATCCAA
CAATTGTCCCTGTTCGTCCAGTTCATT
CCCAATCT 
212 TLG1 SXN8 AAGCAAATGGGCCAGGAGATTGGGAAT
GAACTGGACGAACAGGGACAATTGTTG
GATAATATG 
213 EcoRITLG1 GAATCCTCAAGCAATGAATGCCAAAAC
TAA 
217 TLG2F9AL10ATLG2 GAGATAGAACTAATTTAGCTGCATCAT
ACCGTAGGACT 
218 Reverse complement of 217 AGTCCTACGGTATGATGCAGCTAAATT
AGTTCTATCTC 
326 NcoIinframeSNC2 CCATGGGCATGTCGTCATCAGTGCCAT
ACGATC 
327 BamHIstopstopSNC2 GGATCCTTATTAATCTTTCCACCACAT
TTGCTTTCTG 
328 NcoIinframeVPS45 CCATGGGCATGAACCTTTTTGATGTGG
CTGAC 
329 BamHIstopstopVPS45 GGATCCATTATTTTGCAGATCTAATAG
AATCC 
354 VPS45PacIinframeBamHI 
pACT2 vector sequence 
CTATTAGATCTGCAAAATTAATTAAAA
GGATCCGAATTCGAGCTC 
355 Reverse complement of 354 GAGCTCGAATTCGGATCCTTTTAATTA
ATTTTGCAGATCTAATAG 
358 PacIinframeGFP TTAATTAAAATGGGTAAAGGAGAAGAA
CTTTTC 
360 PacIstopstopGFP TTAATTAATTATTACTAGATCCGGTGG
ATCCCG 
369 VPS45PacIinframeBamHI 
pGBKT7 vector sequence 
TTCTATTAGATCTGCAAAATTAATTAA
AAGGATCCGTCGACCTGC 
370 Reverse complement of 354 GCAGGTCGACGGATCCTTTTAATTAAT
TTTGCAGATCTAATAGAA 
470 TLG2I285ATLG2 GGACTATTGTGGACAGGGCTGATTATA
ATCTGG 
471 Reverse complement of 470 CCAGATTATAATCAGCCCTGTCCACAA
TAGTCC 
474 XhoIstopVPS45 CTCGAGTTATTTTGCAGATCTAAT 
479 NcoITLG2 SNARE domain CCATGGGCCTCGATATTGAAGACTAT 
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480 BamHIstopTLG2 SNARE 
domain 
GGATCCTTATTTTGAGTTCTCTTCTGG 
481 NcoITLG2 Habc domain CCATGGGTACATACCCGATGATG 
482 BamHIstopTLG2 Habc 
domain 
GGATCCTTACAAATCCTTGTTCAAGAA 
 
 
Table 2.5 Table of parental vectors used for cloning in this study 
Parent 
Vectors 
Description Source 
pACT2 ColE1 ori, ApR.  Yeast 
expression plasmid (2µ, 
LEU2). 
Clontech Laboratories Inc 
(Li et al., 1994) 
pACYCDuet-
1 
P15A ori, lacI, CmR; E. coli 
expression vector. 
Merck Chemicals Ltd 
pCOG022 E. coli expression vector 
encoding two repeats of the 
IgG binding domains of S. 
aureus protein A. 
XhoI and PacI were used to remove C 
terminal S tag ORF from pETDuet-1, 
Sequence encoding two synthetic 
repeats of the IgG binding domains of S. 
aureus protein preceded by a thrombin 
cleavage site then inserted with the same 
sites.  Created by Dr. Lindsay Carpp. 
pCR®2.1-
TOPO® 
pUC ori, f1 ori, ApR, KnR,     
E. coli cloning vector. 
Invitrogen Ltd 
pET28(a-c) F1 ori, lacI, KnR; E. coli 
expression vector. 
Merck Chemicals Ltd 
pETDuet-1 ColE1 ori, lacI, ApR; E. coli 
expression vector. 
Merck Chemicals Ltd 
pETDuet-1 
GST 
E. coli expression vector 
encoding glutathione S 
transferase (GST). 
XhoI and PacI were used to remove C 
terminal S tag ORF from pETDuet-1, 
GST ORF sequence preceded by a 
thrombin cleavage site then inserted 
with the same sites.  Created by Dr. 
Fiona Brandie. 
pGEX-3T-1 pBR322 ori, lacI, ApR; E. coli 
expression vector. 
GE Healthcare Bio-Sciences Ltd 
pGEX-4T-1 pBR322 ori, lacI, ApR; E. coli 
expression vector. 
GE Healthcare Bio-Sciences Ltd 
pGEX-6P-1 pBR322 ori, lacI, ApR; E. coli 
expression vector. 
GE Healthcare Bio-Sciences Ltd 
pQE-
TriSystem 
pUC ori, lacO, ApR. E. coli 
expression vector. 
Qiagen Ltd 
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Table 2.6 Plasmids constructed / used in this study 
Stock # Plasmid 
name 
Description Source 
 
 
 
455 
pCMD001 
 
 
 
 
Fragment encoding 
chimera containing Sx8 
residues 135 - 179 
followed by Tlg1p 
residues 166 - 244.  
Flanked by BamHI and 
EcoRI sites in pCR®2.1-
TOPO®. 
PCR SOEing reaction using TLG1 
and SXN8 cDNA was performed 
using external oligos 210 and 213 
containing BamHI and EcoRI sites.  
These oligos were used in 
conjunction with internal oligos 211 
and 212.  Resulting PCR product 
was Taq-treated and sub-cloned into 
pCR®2.1-TOPO®. 
 
 
456 
pCMD002 E. coli expression vector 
encoding an N-
terminally His6-tagged 
version of the Sx8 / 
Tlg1p chimera. 
BamHI / EcoRI fragment sub-cloned 
from pCMD001 into pET28a cut 
with the same enzymes. 
 
 
457 
pCMD003 E. coli expression vector 
encoding an N-
terminally GST-tagged 
version of the Sx8 / 
Tlg1p chimera. 
BamHI / EcoRI fragment sub-cloned 
from pCMD001 into pGEX-4T-1 cut 
with the same enzymes. 
 
 
458 
pCMD004 E. coli expression vector 
encoding an N-
terminally GST-tagged 
version of the Sx8 / 
Tlg1p chimera. 
(Struthers et al., 2009) 
 
 
467 
pCMD007 E. coli expression vector 
encoding a C-terminally 
GST-tagged version of 
cytosolic Tlg2p, residues 
221 - 309. 
(Struthers et al., 2009) 
 
480 
pCMD008 E. coli expression vector 
encoding a C-terminally 
GST-tagged version of 
cytosolic Tlg2p, residues 
1 - 309. 
(Struthers et al., 2009) 
 
 
 
481 
pCMD009 Fragment encoding 
GFPS65T flanked by PacI 
sites, in pCR2.1-TOPO®. 
Sequence encoding GFPS65T was 
PCR amplified from template 
pGO036 (Odorizzi et al., 2003) 
using oligos 358 and 360 to 
incorporate PacI sites.  Resulting 
PCR product was Taq-treated and 
sub-cloned into pCR®2.1-TOPO®. 
 
490 
pCMD011 Yeast expression 
plasmid (2µ, URA3) 
driving production of 
HA-Tlg2pF9A/L10A/I285A. 
SDM was performed on pCMD013 
using oligos 217 and 218. 
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466 
pCMD013 Yeast expression 
plasmid (2µ, URA3) 
driving production of 
HA-Tlg2pI285A. 
SDM was performed on pHA-TLG2 
using oligos 470 and 471. 
 
 
 
 
493 
pCMD014 Fragment encoding 
Vps45p flanked by NcoI 
and XhoI sites, in 
pCR2.1-TOPO®. 
Sequence encoding Vps45p was 
PCR amplified from template 
pNB710 using oligos 328 and 474 to 
incorporate NcoI and XhoI sites.  
Resulting PCR product was Taq-
treated and sub-cloned into 
pCR®2.1-TOPO®. 
 
494 
pCMD015 E. coli expression vector 
encoding a C-terminally 
His6-tagged version of 
Vps45p. 
NcoI / XhoI fragment encoding full 
length Vps45p from pCMD014 was 
sub-cloned into pET28b cut with the 
same enzymes. 
 
 
495 
pCMD016 Yeast expression 
plasmid (2µ, TRP1) 
driving expression of 
Gal4p BD-cMyc-
Vps45p-GFPS65T. 
PacI fragment encoding GFPS65T 
from pCMD009 was sub-cloned into 
pCOG085 cut with the same 
enzymes. 
 
 
496 
pCMD017 Yeast expression 
plasmid (2µ, LEU2) 
driving expression of 
Gal4p AD-HA-Vps45p-
GFPS65T. 
PacI fragment encoding GFPS65T 
from pCMD009 was sub-cloned into 
pCOG084 cut with the same 
enzymes. 
 
 
 
499 
pCMD018 Fragment encoding 
Tlg2p residues 37 - 192 
flanked by NcoI and 
BamHI sites, in 
pCR®2.1-TOPO®. 
Sequence encoding Tlg2p37-192 was 
PCR amplified from template pHA-
TLG2 using oligos 481 and 482 to 
incorporate NcoI and BamHI sites.  
Resulting PCR product was Taq-
treated and sub-cloned into 
pCR®2.1-TOPO®. 
 
 
500 
pCMD019 Yeast expression 
plasmid (2µ, LEU2) 
driving expression of 
Gal4p AD-HA-Tlg2p37-
192. 
NcoI / BamHI fragment encoding 
Tlg2p37-192 sub-cloned from 
pCMD018 into pACT2 cut with the 
same enzymes. 
 
 
501 
pCMD020 Yeast expression 
plasmid (2µ, TRP1) 
driving expression of 
Gal4p BD-cMyc-
Tlg2p37-192. 
NcoI / BamHI fragment encoding 
Tlg2p37-192 sub-cloned from 
pCMD018 into pGBKT7-p53 cut 
with the same enzymes, to drop out 
p53 gene. 
 
 
 
503 
pCMD021 Fragment encoding 
Tlg2p residues 221 - 318 
flanked by NcoI and 
BamHI sites, in 
pCR®2.1-TOPO®. 
Sequence encoding Tlg2p221-318 was 
PCR amplified from template pHA-
TLG2 (Seron et al., 1998) using 
oligos 479 and 480 to incorporate 
NcoI and BamHI sites.  Resulting 
PCR product was Taq-treated and 
sub-cloned into pCR®2.1-TOPO®. 
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504 
pCMD022 Yeast expression 
plasmid (2µ, LEU2) 
driving expression of 
Gal4p AD-HA- 
Tlg2p221-318. 
NcoI / BamHI fragment encoding 
Tlg2p221-318 sub-cloned from 
pCMD021 into pACT2 cut with the 
same enzymes. 
 
 
505 
pCMD023 Yeast expression 
plasmid (2µ, TRP1) 
driving expression of 
Gal4p BD-cMyc-
Tlg2p221-318. 
NcoI / BamHI fragment encoding 
Tlg2p221-318 sub-cloned from 
pCMD021 into pGBKT7-p53 cut 
with the same enzymes, to drop out 
p53 gene. 
 
 
 
35 
pCOG002* Fragment encoding 
cytosolic Snc2p1-88 
flanked by EcoRI and 
HindIII sites, in 
pCR®2.1-TOPO®. 
Sequence encoding the cytosolic 
domain of Snc2p was PCR amplified 
from genomic DNA prepared from a 
9Dα strain using oligos 3 and 4 to 
incorporate EcoRI and HindIII sites.  
Resulting PCR product was Taq-
treated and sub-cloned into 
pCR®2.1-TOPO®. 
 
 
39 
pCOG006* E. coli expression vector 
encoding an N-terminal 
His6 tagged version of 
cytosolic Snc2p, 
residues 1 - 88. 
EcoRI / HindIII fragment sub-cloned 
from pCOG002 into pCAYCDuet-1 
cut with the same enzymes. 
 
 
87 
pCOG025* E. coli expression vector 
encoding a C-terminally 
PrA -tagged version of 
the cytosolic domain of 
Tlg2p, residues 1 - 309. 
(Carpp et al., 2006) 
 
 
201 
pCOG045* E. coli expression vector 
encoding a C-terminally 
PrA -tagged version of 
the cytosolic domain of 
Snc2p, residues 1 - 88. 
KpnI / XhoI fragment encoding 
cytosolic domain from pCOG043 
was sub-cloned into pCOG022 cut 
with the same enzymes. 
 
297 
pCOG066* Yeast expression 
plasmid (2µ, URA3) 
driving production of 
HA-Tlg2pF9A/L10A. 
SDM was performed on pHA-TLG2 
using oligos 217 and 218.   
 
 
317 
pCOG067* E. coli expression vector 
encoding His6-
Vps45pL117R. 
(Carpp et al., 2006) 
 
 
357 
pCOG076* E. coli expression vector 
encoding a C-terminally 
PrA -tagged version of 
cytosolic, (residues 1 - 
309) Tlg2pF9A/L10A. 
SDM was performed on pCOG025 
using oligos 217 and 218.   
 
 
 
 
371 
pCOG077* Fragment encoding 
Snc2p flanked by 
BamHI and NcoI sites, in 
pCR2.1-TOPO®. 
Sequence encoding Snc2p was PCR 
amplified from template pCOG006 
using oligos 326 and 327 to 
incorporate BamHI and NcoI sites.  
Resulting PCR product was Taq-
treated and sub-cloned into 
pCR®2.1-TOPO®.  
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372 
pCOG078* Fragment encoding 
Vps45p flanked by 
BamHI and NcoI sites, in 
pCR2.1-TOPO®. 
Sequence encoding Vps45p was 
PCR amplified from template 
pNB710 using oligos 328 and 329 to 
incorporate BamHI and NcoI sites.  
Resulting PCR product was Taq-
treated and sub-cloned into 
pCR®2.1-TOPO®. 
 
385 
pCOG079* Yeast expression 
plasmid (2µ, LEU2) 
driving expression of 
Gal4p AD-HA-Snc2p. 
BamHI / NcoI fragment encoding 
full length Snc2p from pCOG077 
was sub-cloned into pACT2 cut with 
the same enzymes. 
 
 
386 
pCOG080* Yeast expression 
plasmid (2µ, TRP1) 
driving expression of 
Gal4p BD-cMyc-Snc2p. 
BamHI / NcoI fragment encoding 
full length Snc2p from pCOG077 
was sub-cloned into pGBKT7-p53 
cut with the same enzymes, to drop 
out p53 gene. 
 
387 
 
pCOG081* Yeast expression 
plasmid (2µ, LEU2) 
driving expression of 
Gal4p AD-HA-Vps45p. 
BamHI / NcoI fragment encoding 
full length Vps45p from pCOG078 
was sub-cloned into pACT2 cut with 
the same enzymes. 
 
 
388 
pCOG082* Yeast expression 
plasmid (2µ, TRP1) 
driving expression of 
Gal4p BD-cMyc-
Vps45p. 
BamHI / NcoI fragment encoding 
full length Vps45p from pCOG078 
was sub-cloned into pGBKT7-p53 
cut with the same enzymes, to drop 
out p53 gene. 
 
393 
pCOG084* pCOG081 with a PacI 
site inserted immediately 
after the VPS45 gene. 
SDM was performed on pCOG081 
using oligos 354 and 355.   
 
 
412 
pCOG085* pCOG082 with a PacI 
site inserted immediately 
after the VPS45 gene. 
SDM was performed on pCOG082 
using oligos 369 and 370.   
 
 
 
N / A 
 
pFB09 / 2 E. coli expression vector 
encoding a C-terminally 
GST-tagged version of 
the cytosolic domain of 
Sx4. 
Sequence encoding Sx4 cloned into 
pGEX4T-1.   Constructed by Dr. 
Fiona Brandie. 
 
 
366 
pGBKT7-
LamC 
Yeast expression 
plasmid (2µ, TRP1) 
driving production of 
Gal4p-BD-Lamin C 
(residues 66 - 230). 
Clontech Laboratories Inc 
 
 
365 
pGBKT7-
p53 
Yeast expression 
plasmid (2µ, TRP1) 
driving production of 
Gal4p-BD-p53 (residues 
72 - 390). 
Clontech Laboratories Inc 
 
50 
pHA-TLG2 Yeast expression 
plasmid (2µ, URA3) 
driving production of 
HA-Tlg2p. 
(Seron et al., 1998) 
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239 
pJM081 E. coli expression vector 
encoding a C-terminally 
His6-tagged version 
Snc2p. 
(McNew et al., 2000) 
 
244 
pJM132 E. coli expression vector 
encoding an N-
terminally His6-tagged 
version of Vti1p. 
(Fukuda et al., 2000) 
 
240 
pJM106 E. coli expression vector 
encoding an N-
terminally His6-tagged 
version of Tlg2p, 
residues 37 - 397.
 
Sequence encoding Tlg2p37-397 
cloned into pET28a.  Gift from Dr. 
James McNew. 
 
 
242 
pJM124 E. coli expression vector 
encoding an N-
terminally His6-tagged 
version of  Tlg1p. 
(McNew et al., 2000) 
 
246 
pJM325 E. coli expression vector 
encoding an N-
terminally His6-tagged 
version of Tlg2p, 
residues 1 - 335. 
Sequence encoding Tlg2p1-335 cloned 
into pET28a.  Gift from Dr. James 
McNew. 
 
 
 
N / A 
pKIM001 E. coli expression vector 
encoding an N-
terminally His6-tagged 
version of Tlg2p. 
Sequence encoding Munc18c 
flanked by BamHI and XhoI sites 
was PCR amplified and cloned 
directly into pQE-TriSystem cut 
with the same enzymes.  Performed 
by Kim Boney 
 
 
479 
pMM472 E. coli expression vector 
encoding an N-terminal 
GST tagged version of 
cytosolic Snc2p, 
residues 1 - 94. 
Sequence encoding Snc2p1-94 cloned 
into pGEX3T-1.  Gift from Dr. Mary 
Munson. 
 
56 
pNB710 E. coli expression vector 
encoding a N-terminally 
His6-tagged version 
Vps45p. 
(Carpp et al., 2006) 
 
 
368 
pTD1-1 Yeast expression 
plasmid (2µ, LEU2) 
driving production of 
Gal4p-AD-SV40 Large 
T antigen (residues 87 - 
708). 
Clontech Laboratories Inc 
(Li and Fields, 1993) 
 
N / A 
pT-GroE E. coli expression vector 
encoding GroEL and 
GroES chaperone 
proteins. 
(Yasukawa et al., 1995) 
* All pCOG plasmids were constructed by Dr. Lindsay Carpp. 
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3.1 Introduction 
Regulation of SNARE complex assembly is integral to controlling membrane fusion events 
within the eukaryotic cell (Jahn and Scheller, 2006).  The syntaxin and SM protein families 
are essential for this process, but the mechanisms by which they confer regulation are not 
fully understood (Jahn, 2000, Sudhof and Rothman, 2009).  Structural studies on the 
syntaxin family member responsible for neuronal exocytosis, Sx1a, have revealed that it 
contains an autonomously folded Habc domain (Fernandez et al., 1998), that can fold back 
and form intramolecular interactions with the SNARE motif, thereby prohibiting its entry 
into a SNARE complex (Dulubova et al., 1999).  This has been described as a closed 
conformation (Dulubova et al., 1999), and syntaxin family members from other systems 
have been shown to regulate complex assembly, and fusion, by adopting this conformation: 
the yeast exocytotic Sso1p (Fiebig et al., 1999, Nicholson et al., 1998); mammalian Sx4 in 
adipocytes (Aran et al., 2009, D'Andrea-Merrins et al., 2007); and UNC-64 in C. elegans 
(Johnson et al., 2009, Richmond et al., 2001).   
SM proteins have been identified as essential regulators of vesicle trafficking, but the exact 
role of these highly conserved proteins remains unclear (Sudhof and Rothman, 2009, 
Toonen and Verhage, 2003).  Failure to construct a unifying hypothesis for the role of SM 
proteins has largely been due to apparently conflicting data from studies on various 
transport steps in different experimental systems (Toonen and Verhage, 2003).  The crystal 
structure of the neuronal Sx1a in complex with its cognate SM protein Munc18a revealed 
that the SM protein has an arch shape, with a central cavity that cradles Sx1a in a closed 
conformation (Misura et al., 2000).  The closed conformation of Sx1a is known to be 
incompatible with complex assembly (Dulubova et al., 1999).  This structural data was 
supported by a study that demonstrated binding of Sx1a to its SNARE partners precluded 
binding to Munc18a, and vice versa (Yang et al., 2000).  Binding of Sx1a in a closed 
conformation to Munc18a is perturbed if a double mutation, that disrupts the closed 
conformation (L165A, E166A), is introduced into the linker region between Habc and 
SNARE domains of Sx1a (Dulubova et al., 1999).  These findings have been interpreted as 
indicating that the SM protein has an inhibitory role on complex assembly by actively 
prohibiting the syntaxin from entering into complex (Misura et al., 2000, Yang et al., 
2000).  However, deletion of Munc18a in mice results in a complete lack of synaptic 
neurotransmitter release (Verhage et al., 2000), which is not what would be expected upon 
removal of a negative regulator, and suggests a positive role for the SM protein in 
membrane fusion.  These data taken together suggest that the interaction of Munc18a with 
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the closed conformation of Sx1a is a necessary regulatory step that results in complex 
formation and membrane fusion.   
Understanding the exact mechanisms that control membrane fusion events in the yeast 
endosomal system has also been made difficult by seemingly conflicting data.  In 
agreement with the in vivo Munc18a deletion experiments in mice (Verhage et al., 2000), 
deletion of Vps45p in yeast (vps45∆) has a profound affect on their ability to correctly 
traffic the vacuolar hydrolase CPY (Cowles et al., 1994, Piper et al., 1994).  A model 
whereby Vps45p facilitates a switch of Tlg2p from a closed (inactive) to an open 
conformation that is able to form SNARE complexes, and thus drive fusion, is supported 
by the observation that the requirement of Vps45p in CPY trafficking can be bypassed by 
expressing a mutant version of Tlg2p; the mutant version of Tlg2p lacks the N terminal 
Habc domain, and is therefore unable to adopt a closed conformation (Bryant and James, 
2001).  However, the above model has been contested by NMR studies that suggest Tlg2p 
cannot form a closed conformation, and exclusively binds Vps45p via a distinct 
mechanism (mode-2 binding) involving a small N terminal peptide of Tlg2p (Dulubova et 
al., 2002).  This mode of binding is analogous to the yeast Golgi syntaxin Sed5p 
interacting with cognate SM protein Sly1p (Bracher and Weissenhorn, 2002, Yamaguchi et 
al., 2002).  The authors of this study suggested that an unidentified inhibitory factor acting 
on the N terminal portion of Tlg2p may account for the suppression of vps45∆ trafficking 
defects by the version of Tlg2p lacking the Habc domain, since this would not be able to 
bind to any such inhibitory factor (Dulubova et al., 2002).  However, it could be argued 
that the recombinant proteins used for NMR analysis are not physiologically relevant due 
to necessary truncations used to obtain sufficient concentrations of soluble protein for 
analysis; it is possible that these missing residues are important for stabilising a closed 
conformation.  More experimental data is required to distinguish between these two 
models.  Recently, support for a model of Vps45p interacting with Tlg2p by a mode 
distinct from mode-2 has been inferred from studies on a mammalian homologue of Tlg2p, 
Sx16.  Although the short N terminal peptide of Sx16 is sufficient for binding mVps45, 
full length Sx16 has a greatly enhanced affinity for the SM protein (Burkhardt et al., 2008).  
This study also documented a refined crystal structure of the Sx1a-Munc18a complex, 
which demonstrated that Sx1a could in fact bind Munc18a through its N terminal peptide 
(mode-2) in addition to its well characterised mode-1 binding (Burkhardt et al., 2008).  
This refined crystal structure is in agreement with a previous report that used both in vivo 
and in vitro techniques to demonstrate that Munc18a could bind to Sx1a via mode-2 
binding (Rickman et al., 2007).  The originally confounding discovery of the highly 
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conserved family of SM proteins binding SNARE proteins by multiple, structurally 
disparate, binding modes is becoming more lucid by such demonstrations of individual SM 
proteins binding via multiple modes.  Convergence in experimental data, such as these 
examples, may ease the formulation of unifying hypotheses to describe SM protein 
function. 
 
3.2 Aims of this Chapter 
We propose a model whereby Tlg2p forms a closed conformation incompatible with 
complex assembly; this conformation then undergoes a switch, facilitated by Vps45p, to 
allow complex formation.  To directly test the hypothesis that the presence of the Tlg2p 
Habc domain inhibits formation of SNARE complexes, I set out to use a simplified in vitro 
assay void of any additional regulatory factors that may influence the process.  Once this 
technique was established to assay complex formation, I aimed to add recombinant 
Vps45p, to see if any direct effect could be detected by addition of the SM protein to the 
system.  Further to this, I aimed to use a yeast-2-hybrid technique to test whether an 
intramolecular interaction between the Habc domain and the SNARE domain of Tlg2p 
could be detected, in support of the syntaxin forming a closed conformation.  Finally, using 
mutant versions of Tlg2p in an in vivo trafficking assay we set out to elucidate the 
functional significance of Vps45p binding modes.  Specifically we tested whether 
abrogating the hypothetical mode-1 binding of Vps45p to a closed conformation of Tlg2p 
has functional consequences in vivo.  
 
3.3 Results 
3.3.1 Complex assembly assay 
Tlg2p is unable to bind cognate SNARE partners Tlg1p and Vti1p in the absence of 
Vps45p in vivo, but a mutant version of Tlg2p lacking the N terminal Habc domain 
overcomes this inability to form complexes (Bryant and James, 2001).  This led to our 
hypothesis that Tlg2p forms a closed conformation where the Habc domain interacts with 
the SNARE motif, thus rendering the protein incompatible with complex formation.   
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Furthermore, CPY trafficking is blocked in absence of Vps45p, but this effect can be 
relieved by using a version of Tlg2p lacking the Habc domain (Bryant and James, 2001).  
This led us to propose that Vps45p facilitates a switch in the conformation of Tlg2p, thus 
allowing it to enter into functional complexes.  These observations can not exclude the 
possibility that, in the absence of Vps45p, an unidentified inhibitory factor binds to the N 
terminus of Tlg2p, restricting its ability to enter into SNARE complex in vivo (Dulubova et 
al., 2002).  To distinguish between these two models, we designed a GST pull down assay 
to examine the ability of Tlg2p to form complexes with cognate SNAREs Vti1p, Tlg1p and 
Snc2p in vitro. 
All the proteins for the GST pull down assay were produced recombinantly in E. coli.  To 
determine the effect the Tlg2p Habc domain has on complex assembly, two Tlg2p-GST 
fusion proteins were recombinantly produced.  The first expressing the entire cytosolic 
domain, residues 1 - 309, from plasmid pCMD008; the second expressing a version 
lacking the Habc domain (∆HabcTlg2p), containing residues 221 - 309, from pCMD007.  
Figure 3.1 shows samples analysed by SDS-PAGE followed by Coomassie staining from 
each step in the purification process of both Tlg2p (upper panel) and ∆HabcTlg2p (lower 
panel).  The truncated version of Tlg2p lacking the Habc domain expresses at a much 
higher concentration than the full length version, which is more susceptible to degradation 
in vitro (Carpp et al., 2006).  For this reason we used a larger culture (12 fold) of E. coli 
cells expressing full length protein; more IPTG was also used for a longer induction period 
to raise concentration of full length Tlg2p.  These adjustments resulted in similar 
concentrations of the two Tlg2p-GST fusion proteins produced.   
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Figure 3.1 GST fusion proteins of Tlg2p for complex assembly assay 
Recombinant cytosolic truncations of Tlg2p were produced as GST fusions: plasmids pCMD007 and 
pCMD008 were used to express Tlg2p residues 1 - 309 (full length; upper panel) and residues 221 - 309 
(∆HabcTlg2p; lower panel), respectively; each with a C terminal GST tag.  Full length Tlg2p-GST protein was 
expressed from a 3 L culture; cells were induced with 1 M IPTG overnight at 22oC upon reaching OD600 of 
~0.8 cells.  ∆HabcTlg2p-GST protein was expressed from a 250 ml culture; upon reaching OD600 of ~0.8, cells 
were induced with 0.2 M IPTG at 37oC for 1 hour.  Each expressed GST fusion protein was purified by 
binding to 1 ml settled Glutathione Sepharose 4B beads (GE Healthcare), as described in section 2.3.4.2.  
Purity of proteins were analysed at various stages by SDS-PAGE on a 12% gel followed by Coomassie 
staining: samples of culture before and after IPTG induction (Lanes 1 & 2; 5 µl each); soluble protein 
produced (Lane 4, upper panel; 5 µl & Lane 3, lower panel; 5 µl) compared to protein lost as insoluble (Lane 
3, upper panel; 5 µl & Lane 4, lower panel; 5 µl); protein not bound to beads (Lane 5; 5 µl).  Finally an equal 
volume 1x LSB was added to a sample of the washed  beads before boiling to analyse protein bound to beads 
by SDS-PAGE, 3 volumes were run: 1 µl, 5 µl, and 10 µl (Lanes 6 - 8; 5 µl each).  Molecular weight markers 
are indicated. 
 
 
 
Chris MacDonald, 2009  Chapter III, 97 
Next, we created versions of the Tlg2p cognate binding partners: Vti1p, Tlg1p and Snc2p.  
A chimera, containing the N terminal portion of the Sx8 SNARE motif and the C terminus 
of Tlg1p (subsequently labelled as Sx8 / Tlg1p), was chosen in place of full length Tlg1p, 
which has been shown to require additional activation to fuse liposomes in vitro (Paumet et 
al., 2005; discussed in more detail in Chapter V, sections 5.4.1.2 & 5.4.5).  We wanted to 
eliminate this additional level of regulation in order to directly test the effects of the Habc 
domain and Vps45p on complex assembly.  Figure 3.2 shows SDS-PAGE analysis of 
purified His6-Vti1p (Lanes 1 - 3), untagged Sx8 / Tlg1p (Lanes 4 - 6) and His6-Snc2p 
(Lanes 7 - 9) samples.   
Reactions were set up with 0.36 µg of either Tlg2p-GST or ∆HabcTlg2p-GST bound to 
Glutathione Sepharose 4B beads (shown in Figure 3.1).  Beads were incubated for 20 
minutes or 120 minutes in the presence or absence of a ~10 fold molar excess of the 
cognate SNARE partners shown in Figure 3.2.  The beads were then extensively washed in 
reaction buffer, and the proteins bound to the beads were analysed by SDS-PAGE and 
immunoblot analysis using an α-Snc2p antibody, shown in Figure 3.3 (A) lower panel.  
Snc2p does not bind directly to Tlg2p, but can enter into an assembled SNARE complex in 
the presence of the partner t-SNAREs Vti1p and Tlg1p (Carpp et al., 2006).  Snc2p, 
detected on the beads containing the Tlg2p fusion proteins after washing, can therefore be 
used as an indicator of assembled complexes.  Figure 3.3 (A) upper panel shows that 
approximately equal amounts of full length (Tlg2p) and truncated (∆HabcTlg2p) versions of 
Tlg2p have been used in the assay.  The lower panel shows that the version lacking the 
Habc domain (∆HabcTlg2p) forms complexes more efficiently than the full length version at 
the 20 minute time point (compare Lanes 4 & 5).  The binding reactions carried out for 120 
minutes show little difference in assembled complexes (Lanes 6 & 7).  This shows that the 
full length version of Tlg2p is equally capable of forming SNARE complexes; it is just 
doing so more slowly than the version lacking the Habc domain.  These experiments were 
carried out four times, the average ability of full length Tlg2p to form complexes compared 
with the more efficient ∆HabcTlg2p version (taken as 100%), is presented as a histogram in 
Figure 3.3 (B).  Since these experiments were performed with purified proteins produced in 
E. coli, the inhibitory effect of the Habc domain is not due to the binding of another 
unidentified factor, as suggested by Dulubova and colleagues (Dulubova et al., 2002).  
These results support our model whereby the Habc domain of Tlg2p acts to inhibit 
complex assembly.   
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Figure 3.2  Recombinant input SNARE proteins for complex assembly assay 
Plasmids pJM132 and pJM081 were respectively used to produce versions of full length Vti1p and Snc2p, 
each with an N terminal His6 tag.  Proteins were purified as described in section 2.3.4.1.  Plasmid pCMD004 
was used to produce the Sx8 / Tlg1p chimera with an N terminal GST tag, purified as described in section 
2.3.4.2.  0.04 units / µl PreScission protease was used to cleave the purified Sx8 / Tlg1p protein from beads.  
All proteins were initially analysed by SDS-PAGE followed by Coomassie staining.  Proteins were diluted to 
equal molar concentrations with reaction buffer (400mM KCl, 25 mM imidazole, 4% (w / v) Triton X-100, 5 
mM β-mercaptoethanol).  A serial dilution of each protein was then analysed on a second 15% gel: His6-
Vti1p (Lanes 1 - 3), Sx8 / Tlg1p (Lanes 4 - 6) and His6-Snc2p (Lanes 7 - 9), to ensure equal concentrations.  
Molecular weight markers are indicated. 
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Figure 3.3 In vitro SNARE complex assembly of Tlg2p and ∆HabcTlg2p 
(A) 5 µl of beads containing Tlg2p-GST fusions (shown in Figure 3.1) were incubated in the presence of a 
ten fold molar excess of the cognate SNARE proteins, His6-Vti1p, His6-Snc2p and untagged Sx8 / Tlg1p 
(shown in Figure 3.2).  Reactions were incubated at 4oC on a rotator for 20 and 120 minutes before unbound 
protein was washed from beads 3x with reaction buffer.  Beads were then boiled in 50 µl 1x LSB buffer; 10 
µl of each sample was run out on two 15% SDS-PAGE gels.  The first was Coomassie stained to show equal 
loading of Tlg2p fusions (upper panel), the second gel was transferred to a nitrocellulose membrane and then 
subjected to immunoblot analysis with an α-Snc2p antibody (lower panel).  Positions of molecular weight 
markers are indicated.  (B) The levels of Snc2p bound to full length Tlg2p-GST compared to ∆HabcTlg2p-GST 
from four experiments were analysed by densitometry using Image J software.  The average Snc2p bound to 
∆HabcTlg2p-GST was taken as 100% (grey) and compared with average Snc2p bound to full length Tlg2p-
GST (red).  The standard deviation is indicated by an error bar.   
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To test whether the addition of the SM protein Vps45p has any effect on the ability of 
Tlg2p to form complexes in our system, His6-Vps45p expressed from pNB710 (Carpp et 
al., 2006) was purified as described in section 2.3.4.1.  Figure 3.4 (A) shows purified 
Vps45p used in the complex assembly assay.  The assays were set up as described 
previously, this time also in the presence or absence of Vps45p.  Figure 3.4 (B) shows 
protein samples from beads analysed by SDS-PAGE: one gel being Coomassie stained to 
confirm that equal amounts of full length and ∆Habc Tlg2p-GST fusion proteins were used 
(upper panel); the other being transferred to a nitrocellulose membrane for immunoblot 
analysis with an α-Snc2p antibody, to determine the extent of complex formation in each 
reaction (lower panel).  Binding reactions were run for 20 minutes and proteins bound to 
beads were analysed by SDS-PAGE and immunoblot analysis.  Addition of Vps45p has no 
effect on the rate at which complexes containing truncated ∆HabcTlg2p are assembled 
(compare Lanes 1 & 3).  However, Vps45p relieves the kinetic delay of complex assembly 
observed with full length Tlg2p (Lanes 2 & 4), resulting in levels of assembly comparable 
with the version of Tlg2p lacking the Habc domain (compare Lanes 3 & 4).  These data 
suggest that the Habc domain of Tlg2p confers a negative level of regulation upon SNARE 
complex assembly in vitro, which is alleviated by Vps45p.  The simplest explanation for a 
conformation that precludes complex assembly is a “closed” conformation, previously 
observed in Tlg2p homologues Sx1a and Sso1p (Dulubova et al., 1999, Nicholson et al., 
1998).  More recently Sx16, a mammalian homologue of Tlg2p, has been proposed to also 
form a closed conformation (Burkhardt et al., 2008).  The data presented here indicate that 
like these syntaxin homologues, Tlg2p also forms a closed conformation, which regulates 
its entry into SNARE complexes.  Further to this, and in agreement with in vivo CPY 
trafficking studies (Bryant and James, 2001), a positive regulatory role for the SM protein 
Vps45p in SNARE complex assembly has been demonstrated.  These experiments were 
published, (Struthers et al., 2009; Appendix III). 
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Figure 3.4 In vitro assay to assess complex assembly in presence of Vps45p 
(A) Plasmid pNB710 was co-expressed with pT-GroE plasmid in E coli strain BL21 (DE3) to produce 
recombinant His6-Vps45p in presence of GroEL and GroES chaperone proteins, as described in section 
2.4.3.1.  Three separate dilutions of protein were analysed on a 12% SDS-PAGE gel (Lanes 1 - 3) in order to 
estimate protein concentration.  (B) The in vitro complex assembly assay was set up as described previously.  
5 µl beads containing either full length or ∆Habc versions of Tlg2p were incubated in the presence of a 10 
fold excess of the cognate SNARE partners His6-Vti1p, His6-Snc2p and untagged Sx8 / Tlg1p.  These 
reaction mixtures were incubated for 20 minutes at 4oC in the presence of absence of an 8 fold (to the cognate 
SNARE inputs) excess recombinant His6-Vps45p.  Protein was analysed, as before, by SDS-PAGE (upper 
panel) and immunoblot analysis using an α-Snc2p antibody (lower panel). 
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3.3.2 Yeast-2-hybrid assay 
I set up a yeast-2-hybrid assay, a well characterised system to evaluate protein interactions 
(McAlister-Henn et al., 1999), in attempt to demonstrate an intramolecular interaction 
between the Habc domain and the SNARE domain of Tlg2p.  The yeast-2-hybrid technique 
was developed in S. cerevisiae and is used to study protein-protein interactions (Fields and 
Song, 1989).  The assay takes advantage of the native yeast protein Gal4p, which is a 
transcriptional activator encoded by a member of the family of GAL genes, all of which 
encode enzymes required for galactose utilization (Johnston, 1987).  Gal4p is a large 
protein of 881 residues which activates transcription at specific upstream promoter DNA 
sequences of each GAL gene (Laughon and Gesteland, 1984).  A relatively short N 
terminal domain of the protein is required to actually bind the upstream activating DNA 
sequence (Keegan et al., 1986), and another domain at the distal C terminus is responsible 
for the transcriptional activation of the GAL genes (Ma and Ptashne, 1987).  In order to use 
the assay to test if two proteins interact, they are produced as fusions with the individual 
Gal4p domains responsible for DNA binding and transcriptional activation, and then 
subsequently expressed in a host yeast strain (Chien et al., 1991).  The host strain contains 
a selective auxotrophic marker exclusively under the control of a GAL promoter; if the 
proteins interact, the reconstituted Gal4p domains induce transcription of the selective 
reporter gene.  Yeast transformants capable of growth on selective media are then used to 
identify protein partners that interact.  The principles of a yeast-2-hybrid assay are outlined 
in Figure 3.5. 
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Figure 3.5 Principles of the yeast-2-hybrid assay 
A yeast-2-hybrid assay that can detect possible interactions of protein X with either protein Y or protein Z.  
Protein X is expressed as a fusion with the DNA binding domain of Gal4p (blue), and proteins Y and Z are 
expressed as fusions with the Gal4p activation domain (red) in host yeast strain (upper panel).  Protein X-BD 
fusion is co-expressed with either Y-AD (left panel) or Z-AD (right panel) fusion proteins; in each case 
protein X is localised to the upstream activating sequence (UAS) of a GAL promoter by the DNA binding 
domain.   If proteins interact, such as X and Y (left panel), the Gal4p AD is in proximity of the promoter 
sequence, which induces transcription of a downstream reporter gene (green arrow).  This reporter gene 
remains silent if proteins do not interact, as shown with X and Z (right panel).  Yeast expressing the fusion 
proteins are then grown in a selective environment to ascertain whether the reporter gene has been activated. 
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The yeast-2-hybrid parent vectors pACT2 and pGBKT7, designed by Clontech 
Laboratories Inc, were used to produce a range of constructs for the assay.  The former 
vector encodes residues 768 - 881 of the activating domain (AD) of the Gal4p protein, and 
the latter encodes residues 1 - 147 of the Gal4p DNA binding domain (BD).  The coding 
sequences of either the Habc domain or the SNARE domain of Tlg2p were incorporated 
into the multiple cloning sites following the Gal4p domains in each vector.  This allowed 
hybrid fusion proteins to be produced; fusions of each Tlg2p domain with both Gal4p 
domains were created.  The assay is based on the yeast S. cerevisiae expressing two 
fusions proteins at the same time, the first is a Gal4p AD fusion, the second a Gal4p BD 
fusion.  The plasmids encoding these fusion proteins were co-expressed in yeast strain 
AH109.  Table 3.1 outlines the 8 co-transformation reactions carried out.  Expression of 
the fusion proteins was confirmed by immunoblot analysis of all transformant cell lysates.  
Plasmids encoding an AD fusion protein also contain an influenza viral protein HA epitope 
sequence (YPYDVPDYA); Figure 3.6 shows all transformants expressing an AD fusion 
protein through expression of the HA epitope.  BD fusion plasmids contain a cMyc epitope 
sequence (EEQKLISEEDL), for easy identification of fusion protein expression.  Figure 
3.7 shows all transformants expressing a BD fusion protein.   
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1st Transformation 2nd Transformation Transformant 
          # Plasmid Expressing Plasmid Expressing 
1 pTD1-1 AD-HA-Large TAg   pGBK7-Lam  BD-myc-Lam C 
2 pTD1-1 AD-HA-Large TAg pGBKT7-53 BD-myc-p53 
3 pTD1-1 AD-HA-Large TAg pCMD020 BD-myc-Habc 
4 pTD1-1 AD-HA-Large TAg pCMD023 BD-myc-SNARE 
5 pCMD019 AD-HA-Habc pGBKT7-53 BD-myc-p53 
6 pCMD019 AD-HA-Habc pCMD023 BD-myc-SNARE 
7 pCMD022 AD-HA-SNARE pGBKT7-53 BD-myc-p53 
8 pCMD022 AD-HA-SNARE pCMD020 BD-myc-Habc 
Table 3.1 Table of transformants for yeast-2-hybrid assay 
The S. cerevisiae host strain AH109 was co-transformed with various combinations of Gal4p activating 
domain (AD) and DNA binding domain (BD) containing plasmids for the yeast-2-hybrid assay.  The genetic 
sequence for both the Habc (residues 37 - 192) and the SNARE (residues 221 - 318) domains of Tlg2p were 
incorporated into both pACT2 and pGBKT7 to give fusions of each domain with either an activating or 
binding domain. The SNARE domain AD and BD fusions were co-transformed with Habc AD and BD 
fusions (transformants 16 & 18).  Transformant 2 is an internal positive control containing plasmids encoding 
two proteins known to interact as fusions with the functional Gal4p domains. The other combinations are 
controls to ensure random components of the assay do not give positive reporter gene activation.  
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Figure 3.6 Expression of yeast-2-hybrid Gal4p AD fusion proteins 
S. cerevisiae strain AH109 was co-transformed with plasmids encoding the Gal4p activating domain (AD; 
red) with our proteins of interest or control proteins (see Table 3.1), preceded by an HA tag.  Equal number 
of cells from each transformant, equivalent to 10x OD600, were resuspended in 100 µl 2x Laemmli sample 
buffer containing 8 M urea, then heated at 65oC for 10 minutes.  10 µl of each sample was separated by SDS-
PAGE on a 12% gel, transferred to a nitrocellulose membrane and then subjected to immunoblot analysis to 
detect the fusion proteins using an α-HA antibody.  (A) Upper panel shows transformants containing pTD1-1 
(Clontech Laboratories Inc), used to express AD-SV40 large T antigen (residues 87 - 708) AD fusion protein 
of predicted molecular weight 83.3 kDa (Lanes 1 - 4).  (B) Upper panel shows transformants containing 
plasmids pCMD022 and pCMD019, respectively expressing AD-SNARE, of predicted molecular weight 
24.7 kDa; and AD-Habc, of predicted molecular weight of 31.2 kDa.  Membranes were stripped and re-
probed with an α-Pgk1p antibody to detect levels of the 44.7 kDa cytosolic enzyme, 3-phosphoglycerate 
kinase (Watson et al., 1982), as a loading control, shown in lower panels.  The relative transformants from 
Table 3.1 are shown in the gray coloured boxes above each loading control.  Molecular weight markers are 
indicated. 
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Figure 3.7 Expression of yeast-2-hybrid Gal4p BD fusion proteins 
S. cerevisiae strain AH109 was co-transformed with plasmids encoding the Gal4p binding domain (BD; blue) 
fusions with our proteins of interest or control proteins (see Table 3.1), preceded by a cMyc tag.  Equal 
number of cells from each transformant, equivalent to 10x OD600, were resuspended in 100 µl 2x Laemmli 
sample buffer containing 8 M urea, and then heated at 65oC for 10 minutes. 10 µl of each sample was 
separated by SDS-PAGE on a 12% gel, transferred to a nitrocellulose membrane and then subjected to 
immunoblot analysis to detect the fusion proteins using an α-cMyc antibody.  Upper panel shows 
transformants containing plasmids pGBKT7-Lam C, pGBKT7-53, pCMD023 and pCMD020, respectively 
used to express BD fusions of: human lamin C (residues 66 - 230), predicted molecular weight 35.7 kDa 
(Lane 1); p53 (residues 72 - 390), predicted molecular weight 52.8 kDa (Lanes 2, 5 & 7); Tlg2p SNARE 
domain (residues 221 - 318), predicted molecular weight 28.2 kDa (Lanes 4 & 6); and Tlg2p Habc domain 
(residues 37 - 192), predicted molecular weight 34.7 kDa (Lanes 3 & 8).  Membranes were stripped and re-
probed with an α-Pgk1p antibody to detect levels of the 44.7 kDa cytosolic enzyme, 3-phosphoglycerate 
kinase (Watson et al., 1982), as a loading control, shown in lower panel.  The relative transformants from 
Table 3.1 are shown in the gray coloured box above the loading control.  Molecular weight markers are 
indicated. 
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One important genotypic feature of strain AH109, which is a derivative of PJ69-2A (James 
et al., 1996), is that yeast cells cannot synthesise the amino acids leucine (leu) and 
tryptophan (trp); due to mutations in the LEU2 (leu2-3, 112) and TRP1 (trp1-901) genes, 
respectively.  Successful transformants were identified by complementation of these 
auxotrophic markers.  Transformants containing plasmids derived from pACT2 and 
pGBKT7 have the ability to grow on leucine and tryptophan synthetic drop out plates (as 
they carry the LEU2 and TRP1 auxotrophic markers, respectively).  Transformants 
harbouring plasmids for both AD and BD fusion proteins can grow on media lacking both 
these amino acids (SD -leu, -trp).  Figure 3.8 (A) shows each transformant streaked out on  
-leu, -trp plates.  Figure 3.8 (B) shows the same transformants streaked out on plates also 
lacking histidine (SD -leu, -trp, -his).  Interaction of the fusion proteins brings the two 
Gal4p domains into close proximity and triggers activation of the GAL1 regulated histidine 
reporter gene (HIS3).  Yeast capable of growing on histidine deficient plates (B) display 
intact Gal4p transcriptional activity, due to the BD fusion protein localising to the GAL1 
upstream activating sequence and interacting with the AD fusion protein, which 
subsequently triggers transcription of the gene.  The positive control interaction between 
p53 and the SV40 large T antigen results in successful yeast growth on plates lacking 
histidine (transformant 2).  The combination of BD-SNARE and AD-Habc did give 
activation of the histidine reporter gene (transformant 16), but unfortunately the BD-
SNARE fusion also resulted in a positive reporter signal when co-expressed with the SV40 
large T antigen (transformant 14).  Taken together with the fact that absolutely no growth 
is detected with the opposite combination of AD-SNARE and BD-Habc on histidine 
lacking plates (transformant 18), we assume that the assay is not sensitive enough to detect 
an interaction between the domains, or that additional residues are necessary to stabilise an 
intramolecular Tlg2p interaction.  It is worth noting that the effective concentrations of the 
two domains in vivo, where they exist on the same polypeptide, are considerably higher 
than we could create in the yeast-2-hybrid system. 
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Figure 3.8 Yeast-2-hybrid assay 
A single colony of each transformant (Table 3.1) was incubated in 10 ml liquid media lacking amino acids 
leucine and tryptophan (SD -leu, -trp) overnight at 30oC.  Cells were then diluted to 0.2 OD600 in fresh SD      
-leu, -trp media and grown to mid log phase at 30oC.  An equivalent volume of 1 ml cells at 0.8 OD600 were 
harvested by centrifugation at 1,000 g in a table top centrifuge.  Cells were then resuspended in 1 ml dH2O; 
10 µl of each culture was then streaked out on selective plates lacking leucine and tryptophan (upper panel) 
and onto plates lacking leucine, tryptophan and histidine (lower panel).  All plates were then incubated at 
30oC and yeast growth was recorded after 5 days.  Transformants relative to Table 3.1 are labelled on plates 
in white. Plates are representative of three individual co-transformation reactions. 
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3.3.3 Carboxypeptidase Y trafficking assay 
The trafficking of newly synthesised CPY through the ER and Golgi to the vacuole is a 
well characterised biosynthetic pathway (Stevens et al., 1982).  CPY is synthesised with a 
signal peptide that directs its translocation to the ER before cleavage, leaving a core 
glycosylated 67 kDa precursor protein (p1CPY) remaining (Hasilik and Tanner, 1978).  
p1CPY is modified by oligosaccharide trimming and addition as it traverses the Golgi, 
resulting in a 69 kDa p2CPY precursor of the active enzyme (Stevens et al., 1982, Trimble 
et al., 1983).  p2CPY is then transported to the vacuole where it is cleaved by resident 
proteases to give the mature active 61 kDa enzyme, mCPY (Hasilik and Tanner, 1978).  
Perturbation of trafficking through the endosomal system results in the missorting of CPY 
and the subsequent secretion of p2CPY into the extracellular media (Rothman and Stevens, 
1986).  The CPY pathway, and the missorting of CPY in vps mutants, is outlined in Figure 
3.9 (A). 
Deletion of either Vps45p or Tlg2p in yeast cells results in an obvious CPY secretion 
phenotype (Abeliovich et al., 1998, Cowles et al., 1994, Piper et al., 1994).  However, it 
has been previously shown that abrogation of mode 2 binding between the hydrophobic 
pocket of Vps45p and the N terminal peptide of Tlg2p does not perturb the trafficking of 
CPY (Carpp et al., 2006), so we hypothesised that another binding mode between Tlg2p 
and Vps45p may be required for CPY sorting.  As described earlier in this Chapter, a 
closed conformation would explain why full length Tlg2p can form SNARE complexes 
less readily than a version lacking the Habc domain in vitro, until Vps45p is added to 
relieve the kinetic delay.  The yeast-2-hybrid analysis of the Habc and SNARE domains 
alone did not reveal a closed conformation, so we sought an in vivo approach to test this 
hypothesis. 
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Figure 3.9 The CPY pathway & principles of the CPY-invertase secretion assay 
(A) The CPY pathway is shown by the black arrows.  The inactive enzyme precursor of CPY is synthesised 
in the nucleus.  The N terminal portion of CPY, that is sufficient for the correct trafficking of the vacuolar 
hydrolyase through the pathway, is shown in dark blue.  CPY is translocated into the endoplasmic reticulum 
(ER), where is modified to a 67 kDa p1CPY version (shown in light blue).  p1CPY is then trafficked through 
the Golgi, where further post translational modifications generate the 69 kDa p2CPY (shown in red).  p2CPY 
is then transported through the endosomal system to the vacuole, where it is cleaved to its final 61 kDa 
mature form, mCPY (shown in green).  If trafficking in the endosomal system is perturbed by mutation of a 
key component in the pathway (vps mutants), cells secrete the p2CPY version (shown by the grey arrow).  
(B) The CPY-invertase secretion assay utilises a fusion containing the N terminal portion of CPY responsible 
for correct sorting of CPY (shown in dark blue) and the active element of the enzyme invertase (shown in 
pink); which is expressed in an S. cerevisiae that cannot synthesise native invertase.  The substrate sucrose is 
used to identify the enzymatic activity of invertase.  Total invertase activity is compared with activity 
exclusively in the extracellular fluid.  Enzymatic activity of invertase in extracellular fluid is representative of 
a trafficking defect that has caused the CPY-invertase fusion protein to be missorted. 
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Sx1a is the best characterised example of a SNARE protein in a closed conformation 
(Dulubova et al., 1999).  The isoleucine 233 residue of the SNARE domain of Sx1a is 
known to contact with the central cavity of Munc18a (Misura et al., 2000).  Mutation of the 
analogous isoleucine residue to alanine (I236A) of Sx1a in D. melanogaster was shown to 
abolish affinity to its cognate SM protein, ROP (Wu et al., 1999).  This mutation is thought 
to disrupt the closed conformation, thereby disallowing interaction with SM protein via 
mode-1 binding (Misura et al., 2000).  ITC affinity calculations of mammalian Sx1a 
containing the isoleucine 233 to alanine (I233A) mutant dramatically reduce affinity to 
Munc18a (Burkhardt et al., 2008).  The analogous mutation in Tlg2p, I285A, was created 
in order to investigate further the hypothesis that Tlg2p can form a closed conformation 
akin to that of Sx1a (Dulubova et al., 1999) in vivo.  For this purpose Tlg2pI285A, along 
with a mutant version unable to bind Vps45p via mode-2 binding (Tlg2pF9A/L10A) and a 
version carrying all three mutations (Tlg2pF9A/L10A/I285A) were created in a yeast expression 
vector, each with an N terminal HA tag.  To test if these mutant versions of Tlg2p 
expressed in place of the wild-type protein in vivo resulted in any observable phenotype, a 
CPY-invertase assay was used (Darsow et al., 2000).   
This assay uses a fusion of CPY and invertase, taking advantage of the cell’s ability to 
correctly traffic the vacuolar hydrolase CPY and using invertase enzymatic activity to 
quantify any trafficking defects (Darsow et al., 2000).  If the CPY pathway is perturbed by 
genetic mutation of a gene required for trafficking, (vps mutants; discussed in section  
1.7.1 ), CPY is secreted from the cell as the precursor p2CPY (Bowers and Stevens, 2005).  
In cells lacking Tlg2p, (tlg2∆), about 20% of the total CPY synthesised is secreted as the 
p2CPY precursor (Abeliovich et al., 1998).  The basis of the assay, described by Darsow 
and colleagues (Darsow et al., 2000), is to replace endogenous invertase with a fusion 
protein containing the active element of invertase and the N terminal portion of CPY 
containing the information that targets the protein to the vacuole (Johnson et al., 1987).  
The enzymatic activity of invertase is measured as a total fraction and compared to that of 
the invertase secreted through its association with the CPY signal peptide.  The basis of the 
assay is outlined in Figure 3.9 (B).  The enzymatic hydrolysis of sucrose by invertase 
results in the production of glucose, which is then oxidised by glucose oxidase.  A by-
product of this reaction is H2O2, which can be used by peroxidase to oxidise o-dianisidine 
resulting in a precipitate; absorbance of solution containing precipitate at A540 can be 
indirectly used to quantitatively assess extent of invertase activity (Darsow et al., 2000).  
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Figure 3.10 (A) shows SDS-PAGE analysis of yeast cell lysates from tlg2∆ strain SGSY2 
expressing the relevant plasmids for wild-type Tlg2p and the mutants described above.  An 
equal number of cells from each transformant were then used in the CPY-invertase assay 
as described in methods section 2.6; this experiment was performed in collaboration with 
Dr. Scott Shanks.  The average invertase activity of each transformant from four separate 
experiments is presented in Figure 3.10 (B) as a histogram.  From this we observe a basal 
level of ~5% CPY-invertase secretion from wild-type cells (Lane 1), which is increased to 
~25% when secretion is measured in a strain lacking Tlg2p (Lane 2).  This is in accordance 
with previously reported levels of CPY secretion in tlg2∆ cells being ~ 20% (Abeliovich et 
al., 1998).  Reintroduction of Tlg2p expressed from plasmid pHA-Tlg2p (Seron et al., 
1998) in tlg2∆ cells rescues the CPY-invertase secretion phenotype, with secretion of the 
CPY-invertase fusion reduced to ~10% (Lane 3).  The rescued phenotype of ~10% CPY-
invertase secretion by expression of wild-type Tlg2p in the tlg2∆ strain is also observed by 
introduction of mutant versions of Tlg2p.  Introduction of mutant versions of Tlg2p 
harbouring either the I285A mutation (abrogated mode-1 binding) or the F9A/L10A 
mutation (abrogated mode-2 binding) into the assay results in the same levels of secretion 
as observed with wild-type (compare Lanes 3 with 4 & 5), this suggests that either binding 
mode is sufficient for Tlg2p function.  It is unsurprising that the F9A/L10A mutant of 
Tlg2p, that abrogates binding via mode-2, does not block CPY-invertase trafficking, as 
previous experiments have demonstrated CPY could still be correctly trafficked in cells 
expressing a version of Vps45p incapable of interacting with Tlg2p via mode-2 binding 
(Carpp et al., 2006).  Interestingly, when the triple mutant version of Tlg2p 
(F9A/L10A/I285A), which cannot bind to Vps45p via mode-1 or mode-2, is expressed in 
tlg2∆ cells, CPY is secreted at levels comparable with the tlg2∆ strain alone (Lane 5).  This 
suggests that Tlg2p can facilitate trafficking to the vacuole by binding to Vps45p by either 
mode-1 or mode-2, but cannot function if both binding modes are perturbed.  These 
experiments were published, (Furgason et al., 2009; appendix III). 
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Figure 3.10 Carboxypeptidase Y- invertase trafficking assay 
Wild-type (BHY10) and tlg2∆ (SGSY2) S. cerevisiae strains were used to express a fusion protein containing 
the first 50 amino acids of CPY and residues 3 - 512 of mature invertase.  Both these strains lack endogenous 
invertase.  (A) The tlg2∆ strain was transformed with the following plasmids: pHA-TLG2 to express wild-
type HA-tagged Tlg2p; pCMD013, pCOG066 and pCMD011 to respectively express mutant HA-tagged 
versions Tlg2pI285A, Tlg2pF9A/L10A and Tlg2pI285A/F9A/L10A.  Protein expression was checked by SDS-PAGE 
analysis of yeast cell lysates followed by immunoblot analysis using an α-Tlg2p antibody (upper panel).  As 
a loading control, membranes were stripped and re-probed with an α-Pgk1p antibody (lower panel).  (B) 
Equal numbers of cells were collected from each transformant / strain, topped up to 400 µl with sodium 
acetate buffer.  Each sample was split into two aliquots, one of which was treated with 5 µl Triton X-100 to 
lyse the cells.  50 µl 0.5 M sucrose solution was then added to each sample and incubated at 30oC for 30 
minutes.  300 µl 0.2 M K2PO4 pH 10.0 was added to each sample before boiling for 3 minutes in a water 
bath.  Tubes were then chilled on ice before addition of glucostat reagent (3.5 mM K2HPO4, 80 units / ml 
glucose oxidase, 100 µg / ml Horse radish Peroxidase, 4 mM NEM, 6 mg / ml o-dianisidine), and a further 
incubation at 30oC for 30 minutes.  Reactions were then stopped by addition of 2 ml 6 N HCl.  The 
absorbance at A540 was then measured and lysed samples used to represent total cellular invertase activity, 
and unlysed samples to show secreted invertase activity.  This experiment was performed by Dr. Scott 
Shanks. 
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3.4 Chapter summary 
Using recombinantly produced SNARE proteins from the yeast endosomal system we have 
shown that a version of Tlg2p lacking the Habc domain forms SNARE complexes more 
readily than full length Tlg2p.  Furthermore, we have demonstrated that the kinetic delay 
on complex assembly experienced by full length Tlg2p in vitro can be relieved by addition 
of recombinant Vps45p.  This is in agreement with previous in vivo data suggesting 
Vps45p facilitates a conformational change in Tlg2p to accommodate SNARE complex 
assembly (Bryant and James, 2001).  Also, as these experiments were performed in vitro 
with purified proteins, we have excluded the possibility that the inhibitory effect of full 
length Tlg2p is not via an unidentified factor in yeast (Dulubova et al., 2002).  To test 
whether Tlg2p could form a closed conformation that prohibits complex formation, akin to 
that of Sx1a (Dulubova et al., 1999), we used two different approaches.  The first was a 
yeast-2-hybrid assay, used in attempt to detect a Tlg2p intramolecular interaction.  This 
was done by expressing the Habc and SNARE domains separately as Gal4p fusion 
proteins, and using their ability to reconstitute the transcriptional machinery of a reporter 
gene to signify an interaction.  This assay was inconclusive as although a positive 
interaction was detected between the Habc and SNARE domains of Tlg2p, there was also 
reporter gene activation in a control transformant.  It is possible that the yeast-2-hybrid 
technique is not sensitive enough to detect such an intramolecular interaction, or that the 
constructs we used did not have essential residues beyond the two domains that are 
necessary to stabilise an interaction.  The second approach we used to investigate a closed 
conformation of Tlg2p was an in vivo assay to determine the ability of wild-type and 
mutant versions of Tlg2p to traffic a CPY-invertase fusion protein.  To this assay we 
introduced mutant versions of Tlg2p abrogated in mode-1, mode-2 and both binding 
modes.  The basis of this assay is that sorting defects cause the reporter fusion protein to be 
secreted.  Extracellular invertase activity was compared to total activity, revealing the 
extent of CPY-invertase secretion in the various transformants.  In a tlg2∆ strain, secretion 
of the reporter protein was elevated to ~25%.  This phenotype could be rescued by addition 
of an HA-tagged version of wild-type Tlg2p, which reduced secretion to ~10%; these 
levels are similar to a wild-type strain used as a control.  Introduction of Tlg2pF9A/L10A, a 
mutant known to abrogate mode-2 binding, resulted in no effect on this reduced CPY-
invertase secretion of ~10%.  The same levels were again observed when Tlg2pI285A, a 
mutant analogous to a Sx1a mutant incapable of binding Munc18a via mode-1 binding, 
was expressed in the tlg2∆ background.  This suggests that abrogation of either mode-1 or 
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mode-2 binding of Vps45p does not result in a trafficking defect.  Interestingly, when the 
triple mutant Tlg2pF9A/L10A/I285A was introduced into the tlg2∆ strain, the CPY-invertase 
secretion was elevated to ~25%, resembling levels of secretion observed in the tlg2∆ strain 
alone.  This suggests that Vps45p can bind Tlg2p in a closed conformation, in a manner 
analogous to Sx1a, and that either this mode of binding or mode-2 binding is sufficient to 
facilitate proper trafficking through the cell.  However, abrogation by mutation of both 
binding modes results in complete loss of Tlg2p function. 
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4.1 Introduction 
Initial studies of SM proteins indicated that their regulatory role was carried out through 
interaction with the cognate syntaxin (Peng, 2005).  The yeast syntaxin Sed5p, which 
regulates ER-Golgi (Hardwick and Pelham, 1992) and intra-Golgi (Holthuis et al., 1998) 
trafficking, binds its cognate SM protein Sly1p through the first identified example of  
mode-2 binding, through a short N terminal peptide of Sed5p (Yamaguchi et al., 2002).   
X-ray crystallography studies on Sly1p in complex with the N terminal peptide of Sed5p 
revealed that Sly1p has an arch shaped structure similar to that of Munc18a, but the central 
cavity plays no role in binding the Sed5p peptide (Bracher and Weissenhorn, 2002).  This 
is in stark contrast to mode-1 binding where the SM protein Munc18a cradles the closed 
conformation of Sx1a in this cavity (Misura et al., 2000).  Instead, for mode-2 binding, as 
defined by the Sly1p / Sed5p crystal structure, a small hydrophobic pocket on the exterior 
of domain I of Sly1p forms the sole point of interaction with the Sed5p N terminal peptide 
(Bracher and Weissenhorn, 2002).   
Further studies on Sly1p revealed its capacity to bind non-syntaxin SNARE proteins: GST 
pulldown experiments were used to demonstrate that Sly1p could interact with the R-
SNAREs Bet1p and Sft1p, as well as the non-syntaxin Q-SNAREs Bos1p and Gos1p 
(Peng and Gallwitz, 2004).  The finding that SM proteins have the capacity to bind non-
syntaxin SNARE proteins adds a new dimension to the unresolved issue of explaining SM 
protein function in membrane fusion.  Like Sly1p, the syntaxin responsible for trafficking 
through the yeast TGN / endosomal system, Tlg2p, also binds its cognate SM protein 
Vps45p via a mode-2 interaction (Carpp et al., 2006, Dulubova et al., 2002).  Tlg2p forms 
a functional SNARE complex with Vti1p, Tlg1p and the v-SNARE Snc2p (Bryant and 
James, 2001, Paumet et al., 2001).  Investigations into the interaction of Vps45p with these 
non-syntaxin SNARE proteins revealed that recombinantly produced His6 tagged Vps45p 
binds specifically to the cytosolic domain of Snc2p, but no interaction was detected 
between Vps45p and either Vti1p or Tlg1p (Carpp et al., 2006).  Furthermore, the short N 
terminal domain of Snc2p preceding the SNARE domain is not required for its binding to 
Vps45p since a version lacking the N terminal peptide (Snc2p∆1-19) can be pulled down by 
Vps45p in a manner comparable to full length Snc2p; thus Vps45p binds directly to the 
SNARE motif of Snc2p (Carpp et al., 2006).  These studies also demonstrated that Snc2p 
bound to Vps45p can be displaced by Tlg2p, but Snc2p cannot displace Tlg2p bound to 
Vps45p, even at high concentrations (Carpp et al., 2006).  Very little is known about the 
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mechanism by which SM proteins interact with non-syntaxin SNAREs, and the functional 
relevance of these interactions remains to be elucidated. 
 
4.2 Aims of this Chapter 
The initial aim of this Chapter was to further study the interaction originally described 
between the SM protein Vps45p and the v-SNARE Snc2p (Carpp et al., 2006).  I first set 
out to use a yeast-2-hybrid assay to confirm an interaction between Vps45p and Snc2p.  
The second approach used to confirm that Vps45p can form a complex with Snc2p was the 
more quantitative electrophoretic mobility shift assay (EMSA), which separates unbound 
protein from species in complex through a gel.  Finally, we wanted to further investigate 
the capabilities of Tlg2p to displace Snc2p in complex with Vps45p. 
 
4.3 Results 
4.3.1 Yeast-2-hybrid assay 
The principles behind the yeast-2-hybrid technique are discussed in detail in section 3.3.2 
and outlined in Figure 3.5.  The yeast-2-hybrid parent vectors pACT2 and pGBKT7 
(Clontech Laboratories Inc), were utilised to produce the necessary constructs and controls 
to test for an interaction between Vps45p and Snc2p.  In addition to confirming a protein-
protein interaction between Snc2p and Vps45p, we wanted to design a reverse-2-hybrid 
screen (Vidal et al., 1996a) which could then be used to identify mutant versions of 
Vps45p that are unable to bind Snc2p, thereby allowing us to map residues involved with 
the interaction.  To eliminate Vps45p mutants in the reverse screen that do not bind Snc2p 
due to the introduction of a premature stop codon, we created a construct containing a 
green fluorescent protein (GFP) sequence directly after the VPS45 gene.  The GFP 
sequence encodes a 26.9 kDa protein originally identified in the jellyfish Aequorea 
Victoria (Prasher et al., 1992), which can be used to detect gene expression and protein 
location in living organisms (Chalfie et al., 1994).  A version of GFP containing a single 
residue mutation, serine 65 to threonine (GFPS65T), was used; this mutation results in 
increased fluorescence and photostability (Heim et al., 1995).  Detection of the GFPS65T tag 
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would confirm that any mutant versions of Vps45p identified in the reverse screen were 
full length.  For this reason AD and BD fusions of Vps45p containing a C terminal 
GFPS65T tag were created during the course of this study (see Table 4.1). 
 
 
1st Transformation 2nd Transformation Transformant 
          # Plasmid Expressing Plasmid Expressing 
1 pTD1-1 AD-HA-Large TAg   pGBK7-Lam  BD-myc-Lam C 
2 pTD1-1 AD-HA-Large TAg pGBKT7-53 BD-myc-p53 
3 pTD1-1 AD-HA-Large TAg pCOG080 BD-myc-Snc2p 
4 pTD1-1 AD-HA-Large TAg pCOG082 BD-myc-Vps45p 
5 pTD1-1 AD-HA-Large TAg pCMD016 BD-myc-Vps45p-GFP 
6 pCOG079 AD-HA-Snc2p pGBKT7-53 BD-myc-p53 
7 pCOG079 AD-HA-Snc2p pCOG082 BD-myc-Vps45p 
8 pCOG079 AD-HA-Snc2p pCMD016 BD-myc-Vps45p-GFP 
9 pCOG81 AD-HA-Vps45p pGBKT7-53 BD-myc-p53 
10 pCOG081 AD-HA-Vps45p pCOG080 BD-myc-Snc2p 
11 pCMD017 AD-HA-Vps45p-GFP pGBKT7-53 BD-myc-p53 
12 pCMD017 AD-HA-Vps45p-GFP pCOG080 BD-myc-Snc2p 
Table 4.1 Transformations of Saccharomyces cerevisiae strain AH109 
The S. cerevisiae host strain AH109 was co-transformed with various combinations of Gal4p activating 
domain (AD) and DNA binding domain (BD) containing plasmids for the yeast-2-hybrid assay.  There are 4 
possible combinations for Snc2p expression with either Vps45p or a version containing a C terminal GFPS65T 
tag (transformants 7, 8, 10 & 12).  Transformant 2 is an internal positive control containing plasmids 
encoding two proteins known to interact as fusions with the functional Gal4p domains. The other 7 
combinations are controls to ensure non-specific binding events are not responsible for any positive assay 
results.  
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4.3.1.1 Expression of Gal4p AD fusion proteins 
The genetic sequences encoding the cytosolic domain of Snc2p and full length Vps45p 
were incorporated into the pACT2 vector (Clontech Laboratories Inc) before 
transformation into S. cerevisiae yeast strain AH109.  A third construct was designed to 
place sequence encoding the GFPS65T protein in frame at the C terminus of Vps45p, as 
discussed above.  Expression of all fusion proteins in yeast was regulated by the ADH1 
promoter.  The pACT2 vector also contains an influenza viral protein HA epitope sequence 
(YPYDVPDYA) which was used to check the expression of each fusion using an α-HA 
antibody.  Figure 4.1 shows yeast cell lysates of transformants expressing: (A) AD-HA-
Snc2p; (B) AD-HA-Vps45p and the fluorescently tagged version, AD-HA-Vps45p-
GFPS65T; (C) an AD-HA fusion with the Simian virus 40 (SV40) large T antigen (TAg), 
was included as an internal positive control for the assay. 
 
4.3.1.2 Expression of Gal4p BD fusion proteins   
The complimentary vector pGBKT7 (Clontech Laboratories Inc) containing the sequence 
for the Gal4p binding domain (BD) was used to create constructs containing cytosolic 
SNC2 and full length VPS45 genetic sequences.  As with the pACT2 cloning procedure, we 
created a construct that incorporates the GFPS65T sequence at the 3’ end of the VPS45 gene.  
Expression of all BD-containing fusion proteins was again regulated by the ADH1 
promoter.  To allow easy detection of the expressed fusions, the pGBKT7 parent vector 
contains a c-myc proto-oncogene sequence, which encodes an epitope from the cMyc 
transcription factor (EEQKLISEEDL), at the N terminus of the protein encoded by the 
inserted gene.  Figure 4.2 shows yeast cell lysates of all transformants containing BD-
fusions that have been resolved by SDS-PAGE and subjected to immunoblot analysis to 
detect the cMyc peptide. Figure 4.2 (A) shows Snc2p and control BD fusion proteins.  The 
BD-p53 fusion protein is a positive control as it interacts with the AD-SV40 large T 
antigen (Tag).  The BD-lam C fusion protein is used as a negative control, as it does not 
bind to the SV40 large TAg.  Figure 4.2 (B) shows BD-Vps45p and BD-Vps45p-GFPS65T 
fusion proteins being expressed. 
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Figure 4.1 Expression of AD fusion proteins in yeast strain AH109 
S. cerevisiae strain AH109 was transformed with plasmids encoding the Gal4p activating domain (AD) 
fusion harbouring our proteins of interest or controls (see Table 4.1), preceded by an HA tag.  Equal number 
of cells equivalent to 10x OD600 were resuspended in 100 µl 2x Laemmli sample buffer containing 8 M urea, 
then heated at 65oC for 10 minutes. 10 µl of each sample was separated by SDS-PAGE ((A) 7.5%, (B) & (C) 
10% gels), transferred to a nitrocellulose membrane then subjected to immunoblot analysis to detect the 
fusion proteins using an α-HA antibody.  (A) Transformants containing pCOG079 were used to express AD-
Snc2p at molecular weight 26.8 kDa (upper panel, Lanes 1-3).  (B) Upper panel shows transformants 
containing plasmids pCOG081 and pCMD017, respectively expressing AD-Vps45p of predicted molecular 
weight 78.1 kDa (Lanes 1 & 2) and a GFPS65T tagged version AD-Vps45p-GFPS65T of predicted molecular 
weight 104.6 kDa (Lanes 3 & 4).  Membranes were stripped and re-probed with an α-Pgk1p antibody ((A) & 
(B) lower panels) to detect levels of the 44.7 kDa cytosolic enzyme, 3-phosphoglycerate kinase (Watson et 
al., 1982), as a loading control.  (C) Transformants containing positive control plasmid pTD1-1 (Clontech 
Laboratories Inc) was used to express AD-SV40 large T antigen (residues 87 - 708) fusion protein of 
predicted molecular weight 83.3 kDa (upper panel, Lanes 1 - 5).  The membrane was then stripped and re-
probed using an α-Vph1p antibody as a loading control showing expression of the 95.5 kDa vacuolar integral 
membrane protein Vph1p (Manolson et al., 1992) (lower panel).  The relative transformants from Table 4.1 
are shown in the gray coloured boxes above each loading control.  Molecular weight markers are indicated. 
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Figure 4.2 Expression of BD fusion proteins in yeast strain AH109 
Strain AH109 harbouring an AD fusion plasmids were subsequently transformed with plasmids encoding the 
Gal4p BD fusion protein preceded by a cMyc epitope tag.  An equal number of cells equivalent to 10x OD600 
were resuspended in 100 µl 2x LSB containing 8 M urea, then heated at 65oC for 10 minutes.  10 µl of each 
sample was resolved on (A) 12%, (B) 10% gels by SDS-PAGE, before gels were transferred to a 
nitrocellulose membrane and immunoblot analysis with an α-cMyc antibody.  (A) Control plasmids 
pGBKT7-Lam C and pGBKT7-53 were respectively used to express BD fusions of human lamin C (residues 
66 - 230), predicted molecular weight 35.7 kDa (Lane 1) and p53 (residues 72 - 390), predicted molecular 
weight 52.8 kDa (Lanes 2,4,5 & 7).  Yeast expressing pCOG080 produced BD-Snc2p fusion protein of 
predicted molecular weight 30.3 kDa (Lanes 3,6 & 8).  (B) Transformants containing plasmids pCOG082 and 
pCMD016 produced proteins of 81.6 and 108.1 kDa, respectively representing BD-Vps45p and BD-Vps45p-
GFPS65T fusions.  Membranes from (A) & (B) were stripped and re-probed with an α-Pgk1p antibody, 
showing expression of Pgk1p at 45.7 kDa as a loading control.  The relative transformants from Table 4.1 are 
shown in the gray coloured boxes above each loading control.  Molecular weight markers are indicated. 
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4.3.1.3 Yeast-2-hybrid assay in strain AH109 
The various transformations (outlined in Table 4.1) were carried out in the S. cerevisiae 
strain AH109.  As described in Chapter III, the yeast strain AH109 has mutations that 
prevent it from growing in media lacking the amino acids leucine, tryptophan and 
histidine.  This characteristic was used to isolate successful transformations that contain 
AD and BD fusion plasmids, conferring ability to grow on media lacking leucine and 
tryptophan respectively.  Figure 4.3, upper panel shows that the 12 double transformations 
required have been successful, as demonstrated by their ability to grow on the leucine and 
tryptophan deficient selective media (SD -leu-trp), even at 1/10 and 1/100 dilution. 
Strain AH109 is incapable of producing histidine, due to the his3-200 mutation in the HIS3 
gene, and therefore will not grow in media lacking this amino acid (-his).  The strain does 
however have a functional histidine (HIS3) reporter gene under the control of the GAL1 
promoter, which is the basis for the assay.  Transformants grown on SD -leu -trp media 
above were also spotted out in serial dilution on SD -leu -trp -his selective plates.  Growth 
on these plates demonstrates that the expressed fusion proteins interact, thus reconstituting 
the functional Gal4p transcriptional machinery at the upstream activating sequence of the 
GAL1 promoter, resulting in activation of the histidine reporter gene.  Figure 4.3, lower 
panel shows the transformants ability to grow on SD -leu -trp -his selective media.  
Transformant 2 (Lane 2), containing positive control fusions of AD-SV40 and BD-p53 
shows growth at all dilutions, reflecting the strong interaction of the fusions triggering 
activation of the reporter gene.  None of the negative control transformants show any 
growth on histidine selective plates (Lanes 1, 3, 4, 5, 6, 9 & 11), showing that non-specific 
binding between our proteins of interest and the other components of the assay are not 
responsible for activation of the histidine reporter gene.  Vps45p and Snc2p can be seen to 
interact with each other regardless of which Gal4p domain they are produced as fusions 
with (Lanes 7 & 10).  The addition of a C terminal GFPS65T tag to Vps45p appears to 
reduce the efficiency of the interaction somewhat (compare Lane 7 with 8 & 10 with 12), 
but a level of reporter gene activation is detectable, suggesting this would be a viable 
system to use in a reverse screen for mutant versions of Vps45p that do not interact with 
Snc2p. 
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Figure 4.3 Yeast-2-hybrid assay 
A single colony of each transformant (Table 4.1) was incubated in 10 ml liquid SD minimal media lacking 
amino acids leucine and tryptophan (SD -leu, -trp) overnight at 30oC.  Cells were then diluted to 0.2 OD600 in 
fresh SD -leu, -trp media and grown up to mid log phase at 30oC.  An equivalent volume of 1 ml cells at 0.8 
OD600 were harvested by centrifugation at 1,000 g in a table top centrifuge.  Cells were then resuspended in 1 
ml dH2O and a ten-fold serial dilution was created.  5 µl of each dilution was then spotted out onto selective 
plates lacking leucine and tryptophan (upper panels) and onto plates lacking leucine, tryptophan and histidine 
(lower panels).  All plates were then incubated at 30oC and yeast growth was recorded after 5 days.  Plates 
are representative of three individual co-transformation reactions, each spotted multiple times on selective 
plates. 
 
4.3.1.4 Expression of C terminal GFPS65T tag 
The results presented in Figure 4.3 demonstrate that a version of Vps45p containing a 
GFPS65T tag at the C terminus is capable of interacting with Snc2p, as detected by the 
yeast-2-hybrid technique.  To check that this version of Vps45p expresses the fluorescent 
tag, all transformants containing the C terminal GFPS65T sequence were grown to mid-log 
phase before being fixed and imaged under a microscope.  Figure 4.4 shows fluorescence 
microscopy at 100x magnification of yeast transformants expressing GFPS65T, both 
brightfield (left panels) and fluorescent (right panels) images are shown. Figure 4.4 (A) 
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shows the transformants expressing AD-Vps45p-GFPS65T show fluorescence with diffuse 
GFPS65T detected throughout the cell, with most of the GFP accumulated in a small 
compartment in each cell. Figure 4.4 (B) shows images of cells expressing BD-Vps45p-
GFPS65T, here both transformants display a similar distribution of GFPS65T labelled Vps45p 
as with the AD fusions.  As a control, cells from other transformants containing unlabelled 
Vps45p (transformants 5, 7, 9 & 10) were imaged under the same conditions, but no 
fluorescence could be detected.  These data demonstrate that both constructs can be used to 
successfully produce versions of Vps45p expressing a detectable C terminal GFPS65T tag. 
 
 
Figure 4.4 GFPS65T expression in strain AH109 
Transformants expressing Vps45p with a C terminal GFP tag (5, 8, 11 & 12) were grown to mid-log phase 
before being fixed with 3% formaldehyde and imaged through an 100x oil immersion objective on a Zeiss 
Axiomat fluorescence microscope (Carl Zeiss, Germany).  Brightfield images were recorded at 15 ms 
exposure (left panels) and fluorescent images at 1.2 s (right panels).  The fluorescence images were recorded 
(A) Transformants 5 and 8 expressing GFP fluorescence from BD-Vps45p-GFPS65T.  (B) Transformants 11 
and 12 expressing GFP fluorescence from AD-Vps45p-GFPS65T. 
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4.3.2 Electrophoretic mobility shift assay 
The electrophoretic mobility shift assay (EMSA) relies on the altered mobility of a 
molecule through a gel upon binding with a partner molecule.  It was originally developed 
to identify DNA binding proteins (Fried and Crothers, 1981, Garner and Revzin, 1981), but 
has more recently been adapted to investigate protein-protein interactions (Park and 
Raines, 1997).  The protein of interest is labelled to allow its detection in a native gel.  
Progress of unbound labelled protein is monitored through the gel and compared to the 
progress of protein samples pre-incubated with the proposed binding partner.  If the 
proteins form a complex there is a detectable change in the mobility of the labelled species. 
We wanted to use this technique to investigate the interaction between Vps45p and Snc2p.  
The experimental design for these experiments is outlined in Figure 4.5.  Firstly, Vps45p 
and the cytosolic domain of Snc2p were expressed in E. coli and then extensively purified 
in order to obtain pure and concentrated samples.  This was achieved using 3 independent 
chromatographic steps, separating our expressed proteins from impurities according to: 
affinity for the specific resin, charge (ion exchange) and size (gel filtration).  Finally, 
samples were concentrated using centrifugal filtration devices.  To account for the loss of 
protein during each of these steps, initial culture volumes were increased appropriately.  A 
ninhydrin assay (Rosen, 1957) was used to give an accurate estimate of final protein 
concentrations before the labelling and binding reactions were calculated.  We chose the 
Alexa 488 fluorophore to label the cytosolic domain of Snc2p, to allow us to detect its 
progress through a gel.  
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Figure 4.5 Schematic diagram of experimental design for the EMSA assay 
(A) Full length Snc2p protein (blue), containing cytosolic N terminal residues 1 - 95, including the SNARE 
motif.  The additional C terminal residues, (96 - 115) make up the hydrophobic transmembrane domain.  (B) 
Production of a truncated Snc2p protein, containing cytosolic residues 1 - 94.  Note that the 94th residue of 
Snc2p is the protein’s only native cysteine residue.  Snc2p1-94 incubated with the thiol-reactive Alexa 488 
fluorophore (green) which covalently binds to the cysteine residues of Snc2p1-94.  Labelled species is then 
isolated from excess Alexa 488 fluorophore by size exclusion chromatography.  (C) Labelled Snc2p1-94 is 
then incubated with Vps45p to allow them to bind; varying concentrations of proteins can be used for each 
reaction.  A control reaction containing no Vps45p is also prepared.  (D) Binding reactions are then analysed 
by native gel electrophoresis followed by scanning in a phosphorimager to detect Alexa 488 fluorescence; 
only labelled protein will be detected.  On the right hand side of the gel the mobility of the control reaction 
containing only Snc21-94 bound to Alexa 488 is shown.  If the binding reaction containing Vps45p and 
labelled Snc2p1-94 results in formation of a complex, it will have an altered mobility in the gel compared to 
the control reaction containing only labelled Snc2p1-94.  Consequently, complexes can be identified by their 
slower mobility through the gel, where they run higher, as shown on the left hand side of the gel. 
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4.3.2.1 Expression and purification of Vps45p 
Vps45p containing an N terminal His6 tag was expressed in BL21 (DE3) E. coli cells from 
the plasmid pNB710 (Carpp et al., 2006).  Co-production of the chaperone proteins GroEL 
and GroES was induced at the same time from the pT-GroE plasmid (Yasukawa et al., 
1995; described in more detail in Chapter V, section 5.4.1.4).  Proteins were induced with 
IPTG overnight at a reduced temperature of 15oC.  A sample taken from each step in the 
purification process was analysed by SDS-PAGE and visualised by Coomassie staining, as 
shown in Figure 4.6.  The single band product of the Vps45p purification runs at its 
predicted molecular weight of 67.0 kDa. 
 
4.3.2.2 Expression and purification of Snc2p1-94 
A truncated version of Snc2p lacking the transmembrane domain was expressed as a GST 
fusion protein from plasmid pMM472.  Residues 1 - 94 were expressed, to allow the native 
cysteine at position 94 to be utilised in the subsequent application of labelling.  The protein 
was expressed in BL21 (DE3) E. coli cells and purified as outlined in section 2.3.4.2.  
Figure 4.7 shows a Coomassie stained gel of samples from each step in the purification 
process after analysis by SDS-PAGE.  The Snc2p truncation was cleaved from the N 
terminal GST tag after the affinity purification step using an optimal concentration of 
Factor X, determined by a trial cleavage with a range of protease concentrations, shown in 
Figure 4.8 (A).  A 1:500 dilution (Lane 8) was deemed the optimal concentration; although 
a large proportion of Snc2p1-94-GST is not cleaved at this dilution, the protein that results 
from cleavage has a single band product.  Figure 4.8 (B) shows a Coomassie stained gel of 
the final concentrated sample after the cleaved product had been further purified by ion 
exchange and gel filtration chromatography. 
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Figure 4.6 Expression and purification of Vps45p 
Plasmid pNB710 was used to produce a recombinant His6 tagged version of Vps45p; the plasmid was 
transformed into BL21 (DE3) cells already containing plasmid pT-GroE, which expresses the E. coli 
chaperone proteins GroEL and GroES.  Purity of protein was analysed at various stages by SDS-PAGE on a 
10% gel followed by Coomassie staining (left panel).  Protein expression was induced overnight at 15oC by 
addition of 0.5 M IPTG (Lanes 1 & 2; 7.5 µl each).  Protein was expressed and purified from 10 L of culture 
as outlined in methods section (2.3.4.1).  Soluble protein (Lane 3; 7.5 µl) was bound to 5 ml of washed Ni2+-
NTA beads for 1 hour.  The amount of protein lost as insoluble protein (Lane 4; 7.5 µl) and not bound to 
column (Lane 5; 7.5 µl) is shown.  Protein bound to beads (Lane 6; 7.5 µl) was eluted from column with 
buffer containing 250 mM imidazole.  Eluted protein was then bound to a Mono Q (10 / 10) ion exchange 
column and eluted with an increasing NaCl concentration gradient.  There were 3 absorbance peaks at A280, 
fractions containing Vps45p were identified by SDS-PAGE then pooled and concentrated to approximately 6 
mls.  Concentrated protein was then loaded onto a Superdex 200 (16 / 60) gel filtration column.  Again, 
fractions of interest were analysed by SDS-PAGE on a 12% gel and fractions containing purest samples of 
Vps45p (right panel; 10 µl) were pooled and concentrated, before snap freezing in liquid nitrogen.  Positions 
of molecular weight markers are indicated. 
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Figure 4.7 Expression and purification of Snc2p1-94  
Plasmid pMM472 was used to recombinantly produce a truncated version of Snc2p containing the first 94 N 
terminal residues. The protein was expressed as a GST fusion protein, and then purified from 10 L of culture 
as outlined in methods section (2.3.4.2).  Purity of protein was analysed at various stages by SDS-PAGE on a 
15% gel followed by Coomassie staining.  Protein expression was induced by addition of 1 M IPTG for 2 
hours at 37oC (Lanes 1 & 2; 7.5 µl of each).  Soluble protein (Lane 3; 7.5 µl) was bound to 5 ml Glutathione 
Sepharose 4B beads for 1 hour.  The amounts lost as insoluble protein (Lane 4; 7.5 µl) and not bound to 
column (Lane 5; 7.5 µl,) are shown.  Protein was eluted from beads with buffer containing 25 mM reduced 
glutathione, the elution was then diluted by 1/2, 1/4 and 1/8 (Lanes 7 - 9; 5 µl each), before SDS-PAGE 
analysis.  Positions of molecular weight markers are indicated. 
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Figure 4.8 Further purification of Snc2p1-94  
(A) A trial cleavage of GST from Snc2p was set up with 2.5 µl of eluted protein and 2 µl of Factor X (or a 
serial dilution thereof) and allowed to cleave at 4oC for 18 hours.  5 µl of each dilution was then analysed by 
SDS-PAGE on a 15% gel (Lanes 1 - 8; 5 µl each), including a sample incubated in same conditions with no 
factor X (Lane 9; 5 µl).  A 1:500 dilution of Factor X was estimated to be the optimal concentration for 
cleavage and used to cleave Snc2p from GST in remainder of sample.  Protein was then bound to a Mono S 
(5 / 5) ion exchange column and eluted with an increasing NaCl concentration gradient.  Fractions containing 
Snc2p1-94 were identified by SDS-PAGE then pooled and concentrated to approximately 3 mls.  Protein was 
then loaded onto a Superdex 75 (16 / 60) gel filtration column.  (B) Fractions displaying high absorbance 
peaks at A280 were analysed by SDS-PAGE on 15% gel and elutions containing purest samples of Snc2p1-94 
(right panel; 15 µl) were pooled and concentrated before snap freezing in liquid nitrogen.  Positions of 
molecular weight markers are indicated. 
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4.3.2.3 Labelling Snc2p1-94 with Alexa 488 fluorophore  
I took advantage of the unique native cysteine in the cytosolic Snc2p, found at residue 94, 
to covalently bind the thiol-reactive Alexa Fluor® 488 C5 maleimide (Invitrogen) label.  
Cysteine contains the nucleophillic thiol side chain group, which is easily oxidized and 
ideal for this application.  A binding reaction was set up with purified Snc2p1-94 and a 15 
fold molar excess of the Alexa 488 fluorophore.  All buffers used in the labelling 
procedure contained TCEP as a reducing agent, in place of DTT, as it does not interfere 
with the attachment of thiol-reactive probes (Getz et al., 1999).  The reaction mixture was 
left for 3 hours at room temperature to allow the Alexa 488 fluorophore to bind the reduced 
cysteine residues of the cytosolic version of Snc2p, before being passed over a gel 
filtration column.  This process allows the labelled Snc2p1-94 to be separated from the 
excess fluorophore and TCEP, shown in Figure 4.9 (A).  The fractions collected from the 
gel filtration column were analysed on a 15% gel by SDS-PAGE and then viewed in a 
phosphorimager under a blue laser at 433 nm.  This demonstrates that Alexa 488 labelled 
Snc2p1-94 can be visualised from the gel, shown in Figure 4.9 (B) lower panel.  After 
imaging, the SDS-PAGE gel was stained with Coomassie blue, shown in Figure 4.9 (B) 
upper panel.  Snc2p1-94 fractions that have been successfully labelled with Alexa 488 are 
seen to run at a higher molecular weight than the unlabelled sample of purified Snc2p1-94 
(compare Lane 1 with Lanes 4, 5, 6 & 7).   
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Figure 4.9 Labelling of Snc2p1-94 with Alexa 488 fluorophore 
A sample of purified Snc2p1-94 was diluted in phosphate buffer containing 1 mM TCEP and left for 1 hour at 
room temperature to reduce cysteine residues.  A 15 fold molar excess of Alexa 488 was then added drop-
wise to the meniscus of Snc2p1-94 sample.  The labelling reaction was then sealed from external light and 
allowed to run for 3 hours.  Samples were then loaded onto a Superdex75 (10 / 30) gel filtration column and 
0.5 ml fractions were collected. (A) Chromatograph showing absorbance at A280 from all fractions from the 
gel filtration column.  (B) Fractions of interest were analysed by SDS-PAGE on a 15% gel.  The gel was 
scanned using a phosphorimager with a single laser at 433 nm to detect fluorescence of Alexa 488 (lower 
panel) before Coomassie staining (upper panel).  A sample of unlabelled Snc2p was run (Lane 1; 10 µl), 
followed by fractions of interest (Lanes 2 - 9; 12.5 µl each).  Fractions of Snc2p containing detectable 
concentrations of bound Alexa 488 were collated.  Positions of molecular weight markers are indicated.  
 
 
Chris MacDonald, 2009  Chapter IV, 135 
4.3.2.4 Mobility of Alexa 488 labelled Snc2p1-94 in native gel conditions 
Before attempting to quantify binding of labelled Snc2p1-94 to Vps45p, we wanted to 
optimise the conditions of the protein moving through a native gel.  The choice of the gel 
matrix can amplify or attenuate the mobility experienced by a particular protein (Ryder et 
al., 2008).  Preliminary gels were run in order to identify the overall charge of the protein 
at several pH values; this was uncertain as the predicted isoelectric point of full length 
Snc2p is 9.28 and the Alexa 488 fluorophore carries an overall negative charge.  Once I 
had established that the protein would move towards the anode when an electric potential 
was applied across the field, we set out to optimise the native gel conditions.  We predicted 
that the electrophoretic separation of labelled Snc2p1-94 from a Vps45p bound version 
would be best at an alkaline pH, so native slab gels were prepared with TBE at pH 8.4 and 
pH 9.0.  Vps45p was incubated with labelled Snc2p for 3 hours to allow complex 
formation, before loading on the gels.  A sample of unbound labelled Snc2p1-94 was also 
loaded before the gels were run.  As shown in the two right hand columns of Figure 4.10, 
distinct bands could not be detected at 1 or 2 hour time points and the protein had 
significantly diffused into the gel by the 4 hour time point.  In an attempt to better resolve 
the unbound Snc2p1-94 from protein in complex with Vps45p, a native gel of HEPES / 
imidazole at physiological pH 7.4 was prepared and run as previously described.  The 
proteins moved slower through the gel, but distinct bands were better observed, as shown 
in the left column of Figure 4.8.  We deemed this method most suitable for the gel shift 
assay.   
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Figure 4.10 Optimisation of conditions for gel shift assay  
Binding reactions were prepared containing 2 µM Alexa 488 labelled Snc2p with or without 10 µM Vps45p, 
made up to 60 µl in potassium phosphate buffer containing 1 mM TCEP and 0.1% NP-40.  The reactions 
were allowed to bind for 3 hours at room temperature in the dark.  A 6% native HEPES / imidazole gel and 
two 6% TBE gels of pH 8.4 and pH 9.0 were prepared and immersed in appropriate cold running buffer for 1 
hour prior to loading.  6 µl of 30% glycerol containing 0.01% (w / v) bromocresol dye was added to each 
binding reaction before 50 µl of sample was loaded onto each of the gels.   Gels were each run at 125 volts at 
4oC and imaged at the 1 hour (top row), 2 hour (middle row), and 4 hour (bottom row) time points.  For 
images, gels were scanned in a phosphorimager with a 433 nm laser at each of the time points to detect 
fluorescence of Alexa 488.  Bands detected shown by black and white arrows. 
 
4.3.2.5 Complex determination by gel shift assay 
Binding reactions of Snc2p1-94 at a concentration of 10 µM were set up with a decreasing 
concentration gradient of Vps45p, beginning at 16 µM.  The exact concentrations of 
Vps45p in each binding reaction are shown in Chapter II, Table 2.1.  The reactions were 
left to bind for 3 hours before being prepared for electrophoresis as described in section 
2.1.3.4.  All 10 reactions were loaded onto a large scale HEPES / imidazole native gel at 
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pH 7.4, and then run at constant voltage.  The progress of labelled Snc2p1-94 was monitored 
by scanning in a phosphorimager.  After the gel had been run for 2 hours, different bands 
representing unbound and complexed Snc2p1-94 could not be detected, as shown in the 
upper panel of Figure 4.11.  It does appear that the samples pre-incubated with highest 
concentrations of Vps45p migrate out of wells more slowly than samples containing more 
dilute, or completely lacking, Vps45p.  After 2 hours (upper panel) the samples containing 
most bound Snc2p1-94 (Lanes 1 - 4) had not migrated far from the wells.  After the gel had 
been run for 4 hours a band shift could be detected at high Vps45p concentrations, shown 
in Figure 4.11 lower panel.  The first 5 Lanes show two distinct bands, the concentration of 
Snc2p1-94 in the higher band appears to be proportional to the concentration of Vps45p.  It 
is important to note that even the binding reaction containing the highest concentration of 
Vps45p (Lane 1) did not achieve 100% complex formation, as two bands can still be 
detected.  Samples pre-incubated with lowest concentrations of Vps45p (Lanes 6 - 9) 
migrate through the gel similarly to the unbound Snc2p control sample (Lane 10), 
suggesting that the concentration was too low to allow detectable complex formation.  As 
the highest concentration of Vps45p was insufficient to achieve 100% binding to Snc2p1-94, 
the Kd of the interaction could not be accurately calculated.  However, ~50% binding could 
be observed between Vps45p concentrations of 16 µM (Lane 1) and 5.76 µM (Lane 3).  
We therefore estimate the Kd of the Vps45p-Snc2p interaction to be approximately 10 µM.   
The EMSA technique has also been used to investigate the binding affinity between Tlg2p 
and Vps45p.  Reactions were set up as described above for investigating the Vps45p-Snc2p 
interaction, but an Alexa 488 labelled version of cytosolic Tlg2p lacking the first 36 N 
terminal residues (Tlg2p37-318) was incubated with Vps45p.  A full range of binding was 
achieved; the calculated affinity of the interaction from this assay is 280 nM (Furgason et 
al., 2009).  Unlabelled full length cytosolic Tlg2p (Tlg2p1-318) was also added to a reaction 
as described above; this allowed the competition between the unlabelled Tlg2p1-318 and the 
labelled Tlg2p36-318 to be assessed.  The binding competency, and therefore the apparent 
affinity, of the unlabelled molecule can then be calculated (Furgason et al., 2009).  From 
these experiments the full length molecule was shown to have a Kd of 190 nM (Furgason et 
al., 2009).  Both these experiments demonstrate that the affinity of Vps45p for Tlg2p is 
significantly greater than its affinity for Snc2p.  These experiments were published, 
(Furgason et al., 2009; Appendix III). 
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Figure 4.11 Gel shift assay with concentration gradient of Vps45p 
A concentration gradient of Vps45p was added to equal samples of Snc2p1-94 to produce 10 individual 
binding reactions. 10 µl Alexa 488 labelled Snc2p at a concentration of 10 µM in binding buffer containing 
1mM TCEP and 0.1% NP-40 was added to 10 wells of a 96 well plate.  Vps45p at a concentration of 16 µM 
was used to create a 9 point 3/5 serial dilution from 16 µM to 161 nM (exact concentrations shown in Table 
2.1).  40 µl of each of these dilutions were added to the wells containing labelled Snc2p, no Vps45p was 
added to the final well (Lane 10).  The reactions were left to bind in the dark for 3 hours and then 6 µl of 
30% glycerol containing 0.01% (w / v) bromocresol dye was added to each binding reaction.  A 6% HEPES / 
imidazole native gel was prepared and chilled in running buffer at 4oC for 1 hour before 50 µl of each sample 
was loaded onto the gel, which was then run at 125 volts for 4 hours.  Gels were scanned in a 
phosphorimager with a 433 nm laser at 2 (upper panel) and 4 (lower panel) hour time points to detect 
fluorescence of Alexa 488.   
 
4.3.3 Competition binding experiments 
It has been previously shown using an in vitro pull down assay that Tlg2p can displace the 
cytosolic domain of Snc2p (Snc2p1-88) from Vps45p (Carpp et al., 2006).  The reverse of 
this is not true, and even high concentrations of Snc2p1-88 will not displace Tlg2p in 
complex with Vps45p (Carpp et al., 2006).  This is unsurprising given that we have 
previously shown in this Chapter that the interaction between Vps45p and Snc2p1-94 to be 
in the micromolar range (~10 µM), which is relatively weak compared to its affinity with 
Chris MacDonald, 2009  Chapter IV, 139 
the cytosolic domain of Tlg2p (190 nM; Furgason et al., 2009; discussed in section 
4.4.1.5).  These experiments were repeated with a better defined concentration gradient of 
Tlg2p.  We also used mutant versions of Vps45p and Tlg2p unable to bind via mode-2, to 
test if the ability of Tlg2p to displace Snc2p1-88 in complex with Vps45p was mediated 
through this binding mode.   
The experiment was set up as previously described (Carpp et al., 2006).  Briefly, a His6 
tagged version of wild-type Vps45p was bound to Ni2+-NTA agarose beads.  An identical 
binding reaction was set up with His6 tagged mutant Vps45p that cannot interact via mode-
2 (Vps45pL117R).  Unbound protein was then washed from the beads before each set of 
reactions were incubated with a Protein A tagged version of Snc2p1-88.  The complexes 
bound to beads were then washed again to remove any uncomplexed Snc2p.  The proteins 
used to form complexes of wild-type Vps45p and the mutant Vps45pL117R are shown in 
Figure 4.12 (A) and (B) respectively.  50 µl of settled beads containing complexes were 
added to a series of tubes, to which the competing proteins were added.  Figure 4.12 (C) 
shows SDS-PAGE analyses of the competing proteins produced in E. coli: wild-type Tlg2p 
(Lanes 1 & 2); a version of Tlg2p containing a double alanine mutation (Tlg2pF9A/L10A) 
which disrupts mode-2 binding (Lanes 3 & 4); and Sx4, a mammalian syntaxin that does 
not bind Vps45p (Struthers et al., 2009), used here as a negative control (Lanes 5 & 6).  
These proteins were normalised so that they were all of equal molar concentrations (22.8 
µM).  300 µl of competing protein, or dilutions thereof, was added to each tube containing 
beads bound to wild-type or mutant Vps45p in complex with Snc2p1-88.  300 µl of Tlg2p 
and Tlg2pF9A/L10A samples were added undiluted or at a 1:2 or a 1:4 dilution.  Reactions 
were made up to 1 ml with reaction buffer.  As controls, tubes were set up and incubated 
with either 1 ml reaction buffer alone or 300 µl 25 µM mammalian Sx4; 700 µl reaction 
buffer was also added to this control reaction so all volume were equal.  The competing 
proteins were incubated for 3 hours on a rotator at 4oC, before being washed 3x with PBS 
containing 20 mM imidazole.  The proteins bound to beads were resolved by SDS-PAGE 
followed by immunoblot analysis using an α-Vps45p antibody, which also detects the IgG 
domain of the protein A tag.   
The competition analysis of Snc2p1-88-PrA bound to either wild-type or mutant Vps45p is 
shown in Figure 4.13 (A) and (B) respectively.  In each case, addition of reaction buffer 
alone or Sx4 does not result in any displacement of Snc2p1-88 bound to versions of Vps45p 
(Lanes 1 & 2 in both (A) & (B)).  In contrast, addition of Tlg2p to either Vps45p-Snc2p1-88 
or Vps45pL117R-Snc2p1-88 complexes displaces Snc2p in a concentration dependent manner 
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(Lanes 3 - 5 in both (A) & (B) respectively).  This suggests that mode-2 binding is not 
involved with the ability of Tlg2p to displace Snc2p1-88 in complex with Vps45p.  This is 
corroborated by the fact that addition of Tlg2pF9A/L10A, which cannot interact via mode-2 
binding, displaces Snc2p1-88 from Vps45p similarly to wild-type Tlg2p (compare Lanes 3 - 
5 & 6 - 8 in Figure 4.13 (A)).  There is also no detectable difference between displacement 
from Vps45pL117R bound to Snc2p1-88 with wild-type Tlg2p and Tlg2pF9A/L10A, again 
demonstrating that mode-2 is not important for Tlg2p to bind Vps45p and displace Snc2p1-
88 (Carpp et al., 2006). 
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Figure 4.12 Proteins for competition binding assay 
For the binding reactions, plasmids pNB710 and pCOG067 were respectively used to produce wild-type 
Vps45p and a version containing the single residue mutation, Vps45pL117R.  Both versions of Vps45p were 
co-expressed with chaperone proteins GroEL and GroES (as described in section 3.4.4) then purified as 
described in section 2.3.4.1.  Left panels of (A) & (B) show samples from each 1 ml elution of both versions 
of Vps45p running at 68 kDa (Lanes 1, 5 µl each).  Plasmid pCOG045 was used to express the cytosolic 
domain of Snc2p with two IgG-binding domains of PrA at the C terminus, as described in section 2.3.4.3.  
Two separate preparations are shown in (A) and (B) right panels (Lanes 2; 5 µl each).  The input proteins for 
the experiment were also produced with a double IgG-binding domains PrA tag for Tlg2p, the mutant 
Tlg2pF9A/L10A, and the mammalian Sx4 with a C terminal GST tag, were all produced in BL21 (DE3) E. coli 
from plasmids pCOG025, pCOG076 and pFB09 / 2 respectively.  (C) shows samples from the 1 ml first and 
second elutions from input protein purifications (Lanes 1 - 6; 5 µl each).  All proteins were dialysed against  
4 L 1x PBS before stored at 4oC. 
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Figure 4.13 Competition binding studies 
Recombinant proteins, shown in Figure 4.12, were used to prepare the binding experiments.  200 µl of either 
wild-type His6-Vps45 or His6-Vps45pL117R was added to 500 µl settled Ni2+-NTA agarose beads (Qiagen) and 
left to rotate at 4oC for 1 hour.  Beads were then washed 3x with 1 ml PBS containing 20 mM imidazole.  900 
µl of cytosolic Snc2p-PrA was then added to each tube of beads containing version of Vps45p and left to 
incubate on a rotator overnight at 4oC.  Beads were again washed 3x with PBS containing 20 mM imidazole, 
before 50 µl of settled beads containing Vps45p-Snc2p complexes was then added to separate tubes.  Before 
input proteins were added to beads they were normalised so that they were of equal concentrations; 25 µl, 
100 µl and 300 µl of both Tlg2p and Tlg2pF9A/L10A were added to separate tubes containing beads.  As 
controls, 300 µl of PBS or Sx4 was also added to different tubes.  Tubes were left to incubate at 4oC for ~16 
hours, before another 3x washes with PBS.  50 µl 1x LSB was then added to each sample of beads and boiled 
at 95oC for 5 minutes.  Samples were resolved on a 12% gel by SDS-PAGE followed by transfer to a 
nitrocellulose membrane and immunoblot analysis using an α-Vps45p antibody to detect the Vps45p protein 
or the IgG binding domain of the double PrA tag.  Immunoblot analysis from competition experiments of 
Vps45p-Snc2p and Vps45pL117R-Snc2p are presented in (A) & (B) respectively. 
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4.4 Chapter summary 
The data presented in this Chapter confirm the observations that the yeast SM protein 
Vps45p interacts directly with the v-SNARE Snc2p (Carpp et al., 2006).  The protein-
protein interaction can be detected through a yeast-2-hybrid assay.  Further to this, we have 
created two plasmids that express Vps45p with a C terminal GFPS65T tag and shown it to 
also interact via the yeast-2-hybrid technique.  The full length fusion protein is identifiable 
through expression of the GFPS65T tag; we plan to utilise this characteristic in future 
experiments to screen a library of randomly mutated Vps45p proteins, and then assay their 
ability to form a complex with Snc2p.  The second section of this Chapter has used a 
complimentary technique, an electrophoretic mobility shift assay, to demonstrate the 
Vps45p-Snc2p interaction.  The advantage of this approach, that involves determining the 
ability of Snc2p to bind a concentration gradient of Vps45p, is that estimations of affinity 
can be calculated from the results.  Unfortunately accurate calculations could not be 
performed in this instance, because the concentrations required to achieve a complete 
range of binding were unattainable.  We did however observe more than 50% binding, and 
a rough estimation of the dissociation constant (Kd) reveals the interaction to be very weak, 
approximately 10 µM.  Another more sensitive approach may be required to make accurate 
affinity estimations of the Vps45p-Snc2p interaction.  Biacore surface plasmon resonance 
(SPR) and isothermal titration calorimetry (ITC) are two such techniques discussed in 
Chapter VI.  Finally, Snc2p that is bound to Vps45p can be displaced by Tlg2p in a 
concentration dependent manner.  Further to this, we have eliminated this displacement 
occurring via mode-2 binding using mutant versions of both Vps45p and Tlg2p.  The 
ability of Tlg2p to displace Snc2p from Vps45p may be indicative of a sequential binding 
model, (a bridging role of the SM protein, discussed in Chapter I).  The respective 
affinities of Tlg2p and Snc2p for Vps45p also support a model whereby Vps45p is carried 
to the site of action with a weak interaction with the v-SNARE, and then binds to the 
syntaxin through a higher affinity interaction to fulfil its role. 
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5.1 Introduction 
In vitro protein based assays, such as those described in Chapters III and IV, are conducive 
to understanding simplistic factors of SNARE mediated membrane fusion events; however, 
they may not accurately represent intracellular conditions.  On the other hand, it can be 
difficult to identify factors responsible for any individual event in the complex series of 
membrane fusion steps from studies of whole cells and / or organisms.  A variety of 
simplified assays have been developed, using either partially intact cellular components or 
completely synthetic membranes, in order to bridge this gap (Avery et al., 1999).  One 
such system, designed in the early 1980’s by Struck and colleagues, monitors the rate of 
fusion using fluorescence resonance energy transfer (FRET) (Struck et al., 1981).  The 
FRET pair used in the assay are two fluorophores: NBD (N-(7-nitro-2,1,3-benzoxadizol-4-
yl) and rhodamine (N-(lissamine rhodamine B sulfonyl) (Struck et al., 1981).  The 
emission band of NBD, which acts as the energy donor, overlaps with the excitation band 
of the acceptor rhodamine; when the two probes are in close proximity the NBD 
fluorescence is quenched by rhodamine (Fung and Stryer, 1978).  These probes are used to 
label the polar headgroups of phosphatidylethanolamine, before the lipid is used to 
generate liposomes, which can contain other lipid(s) as desired (Struck et al., 1981).  The 
basis of the assay is to mix a vesicle population containing these labelled lipids with an 
unlabelled vesicle population.  If the vesicles fuse, the labelled probes will be distanced 
spatially as the unlabelled membrane dilutes the labelled membrane, resulting in a decrease 
in rhodamine quenching, and an increase in NBD fluorescence (Struck et al., 1981).  The 
principles of the in vitro fusion assay are outlined in Figure 5.1   
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Figure 5.1 Principles of the in vitro fusion assay 
Schematic diagram of the in vitro fusion assay.  Fluorescently labelled lipids are reconstituted into the 
phospholipid bilayer of donor vesicles. The fluorescence resonance energy transfer (FRET) pair NBD (light 
spheres) and rhodamine (dark spheres) are reconstituted at a concentration in which NBD fluorescence is 
quenched by rhodamine through FRET.  When donor vesicles fuse with acceptor vesicles the fluorescently 
labelled lipids are diluted in the membrane and fluorescence quenching by FRET is decreased.  The resultant 
increase in NBD fluorescence over time can be used as an indicator of the rate of fusion.  Taken from (Scott 
et al., 2003). 
This simplified in vitro fusion assay was further developed to allow incorporation of 
SNARE proteins into generated vesicle populations (Weber et al., 1998).  SNARE proteins 
that contain hydrophobic transmembrane domains can be purified in the presence of 
detergent then added to a lipid mixture.  Liposomes are created by diluting the detergent 
below its critical micelle concentration (CMC), the threshold at which the detergent can no 
longer maintain the lipids in solution.  Dilution results in spontaneous formation of 
liposomes composed from the lipid mixtures, with SNARE proteins integrated into the 
membrane through their transmembrane domains (Weber et al., 1998).  Resultant 
proteoliposomes are then used to investigate the fusogenic properties of the reconstituted 
SNARE proteins in this simplified system that, in many ways, mimics biological 
membranes.  This study was used to support the hypothesis that SNARE proteins alone are 
sufficient to drive fusion of opposing lipid membranes (Weber et al., 1998).  The fusion 
observed was confirmed as SNARE dependent by the inclusion of a negative control in 
which the t-SNARE containing liposomes are pre-incubated with the cytosolic domain of 
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the v-SNARE (Weber et al., 1998).  These t-SNARE complexes are then unable to form 
functional SNARE complexes when the v-SNARE containing liposomes are added, and 
fusion is thus inhibited (Weber et al., 1998). 
This in vitro fusion assay has been widely used to study SNARE mediated membrane 
fusion, and can be used to investigate the regulation of this process.  The regulatory role of 
SM proteins on SNARE mediated membrane fusion has been examined using this assay.  
The first example of this involved the addition of the yeast SM protein Sec1p to the 
exocytotic t-SNARE complex of Sso1p / Sec9p before reconstitution into liposomes (Scott 
et al., 2004).  Sec1p addition enhances the rate of fusion recorded with liposomes 
harbouring v-SNARE Snc2p approximately three fold over fusion lacking Sec1p (Scott et 
al., 2004).  A similar effect is observed with liposomes reconstituted with the neuronal 
exocytotic t- and v-SNARE proteins, Sx1a / SNAP-25 and VAMP respectively (Shen et 
al., 2007).  In this study, proteoliposomes were pre-docked at low temperature (4oC), 
which prohibits fusion but allows complex formation (Parlati et al., 1999); subsequent 
addition of cognate SM protein Munc18a to docked liposomes enhances the rate of 
liposome fusion upon incubation at 37oC (Shen et al., 2007).  A third study reported that 
SM protein Munc18c has an inhibitory effect on the rate of liposome fusion of its cognate 
SNARE proteins responsible for exocytosis at the mammalian plasma membrane, Sx4 / 
SNAP-23 and VAMP2; this system likely has additional regulatory requirements to 
promote fusion in vitro (Brandie et al., 2008). 
The yeast endosomal syntaxin Tlg2p interacts with Vti1p and Tlg1p to form a ternary t-
SNARE complex capable of forming a functional SNARE complex with v-SNARE Snc2p 
(Bryant and James, 2001, Coe et al., 1999).  These proteins have been shown to facilitate 
fusion of synthetic liposomes in the in vitro fusion assay described (Paumet et al., 2001).  
Vps45p is required for formation of functional Tlg2p containing complexes in vivo, which 
suggests that the SM protein has a positive regulatory role on complex assembly and fusion 
(Bryant and James, 2001). 
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5.2 Aims of this Chapter 
The aim of this Chapter was to establish the liposome fusion assay using the SNAREs 
responsible for endosomal trafficking in the yeast S. cerevisiae: Tlg2p, Vti1p, Tlg1p and 
Snc2p.  Further to this, I planned to examine the role of Vps45p on membrane fusion 
mediated by this SNARE complex 
 
5.3 Results 
5.3.1 Producing protein components of in vitro liposome assay 
Recombinant SNARE proteins were produced in E. coli, and then purified by affinity 
chromatography.  To allow reconstitution into synthetic lipid membranes it was necessary 
that the proteins produced contained their C terminal transmembrane domain.  To stop 
these hydrophobic residues causing aggregation and precipitation of protein, all SNARE 
protein purifications were carried out in the presence of the detergent Octyl-β-D-
glucopyranoside (OG), which solubilises the transmembrane domain.  This particular 
detergent was chosen on account of its small size, which allows easy removal by dialysis 
after proteoliposome production (Weber et al., 1998). 
Where possible full length SNARE proteins were created for the assay, however, this was 
not possible for Tlg2p and Tlg1p, so alternative versions of these proteins were used, 
discussed in the following sections.  Plasmids encoding Tlg2p and truncations thereof, 
Vti1p, Tlg1p and Snc2p were kind gifts from Dr. James McNew, Rice University, Texas, 
USA. 
 
5.3.1.1 Expression and purification of Tlg2p 
Tlg2p contains a C terminal luminal domain that is not essential for its membrane 
trafficking function (Abeliovich et al., 1998); plasmid pJM135 was used to produce a His6 
tagged version of Tlg2p lacking this region, Tlg2p1-335, which expresses better than the full 
length protein (Paumet et al., 2001).  In agreement with Paumet and colleagues, our 
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attempts to optimise the purification of this protein did not result in sufficient 
concentrations to allow reconstitution (Paumet et al., 2001); this was unsurprising, as 
degradation of Tlg2p in vitro has been previously documented (Carpp et al., 2006).  For 
this reason a version of Tlg2p lacking the first 36 N terminal residues (Tlg2p37-397), a 
truncation known to significantly enhance protein expression, was produced in E. coli from 
plasmid pJM325 (Paumet et al., 2001).  Figure 5.2 shows SDS-PAGE analysis of Tlg2p37-
397 samples from each step in the purification process. 
 
Figure 5.2 Expression and purification of Tlg2p37-397 
(A) Schematic diagram of Tlg2p37-397.  (B)  Plasmid pJM106 was used to recombinantly produce a truncated 
version of Tlg2p lacking the first 36 N terminal residues in BL21 (DE3) E. coli cells.  The His6 tagged 
protein was expressed and purified from 12 L of culture, as outlined in methods section (2.3.4.1).  Purity of 
protein was analysed at various stages by SDS-PAGE on a 12% gel followed by Coomassie staining.  Lysate 
after 4 hour induction with 1 mM IPTG (Lane 1; 0.001%); examples of the 5 ml washes with 20 mM 
imidazole (Lanes 2 - 4; 0.1% of each); protein on beads before elution (Lane 5; 5 µl); 1 ml elutions with 250 
mM imidazole (Lanes 6 - 8; 5 µl of each); protein on beads after elutions (Lane 9; 20 µl).  Positions of 
molecular weight markers are indicated. 
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5.3.1.2 Expression and purification of Vti1p and Tlg1p 
His6 tagged versions of Vti1p and Tlg1p were expressed from plasmids pJM132 (Fukuda 
et al., 2000) and pJM124 (McNew et al., 2000) respectively; both proteins expressed well 
and resulted in large quantities of purified protein, as shown in Figures 5.3 and 5.4.  The 
reason full length Tlg1p was not used for the in vitro fusion assay is that it has previously 
been shown to require additional activation to fuse synthetic vesicles in vitro (Paumet et 
al., 2001).  The additional activation required is the presence of a short C terminal peptide 
of the v-SNARE motif of Snc2p which reversibly binds the t-SNARE complex, 
structurally priming it for entry into SNARE complexes (Melia et al., 2002).  The SNARE 
domain of Tlg1p alone reconstituted into this system with cognate t-SNAREs also requires 
this activation (Paumet et al., 2004).  This feature appears not to be conserved through 
evolution, as the SNARE domain of Sx8, the mammalian homologue of Tlg1p, functions 
to fuse liposomes in place of Tlg1p without requiring any activation (Paumet et al., 2005).  
Paumet and colleagues identified the N terminal portion of the Tlg1p SNARE domain to be 
responsible for this additional regulatory requirement of complexes containing the entire 
Tlg1p SNARE domain; by demonstrating that chimeric versions of the Tlg1p and Sx8 
SNARE domains would only facilitate fusion if the N terminus of Tlg1p was replaced by 
that of Sx8 (Paumet et al., 2005).  Given that our primary aim was to investigate any 
regulatory role Vps45p may have on SNARE fusion, it was therefore preferable to 
eliminate this second level of regulation from our experiments.  For this reason, a chimeric 
protein containing the N terminus of Sx8 SNARE motif and the C terminus of Tlg1p was 
created, (depicted in Figure 5.5).  The expression and purification of the Sx8 / Tlg1p 
chimera required considerable optimisation to yield a final sample of sufficient 
concentration to reconstitute into liposomes.   
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Figure 5.3 Expression and purification of full length Vti1p 
(A) Schematic diagram of Vti1p. (B)  Plasmid pJM132 was used to produce full length recombinant Vti1p.  
The protein was expressed with an N terminal His6 tag in BL21 (DE3) E. coli cells, and then purified from 12 
L of culture as outlined in methods section (2.3.4.1).  Purity of protein was analysed at various stages by 
SDS-PAGE on a 12% gel followed by Coomassie staining.  Lysate after 4 hour induction with 1 mM IPTG 
(Lane 1; 0.001%); examples of the 5 ml washes with 20 mM imidazole (Lanes 2 - 4; 0.1% of each); protein 
on beads before elution (Lane 5; 5µl); 1 ml elutions with 250 mM imidazole (Lanes 6 - 8; 5 µl of each); 
protein on beads after elutions (Lane 9; 20 µl).  Molecular weight markers are indicated. 
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Figure 5.4 Expression and purification of full length Tlg1p 
(A) Schematic diagram of Tlg1p. (B) Plasmid pJM124 was used to recombinantly produce full length Tlg1p 
in BL21 (DE3) E. coli cells.  The His6 tagged protein was expressed and purified from 12 L of culture as 
outlined in methods section (2.3.4.1).  Purity of protein was analysed at various stages by SDS-PAGE on a 
12% gel followed by Coomassie staining.  Lysate after 4 hour induction with 1 mM IPTG (Lane 1; 0.001%); 
examples of the 5 ml washes with 20 mM imidazole (Lanes 2 - 4; 0.1% of each); protein on beads before 
elution (Lane 5; 5 µl); 1 ml elutions with 250 mM imidazole (Lanes 6 - 8; 5 µl of each); protein on beads 
after elutions (Lane 9; 20 µl).  Positions of molecular weight markers are indicated. 
Chris MacDonald, 2009  Chapter V, 153 
 
Figure 5.5 Syntaxin 8 / Tlg1p chimera 
Schematic representaions of mammalian Syntaxin 8 (yellow) and Tlg1p (grey) are depicted.  The hatched 
boxes represent each SNARE domain.  The chimera consists of the N terminal residues of the Sx8 SNARE 
domain (residues 135 - 179), directly followed by Tlg1p residues from the zero layer to the end of the 
transmembrane domain (residues 165 - 224).  Adapted from (Paumet et al., 2005).   
Initial attempts to purify a His6 tagged version were unsuccessful, with very little protein 
being expressed.  For this reason I constructed pCMD003, which was used to express a 
version of the Sx8 / Tlg1p chimera harbouring an N terminal GST tag; an approach which 
sometimes increases yield of expression and solubility of recombinant proteins (Smith and 
Johnson, 1988).  The parent vector, pGEX4T-1 (GE Healthcare) is designed to encode a 
thrombin cleavage site (Leu-Val-Pro-Arg-Gly-Ser) to allow the GST tag to be removed 
from recombinant proteins after purification, as shown in Figure 5.6 (A).  The low final 
concentration of cleaved protein was partially due to the instability of the protein at room 
temperature (the optimal temperature for thrombin cleavage is 25oC; Chang, 1985).  
Utilisation of filtration devices to concentrate the Sx8 / Tlg1p chimera was reasonably 
effective at increasing the concentration, shown in Figure 5.6 (B).  This was a time 
consuming exercise involving protein being purified from 4 separate 12 L cultures being 
concentrated to give less than 1 ml of protein at 48 µM; giving enough material for 4 
liposome reconstitutions.  For this reason I sought an alternative method, and created 
pCMD004 based on parent vector pGEX6P-1 (GE Healthcare), to produce another GST 
fusion of the Sx8 / Tlg1p chimera, which contains a PreScission protease cleavage site 
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(Leu-Glu-Val-Leu-Phe-Gln / Gly-Pro) to assist with removal of the GST tag (Walker et al., 
1994).  This protease optimally cleaves at 4oC (Walker et al., 1994), which overcame the 
degradation problem encountered with thrombin cleavage and allowed sufficient protein 
concentration for 4 reconstitution procedures to be obtained from a single 6 L culture.  
Figure 5.6 (C) compares the yield obtained from these two vectors.  The only fundamental 
difference between these two systems was the ability of the different proteases to cleave 
protein from the GST tag at different temperatures; the stability of protein at 4oC results in 
substantially higher concentrations of protein obtained. 
 
Figure 5.6 Optimisation of expression and purification of Sx8 / Tlg1p chimera 
The Sx8 / Tlg1p chimera was produced as a GST fusion protein from two vectors: pCMD003, which 
contains a thrombin cleavage site; and pCMD004, which contains a PreScission protease cleavage site.  
Proteins were expressed in RosettaTM 2 (DE3) E. coli cells and purified onto Glutathione Sepharose 4B beads 
(GE Healthcare), as described in section 2.3.4.2.  The respective proteases were used to cleave protein from 
beads, following the manufacturer’s instructions (GE Healthcare), before samples were separated on 15% 
SDS-PAGE gels then stained with Coomassie Blue.  (A) Sx8 / Tlg1p chimera produced from pCMD003 was 
cleaved from beads using 0.05 units / µl thrombin, 5µl was resolved on gel.  (B) Protein produced from 
pCMD003 was concentrated using a centrifugal filtration device (Millipore) with a molecular weight cut off 
of 3 kDa.  Samples were centrifuged at 3,000 g for 15 minutes at 4oC; this centrifugation step was repeated 
until ~8 ml of the Sx8 / Tlg1p sample had been reduced to ~1 ml.  Panel shows filtrate (left Lane, 5 µl) and 
final product (right Lane, 5 µl) from concentration process.  (C) A sample of Sx8 / Tlg1p produced from 
pCMD004 and cleaved from beads using 0.04 units / µl PreScission protease (right Lane, 5 µl) was compared 
with the ~8 fold concentrated sample from pCMD003 (left Lane, 5 µl).  Positions of molecular weight 
markers are shown. 
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5.3.1.3 Expression and purification of Snc2p 
For reconstitution of labelled donor liposomes an N terminally His6 tagged version of full 
length Snc2p was expressed from plasmid pJM081 (McNew et al., 2000).  Purified Snc2p 
runs significantly higher than its predicted molecular weight of 12.9 kDa, as shown in 
Figure 5.8; this is consistent with a previous report (Protopopov et al., 1993).  In order to 
create a negative control that could block the entry of this full length v-SNARE into 
SNARE complexes, a cytosolic version of Snc2p, containing only residues 1 - 88 and 
harbouring an N terminal His6 tag, was produced from plasmid pCOG006, shown in Figure 
5.7 (B).  Protein was snap frozen in liquid nitrogen and stored at -80oC in aliquots of 100 
µl. 
 
Figure 5.7 Expression and purification cytosolic Snc2p1-88 
(A) Schematic diagram of Snc2p. (B) Plasmid pCOG006 was used to recombinantly produce a version of 
Snc2p lacking the transmembrane domain, expressing only residues 1 - 88.  The His6 tagged protein was 
expressed and purified from 6 L of culture as outlined in methods section (2.3.1.4).  Expression was induced 
with 1 mM IPTG for 4 hours at 37oC.  Protein was then bound to 2 ml settled Ni2+- NTA beads and eluted 
with buffer containing 250 mM imidazole after several washes.  5 µl of elution was run on a 15% SDS-
PAGE gel, and visualized by Coomassie staining.  Molecular weight markers are indicated.  
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Figure 5.8 Expression and purification of full length Snc2p 
Plasmid pJM081 was used to recombinantly produce full length Snc2p with an N terminal His6 tag.  The 
protein was expressed in BL21 (DE3) E. coli cells and purified from 12 L of culture as outlined in methods 
section (2.3.4.1).  Purity of protein was analysed at various stages by SDS-PAGE on a 12% gel followed by 
Coomassie staining (upper panel).  Lysate after 4 hour induction with 1 mM IPTG (Lane 1; 0.001%); 
examples of the 5 ml washes with 20 mM imidazole (Lanes 2 - 4; 0.1% of each); protein on beads before 
elution (Lane 5; 20µl); 1 ml elutions with 250 mM imidazole (Lanes 6 - 8; 5 µl of each); protein on beads 
after elutions (Lane 9; 5 µl).  The same samples were run on a second SDS-PAGE gel, and subsequently 
transferred to a nitrocellulose membrane for immunoblot analysis with α-Snc2p antibody (lower panel).  
Molecular weight markers are indicated. 
 
5.3.1.4 Expression and purification of Vps45p 
Production of recombinant protein in E. coli often results in large amounts of insoluble 
aggregates due to improper protein folding.  A large family of chaperone proteins function 
in vivo by stabilising partially folded protein intermediates allowing correct conformation 
to be achieved (Gething and Sambrook, 1992).  One member of the chaperone family 
found in bacteria is the oligomer GroEL, which forms a functional complex with its 
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regulator oligomer GroES (Chandrasekhar et al., 1986).  Partially folded proteins are 
bound and released by the GroESL complex in a sequential cycle (Martin et al., 1993, 
Weissman et al., 1994), which allows progressive ATP dependent folding of the protein 
(Azem et al., 1994).  The GroEL and GroES chaperone proteins were used to increase the 
concentration of soluble Vps45p achieved from affinity purification.  
Recombinant production of the SM protein Sec1p has previously been shown to be 
enhanced by co-expression with the bacterial chaperone protein GroEL and its regulator 
GroES (Scott et al., 2004).  Protein yield from purifications of Vps45p with and without 
GroEL and GroES co-expression were compared, keeping all other parameters in the 
process identical.  The pT-GroE plasmid (Yasukawa et al., 1995) was used to produce both 
GroEL and GroES.  This plasmid was co-expressed in E. coli with pNB710 (Carpp et al., 
2006), which encodes a version of Vps45p with an N terminal His6 tag.  Proteins were 
purified as described in methods section (2.3.4.1).  I found that inducing production of 
proteins with 0.2 mM IPTG overnight at 15oC was the best method to obtain highest levels 
of soluble Vps45p.  Figure 5.9 (A) shows samples of protein eluted from each purification.  
Vps45p concentrations obtained are much greater when co-expressed with GroEL and 
GroES (compare - and + Lanes for each elution, E1 - E4).  Vps45p of predicted molecular 
weight 68.0 kDa can be more easily identified after Western blot analysis, shown in Figure 
5.9 (B).   
To ensure that any observed effects of Vps45p addition to the system were not due to the N 
terminal affinity tag, I created plasmid pCMD015, which was used to express a version of 
Vps45p with a C terminal His6 tag.  Both the N and C terminally His6 tagged versions of 
Vps45p were purified under exactly the same conditions, to ensure they were added to the 
assay in equal concentrations.  Both proteins were then concentrated using centrifugal 
filtration devices until there was visible signs of precipitation.  Figure 5.10 shows samples 
of N and C tagged Vps45p both before and after centrifugal filtration.  The protein 
concentration of Vps45p alone, and not that of chaperone proteins and impurities, was 
estimated by analysing samples on an 8.5% SDS-PAGE gel, alongside BSA standards, 
followed by Coomassie staining.  The relative concentration of each band was determined 
by densitometry using Image J software.  The concentration of samples was estimated from 
the equation derived from a calibration curve plotted of the BSA standards.  The 
concentrations of Vps45p are very similar regardless of which side the tag is on; example 
preparations shown in Figure 5.10 were calculated as N terminally tagged Vps45p being 
31.9 µM and C terminally tagged 30.1 µM. 
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Figure 5.9  Co-expression of Vps45p with GroEL and GroES 
Plasmid pNB710 was used to recombinantly produce an N terminally tagged version of Vps45p into BL21 
(DE3) E. coli cells.  The same construct was also used to express protein in BL21 (DE3) cells harbouring 
plasmid pT-GroE, which expresses the E. coli chaperone proteins GroEL and GroES.  6 L cultures of each 
transformation were grown to OD600 ~0.6 before expression of proteins was induced by 0.2 M IPTG 
overnight at 15oC.  Proteins from each culture were purified in exactly the same manner, as outlined in 
methods section (2.3.4.1).  Both purified lysates were bound to 2 ml settled Ni2+-NTA beads for 1 hour 
before 4x 1 ml elutions in buffer containing 250 mM were carried out. (A) 5 µl of each elution (E1 - E4), 
with (+) and without (-) co-expression of chaperone proteins, was boiled in 2x LSB and then analysed by 
SDS-PAGE on a 12% gel before Coomassie staining.  Vps45p and GroEL, predicted molecular weights 68 
and 58 kDa respectively, are indicated. (B) 5 µl of sample co-expressed with GroEL and GroES (Lane 1) was 
also run on a 12% gel then transferred to a nitrocellulose membrane and subjected to immunoblot analysis 
using an α-Vps45p antibody.  Positions of molecular weight markers are indicated.  
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Figure 5.10 Comparison of N and C terminally His6 tagged Vps45p 
Plasmids pNB710 and pCMD015 were respectively used to express versions of Vps45p containing either an 
N or C terminal His6 tag in E. coli cells as described above.  Purifications of both proteins were carried out as 
before (described above); all parameters and conditions were identical.  Samples were then concentrated 
using centrifugal filtration devices with a molecular weight cut off of 30 kDa.  All samples were analysed on 
an 8.5% SDS-PAGE gel followed by Coomassie staining.  Both N and C terminally tagged versions before 
(Lane 1 & 3; 5 µl each) and after (Lane 2 & 4; 5µl each) centrifugal concentration are analysed.  Positions of 
molecular weight markers are indicated.   
 
5.3.2 Reconstitution of recombinant SNARE proteins into 
liposomes  
To produce unlabelled acceptor liposomes, the t-SNARE proteins were added to a lipid 
mixture consisting of 85 mol% 1-palmitoyl-2-oleoyl phosphatidylcholine (POPC) and 15 
mol% 1,2-dioleoylphosphatidylserine (DOPS).  To produce donor liposomes a lipid 
mixture of 82 mol% POPC and 15 mol% DOPS was used, with fluorescent probes NBD 
and rhodamine added as head group labels of 1,2-dipalmitoyl phosphatidylethanolamine 
(DPPE), at 1.5 mol% each.  POPC was chosen by Rothman and colleagues to be the main 
constituent of the synthetic lipid membrane for SNARE protein incorporation as it is 
relatively inert, the addition of DOPS was due to the negative charge of 
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phosphatidylserine, which appears to assist with protein reconstitution (Liu et al., 2007, 
Scott et al., 2003, Weber et al., 1998). 
In order to reconstitute the t-SNARE proteins in an assembled ternary complex, Tlg2p37-
397, Vti1p and Sx8 / Tlg1p proteins were pre-incubated overnight at 4oC; these proteins 
were added at an equal molar ratio (reactions typically contained ~250 µl Tlg2p37-397 at ~21 
µM; ~150 µl Vti1p at ~37 µM; and ~100 µl Sx8 / Tlg1p chimera at ~48 µM).  The 
overnight t-SNARE sample was then added to the dried down lipid mixture of 85% POPC 
and 15% DOPS to create an acceptor liposome population.  The stock solution of Snc2p 
was thawed from storage at -80oC, subjected to centrifugation at 18,000 g at 4oC to remove 
any precipitate, and then transferred to the donor lipid mix containing 15% DOPS and a 
slightly reduced concentration of 82% POPC, to accommodate addition of the 
fluorescently labelled lipids (1.5% DPPE-NBD and 1.5% DPPE-rhodamine).  
Proteoliposome populations of both t- and v-SNAREs were created by diluting the OG 
concentration below its CMC (19 - 25 mM; le Maire et al., 2000) to form liposome 
populations.  The detergent was removed by dialysis against A200 buffer after production of 
proteoliposomes to ensure it did not interfere with any subsequent applications.  
Proteoliposomes were then separated from soluble protein by floatation on a gradient of 
Nycodenz (Sigma-Aldrich Ltd). 
To determine success of reconstitution, samples were analysed by SDS-PAGE both before 
and after the procedure.  Figure 5.11 shows the samples of premixed Tlg2p37-397, Vti1p, 
Sx8 / Tlg1p and Snc2p before (Lanes 1 & 3) and after (Lanes 2 & 4) the reconstitution 
process.  This demonstrates that all proteins have been successfully incorporated into their 
respective vesicles.  The additional protein bands from the affinity purification seen on the 
gel before reconstitution are not reconstituted, presumably because they do not contain a 
transmembrane domain to facilitate incorporation into the lipid membrane. 
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Figure 5.11 Reconstitution of yeast endosomal SNAREs into liposomes 
Purified t-SNAREs Tlg2p37-397, Vti1p and Sx8 / Tlg1p chimera were mixed together to a total volume of 500 
µl at a molar ratio of 1:1:1 on a rotator overnight at 4oC, to allow ternary complex formation in preparation 
for acceptor liposome reconstitution.  100 µl of purified Snc2p stock was thawed for reconstitution into donor 
liposomes, and added to 400 µl A200 buffer containing 1% OG.  100 µl of 15 mM acceptor lipid mixtures and 
500 µl of 3 mM donor lipid mixtures, stored in chloroform, were dried down under a stream of nitrogen gas 
before vacuum desiccation.  Purified t- and v-SNAREs were added to lipids respectively, and then 
thoroughly mixed by vortexing.  The 500 µl solution of each lipid-protein mixture was then diluted, by the 
addition of 1 ml A200 buffer (200 mM KCl, 25 mM HEPES), below the CMC of OG, to allow spontaneous 
formation of liposomes.  The lipid mixture of each reaction was then dialysed against 4 L of A200 buffer 
containing 4 g BioBeads (BioRad Laboratories Ltd) to assist with removal of detergent.  Dialysed t- and v-
SNARE populations were then mixed with 1.5 ml 80% (w / v) Nycodenz (Sigma-Aldrich Ltd) in A200 buffer 
in a SW60 tube (Beckman Coulter Ltd, London, UK).  A 1 ml layer of 30 % (w / v) Nycodenz in A200 buffer 
was then carefully overlaid onto each mixture, before a 250 µl layer of A200 buffer was finally overlaid on 
top.  Formed proteoliposomes were separated through the Nycodenz gradient by centrifugation in a Beckman 
Coulter SW60 rotor at 46,000 rpm for 4 hours at 4oC.  t and v-SNARE populations were harvested from the 
top layer and the interface between the 30% layer.  10 µl of each population was then analysed by SDS-
PAGE (Lanes 2 & 4) and compared with 10 µl samples from before the reconstitution (Lanes 1 & 3).  
Molecular weight markers are indicated. 
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5.3.3 Characterisation of proteoliposomes 
In addition to checking SNARE proteins had been successfully reconstituted into 
liposomes by SDS-PAGE analysis, it was important to characterise the liposomes.  This is 
necessary to gauge how accurately fusion observed represents the biological system we 
have based our investigations on.  Firstly, I wanted to know the protein and lipid content of 
each liposome population.  Size determination is another important factor, as if the 
liposome sizes vary dramatically then the results obtained from the dequenching assay may 
not represent the actual rate of fusion.  I also wished to investigate the orientation of the 
proteins in the reconstituted liposomes, as a large amount of internally orientated proteins 
may result in misinterpretation of any fusion assay results correlated to the total protein 
concentrations.   
 
5.3.3.1 Estimation of protein and lipid content 
The total protein concentration in reconstituted liposomes was determined by amido black 
protein assay (Schaffner and Weissmann, 1973), which has previously been used to 
accurately determine protein content in presence of  high lipid concentrations (Kaplan and 
Pedersen, 1989), described in methods section 2.3.12.3.  The molar concentrations of 
Snc2p in donor liposomes were generally 6 - 10 fold greater than t-SNARE proteins in 
acceptor liposomes.  The calculated molar concentrations for Snc2p and the t-SNARE 
complex samples shown in Figure 5.11 were 32.9 µM and 5.6 µM respectively.  The lipid 
recovery was calculated by addition of trace amounts of tritiated 1,2-dipalmitoyl 
phosphatidylcholine ([3H]DPPC) to the lipid stocks.  Samples from both the lipid stocks 
and the harvested liposomes were compared by measuring radioactivity from equivalent 
volumes in a scintillation counter. 
 
5.3.3.2 Estimating size of proteoliposomes 
A dynamic light scattering (DLS) technique was used to estimate the size of reconstituted 
proteoliposomes containing either t- or v-SNAREs.  This technique relies on the scattering 
experienced by light when it collides with particles of smaller wavelength (Rayleigh 
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scattering).   The Brownian motion experienced by particles in solution causes fluctuations 
in the scattered light; a digital correlator can be used to determine the intensity auto-
correlation function, which can be used to calculate the hydrodynamic radii of the 
liposomes (Kinuta and Takei, 2002).  The DynaLS algorithm (DynaPro; Wyatt Technology 
Corp.) was used to invert the correlation function to find the best fitting size distribution.  
Measurements of both populations of proteoliposomes were made; Figure 5.12 (A) shows 
the range of hydrodynamic radii for the donor population containing Snc2p.  The 
measurements for this v-SNARE proteoliposome population were used to estimate an 
average size of 43.3 ± 6.42 nm.  Figure 5.12 (B) shows the size distribution of the acceptor 
liposomes containing Tlg2p37-397, Vti1p and the Sx8 / Tlg1p chimera.  The scattering 
measurements for this population were more varied and disallowed an accurate estimate to 
be achieved.  From the graph we can see that the range of liposome sizes was between 10-
90 nm, which is the same range as our donor liposomes, which we would expect, although 
we cannot accurately estimate their size from these measurements.  The raw data from the 
dynamic light scattering measurements are displayed in appendix I. 
To complement the dynamic light scattering size estimations, and with the hope of getting 
a better approximation of the t-SNARE liposome size, transmission electron microscopy 
was used to image the liposomes and measure their size directly.  The samples were diluted 
1/10 before being imaged at 16,000x magnification.  Figure 5.13 (A) and (B) shows 
examples of images taken from liposomes containing the yeast endosomal t-SNAREs and 
v-SNAREs respectively.  Proteoliposome diameters from several preparations of each 
population were estimated from the images using SIS iTEM software (Olympus).  The 
range of diameters from each population is presented as a percentage of the total, shown in 
Figure 5.13 (C) and (D).  This data shows that the liposomes ranged in size between 10 and 
100 nm, with the majority measuring between 40 and 70 nm in size, which is in agreement 
with the dynamic light scattering results previously described in this section. 
Both our dynamic light scattering and electron microscopy results correlate well with other 
examples of reconstituted yeast SNARE proteins in liposomes composed of 85% POPC 
and 15% DOPS (Scott et al., 2003). 
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Figure 5.12 Determination of proteoliposome size by dynamic light scattering 
Each population of donor and acceptor liposomes was diluted 1/20 with A200 buffer and then centrifuged at 
18,000 g for 10 minutes.  Samples were applied through a 200 nm filter into a DynaPro 801 Dynamic light 
scattering instrument (Wyatt Technology Corp.).  Measurements were taken at ~37oC.  The laser power was 
adjusted to keep the intensity between 500,000 counts and 2,000,000 counts.  The results were then 
processed with the program Dynamics V2 software (Wyatt Technology Corporation).  The hydrodynamic 
radii of each population were calculated with the regularisation algorithm provided by this software. 
Chris MacDonald, 2009  Chapter V, 165 
 
Figure 5.13 Determination of proteoliposome size by electron microscopy 
Recovered acceptor and donor proteoliposomes were diluted 1/10 before 10 µl of each sample was applied to a 
glow discharged copper grid.  1% aqueous methylamine vanadate was then applied as a negative stain before 
samples were imaged with a LEO 912 energy filtering transmission electron microscope at 120 kV.  
Representative images of both acceptor liposomes containing Tlg2p37-397, Vti1p and Sx8 / Tlg1p chimera (A) 
and donor lipsomes containing Snc2p (B) are shown.  Scale bars indicated.  Liposome diameters were 
measured directly from images produced from several different grids from each sample using SIS iTEM soft 
imaging software (Olympus).  Data presented as a percentage of total liposome population in histograms for 
acceptor (C) and donor (D) liposomes. 
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5.3.3.3 Estimating orientation of reconstituted SNARE proteins 
The external orientation of SNARE proteins is crucial for their ability to interact with 
cognate partners and facilitate fusion.  For this reason I designed a technique to allow the 
percentage of technically redundant, internally orientated, SNARE proteins to be 
estimated.  Trypsin was used to digest the external portion of the SNARE proteins; this 
was compared to a trypsin digest where the internal SNAREs were also made accessible to 
the protease by addition of detergent to disrupt the liposomes.  Figure 5.14 (A) shows an 
example of a trypsin digest to estimate the orientation of proteins.  Proteoliposomes were 
incubated at 37oC as a control (Lanes 1 & 4), external SNAREs were digested with trypsin 
and compared with total SNARE digestion, when Triton X-100 was also added (compare 
Lanes 2 with 3 & 5 with 6).  Figure 5.14 (B) shows average external orientation of 
SNAREs from at least 5 separate reconstitutions.  The Sx8 / Tlg1p chimera is not 
represented; it resolved poorly on the gel due to its small size; the resultant images were 
not suitable for densitometry analysis. 
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Figure 5.14 Orientation determination of reconstituted proteins in liposomes 
(A) Example of an SDS-PAGE gel used to determine the orientation of SNARE proteins reconstituted into 
acceptor and donor liposomes. 10 µl of liposomes were incubated at 37oC for 3 hours in the presence of 
trypsin either with or without Triton X-100. v-SNARE liposomes contain Snc2p, and t-SNARE liposomes 
contain Tlg2p, Vti1p and Sx8 / Tlg1p chimera.  Each reaction was then analysed by SDS-PAGE followed by 
Coomassie staining.   As a control a 10 µl sample from each population was also incubated with no trypsin 
(Lanes 1 & 4).  Molecular weight markers indicated.  (B) Histogram displaying average externally orientated 
SNARE proteins from at least 5 separate reconstitutions.  The standard deviation of each externally 
orientated SNARE protein is indicated by error bars. 
Chris MacDonald, 2009  Chapter V, 168 
5.3.4 In vitro fusion of liposomes containing the yeast endosomal 
SNAREs 
Reconstituted acceptor and donor liposomes were used to set up an in vitro fusion assay.  
Two reactions were prepared, each with 45 µl of the acceptor liposome population 
containing Tlg2p37-397, Vti1p and Sx8 / Tlg1p chimera at 4oC.  To the first reaction 5 µl of 
A200 buffer was added, to the second reaction 5 µl of cytosolic Snc2p1-88 was added as a 
negative control, to ensure that any increase in fluorescence was due to SNARE mediated 
membrane fusion.  Reactions were then incubated at 4oC for 1 hour to allow the binding of 
Snc2p1-88 to the ternary t-SNARE complex.  5 µl of donor liposomes containing 
reconstituted Snc2p were then added to each reaction.  The reason an excess of t-SNARE 
liposomes are added to the reaction is to account for the higher concentration of v-
SNAREs per liposome, at these volumes the ratio of t-SNARE complexes to v-SNARE is 
approximately 1:1 (Parlati et al., 1999).  Since there is a ~10 fold excess of Snc2p proteins 
per liposome in the donor population, each vesicle can undergo fusion with multiple 
acceptor liposomes mediated via different t-SNARE complexes.  Once the v-SNAREs had 
been added to the reaction and thoroughly mixed, the microtitre plates containing the 
reactions were transferred to the spectrophotometer pre-heated to 37oC.  Following a 5 
minute incubation, NBD fluorescence was measured at 2 minute intervals for 2 hours.  
Maximal fluorescence was then determined by the addition of n-dodecylmaltoside to each 
reaction and fluorescence measurements recorded for a further 40 minutes.  Figure 5.15 
shows the data normalised to the maximal fluorescence measurements for each reaction.  
The gradual increase in NBD fluorescence measured due to the decrease in rhodamine 
quenching as the acceptor liposomes dilute the donor liposomes, thus represents fusion 
(solid blue line).  The fusion of liposome populations is due to the formation of SNARE 
complexes, demonstrated by the inability of the same populations to fuse in the control 
reaction pre-incubated with cytosolic Snc2p (red dotted line).  The cytosolic Snc2p1-88 
competitively interacts with t-SNARE complexes rendering them inaccessible to Snc2p 
carried by the donor vesicles.  The raw fluorescence data recorded is shown in appendix II. 
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Figure 5.15 Reconstituted endosomal yeast SNAREs form a functional complex 
Fusion assays were set up with 45 µl acceptor t-SNARE and 5 µl v-SNARE liposomes.  Populations were 
mixed in a 96 well plate before transfer to a FLUOstar Optima spectrophotometer at 37oC.  Samples were 
incubated for 10 minutes before NBD fluorescence was measured at 2 minute intervals for 2 hours, with the 
excitation set to 460 nm and the emission set to 535 nm.  10 µl 2.5% (w / v) n-dodecylmaltoside detergent 
was then added to each reaction, and fluorescence was measured for a subsequent 40 minutes.  The maximal 
fluorescence was determined by this addition of detergent, raw fluorescence measurements were then 
normalised to this maximum.  Graph shows normalised data for t-SNAREs containing Tlg2p37-397, Vti1p, Sx8 
/ Tlg1p and v-SNARE Snc2p (blue line, filled circles).  As a control, a replica reaction was set up with the t-
SNAREs previously incubated for 1 hour with 5 µl soluble Snc2p1-88 before mixing with donor liposomes 
(red dotted line).  The raw fluorescence measurements for this experiment are presented in Appendix II. 
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5.3.5 Tlg1p SNARE complexes cannot facilitate fusion of vesicles 
in vitro  
It has previously been shown that the N terminal residues of the Tlg1p SNARE motif 
contain a regulatory element that inhibits its ability to facilitate fusion of vesicles in vitro 
(Paumet et al., 2005).  To confirm that Tlg1p could not fuse vesicles in our system we 
compared acceptor liposomes reconstituted with t-SNARE complexes containing Tlg2p37-
397 and Vti1p with either Tlg1p or the Sx8 / Tlg1p chimera.  Fusion assays containing 45 µl 
of the two populations of acceptor liposomes containing either Tlg1p or Sx8 / Tlg1p were 
set up with 5 µl of the same population of donor liposomes containing Snc2p.  Control 
reactions were again prepared in which the cytosolic domain of Snc2p1-88 was pre-
incubated with t-SNARE complexes for an hour at 4oC to block fusion.  Figure 5.16 shows 
the NBD fluorescence results normalised against maximal fluorescence determined by 
liposome disruption with detergent.  Successful fusion of Snc2p donor liposomes with 
acceptor liposomes containing t-SNARE complexes with the Sx8 / Tlg1p chimera is 
observed, as previously described (solid blue line).  Acceptor lipsomes containing Tlg1p 
do not fuse with the donor vesicles, indicated by no increase in NBD fluorescence above 
controls (solid red line compared with blue and red dotted lines).  This confirms the 
previously reported observation that Tlg1p is not capable of facilitating fusion of vesicles 
in vitro whereas a chimeric version, replacing the N terminal residues of the SNARE motif 
with those of mammalian Sx8, results in fusion of synthetic liposomes (Paumet et al., 
2005). 
Chris MacDonald, 2009  Chapter V, 171 
 
Figure 5.16 N terminal domain of Tlg1p SNARE motif inhibits fusion 
Fusion assays were set up as described previously. 45 µl t-SNARE populations containing Tlg2p37-397, Vti1p, 
and either Tlg1p (red) or Sx8 / Tlg1p (blue) were mixed with Snc2p containing donor liposomes.  NBD 
fluorescence at 535 nm was measured at 2 minute intervals, data was normalised to a percentage of maximal 
fluorescence, determined by addition of n-dodecylmaltoside after 2 hours.  Control reactions were set up with 
the addition of cytosolic Snc2p for 1 hour with Tlg1p and Sx8 / Tlg1p containing acceptor liposomes (red 
and blue dotted lines respectively).  The raw fluorescence measurements for this experiment are presented in 
Appendix II. 
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5.3.6 Inhibition of SNARE mediated membrane fusion 
The addition of cytosolic v-SNARE to competitively interact with t-SNARE complexes, 
thus inhibiting fusion of liposomes containing these t-SNAREs, is a necessary control to 
demonstrate that the fusion observed is SNARE dependent (Weber et al., 1998).  A small 
gradual increase in fluorescence in these control reactions is still detected (dotted lines in 
Figure 5.15 and 5.16).  I wanted to ensure that maximum inhibition was being achieved in 
these reactions.  In order to do this, I wanted to test if varying concentrations of Snc2p1-88 
resulted in a concentration dependent inhibition.  As we had previously been using 5 µl 
Snc2p1-88 at 38.4 µM to inhibit fusion, we chose to add 1 µl and 10 µl of Snc2p1-88 at 38.4 
µM to the t-SNARE liposomes prior to mixing with v-SNARE liposomes.  If the 5 µl 
Snc2p1-88 we were using previously was only partially inhibiting fusion, we should see 
more inhibition with 10 µl and less with 1µl.  As with previous experiments, Snc2p1-88 
samples were added to 45 µl t-SNARE containing liposomes and incubated for 1 hour at 
4oC.  A200 buffer was added to ensure reactions contained the same volume.  5 µl v-
SNARE liposomes were then added to each reaction, and the rate of fusion was measured 
as before and normalised to the maximal fluorescence achieved by addition of detergent.  
Figure 5.17 shows that 1 µl of Snc2p1-88 is sufficient to block fusion to the levels that I 
have previously documented from the in the in vitro fusion assay, approximately 2% after 
2 hours (solid red line).  Increasing the volume of Snc2p1-88 incubated with 45 µl of the 
same t-SNARE populations to 10 µl results in no additional inhibition of fusion (solid blue 
line). 
An intrinsic property of the fluorescently labelled lipids in the donor population at 37oC 
(e.g. induction of liposome disruption by an unknown factor) may account for this basal 
increase in fluorescence detected in the control experiments.  To test this explanation, a 
control reaction containing only 5 µl of the Snc2p containing donor liposomes was 
prepared, and again A200 buffer was added to make all volumes equal.  Donor liposomes 
alone do not result in any fluorescence (Figure 5.17, black dotted line), so we can exclude 
liposome lysis or any artefact associated with the donor liposomes alone causing this basal 
level of fusion observed.   
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Figure 5.17 Optimising cytosolic Snc2p1-88 control reactions 
Fusion assays were set up as described previously.  45 µl of liposomes containing reconstituted Tlg2p37-397, 
Vti1p, Sx8 / Tlg1p were incubated with 1 µl or 10 µl cytosolic Snc2p1-88 for 1 hour at 4oC to inhibit complex 
assembly.  5 µl of Snc2p containing donor liposomes was then added to each reaction.  A third reaction 
containing only 5 µl Snc2p liposomes and 55 µl A200 buffer was also prepared in a separate well.  NBD 
fluorescence at 535 nm was measured.  Graph shows fluorescence data normalised to a maximum determined 
by addition of detergent to achieve maximum fluorescence.  Blue and red lines represent fusion of yeast 
SNARE liposomes previously inhibited with 1 µl or 10 µl Snc2p1-88 respectively.  Black dotted line depicts 
fluorescence of donor liposomes alone over 2 hours at 37oC.  The raw fluorescence measurements for this 
experiment are presented in Appendix II.  
 
In order to ascertain if this basal level of fusion observed in control reactions occurred 
through some non-SNARE mediated fusion event, fusion reactions mixing 
proteoliposomes and empty liposomes were prepared.  45 µl of either t-SNARE (T) or 
empty (T*) acceptor liposomes were incubated with 5 µl of both v-SNARE (V) and empty 
(V*) donor liposomes.  Assays were run as previously described.  Figure 5.18 shows no 
fusion occurs between Tlg2p37-397, Vti1p, Sx8 / Tlg1p and empty donor liposomes (blue 
line) or Snc2p and empty acceptor liposomes (red line).  Both empty liposome controls 
show a basal rate of fusion which correlates with the control reaction previously incubated 
with Snc2p1-88 to inhibit fusion (black dotted line).  We then assume the basal rate is 
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representative of maximum inhibition achieved in our control reaction and is an 
unavoidable artefact from the assay conditions.  We consequently assume SNARE 
inhibition is maximised by addition of cytosolic Snc2p1-88 in our previous experiments, and 
fusion above this level represents the fusogenic effects of the SNARE proteins. 
 
Figure 5.18 Control fusion assay with liposomes lacking SNARE proteins  
Fusion assays were set up as described previously.  45 µl of liposomes containing reconstituted Tlg2p37-397, 
Vti1p, Sx8 / Tlg1p were incubated with 5 µl cytosolic Snc2p1-88 for 1 hour at 4oC as a negative control.  
Fusion reactions containing 45 µl t-SNARE with 5 µl empty donor liposomes (V*) or 45 µl empty acceptor 
(T*) and 5 µl Snc2p donor liposomes were incubated at 37oC; NBD fluorescence at 535 nm was measured.  
Graph shows fluorescence data normalised to a maximum determined by addition of detergent to achieve 
maximum fluorescence.  The black dotted line depicts fluorescence of control reaction previously incubated 
with Snc2p1-88.  Blue and red lines represent fusion of yeast SNARE liposomes with empty donor and 
acceptor liposomes respectively.  The raw fluorescence measurements for this experiment are presented in 
Appendix II.   
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5.3.7 Addition of Vps45p to in vitro fusion assay 
Firstly, to introduce the SM protein Vps45p into the fusion assay directly, we set up 
reactions (including controls) as previously described: 45 µl of t-SNARE liposomes pre-
incubated with 5 µl v-SNARE liposomes overnight at 4oC, to allow complex formation.  
Reactions were then incubated in the presence or absence of 80 µl C terminally His6 tagged 
Vps45p at a concentration of 30.1 µM.  The rate of fusion was measured as described 
previously, and compared to the maximal signal determined by liposome disruption with 
detergent.  Figure 5.19 shows the NBD fluorescence measurements.  Unfortunately the 
fusion reaction lacking SM protein showed no fusion above that of the cytosolic control 
(compare solid and dotted red lines).  This has been observed previously, but we have not 
ascertained the exact cause.  Certainly liposomes stored at 4oC for more than several days 
appear to lose their fusogenic capabilities, possibly due to degradation of proteins 
reconstituted in the liposomes; there are possibly other contributory factors that result in no 
fusion that we have yet to identify.  All reaction volumes for fusion assays are identical; 
this suggests that dilution of the liposomes does not affect their ability to fuse.  The 
reaction containing Vps45p does show elevated levels of fusion (solid blue line), that may 
suggest fusion has been stimulated above the basal rate in these reaction conditions, but 
without a control reaction resulting in fusion we cannot make these assumptions. 
A second approach was also used to incorporate Vps45p into the fusion assay.  45 µl t-
SNARE liposomes were incubated with 80 µl C terminally His6 tagged Vps45p or 
Munc18c for 24 hours at 4oC.  We thought it necessary to include a control reaction 
containing a non-cognate SM protein, so a C terminally His6 tagged version of Munc18c 
was expressed from pKIM001 and purified as described in section 2.3.4.1.  This was 
primarily because it is known that Vps45p can interact directly with cytosolic Snc2p in 
vitro (Carpp et al., 2006).  Since this was likely during an overnight incubation, we feared 
this would invalidate the control reaction.  As before, a control was set up incubating 45 µl 
t-SNAREs with cytosolic Snc2p1-88 before the 24 hour incubation step.  A200 buffer was 
added to reactions not containing SM proteins, so that all reactions contained an equal 
volume.  Each reaction was then heated to 37oC before addition of 5 µl v-SNARE 
liposomes.  NBD fluorescence was measured as before and compared to the maximum 
signal, determined by addition of detergent.  Figure 5.20 shows these results.  There 
appears to be no difference in the fusion reactions containing only buffer (red solid line) or 
Vps45p (blue solid line).  The control reaction is greater than we have observed for 
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previous cytosolic control reactions (red dotted line), possibly fusion has not been inhibited 
to its maximum in this reaction.  Addition of the control SM protein also appears to have 
no effect (green solid line); it is slightly less than the reactions containing Vps45p and 
buffer.  These experiments would have to be repeated to ascertain if this reduction in rate 
of fusion is significant or not. 
 
Figure 5.19 Addition of Vps45p to in vitro fusion assay 
Fusion assay reactions were prepared consisting of 45 µl t-SNARE liposomes containing Tlg2p37-397, Vti1p, 
Sx8 / Tlg1p and 5 µl v-SNARE liposomes containing Snc2p.  Liposome populations were incubated 
overnight at 4oC to allow complex formation.  The reaction mixtures were then incubated with either 80 µl 
Vps45p (at concentration 26.4 µM) or 80 µl A200 buffer; reactions were then incubated at 4oC for a further 3 
hours.  As for previous experiments, identical control reactions were prepared, in which 5 µl cytosolic 
Snc2p1-88 was incubated with the t-SNARE liposomes for 1 hour at 4oC, before addition of v-SNARE 
liposomes.  Liposomes were then incubated at 37oC for 10 minutes, before NBD fluorescence at 535 nm was 
measured every 2 minutes.  Graph shows fluorescence data normalised to a maximum determined by 
addition of detergent.  Reactions containing only buffer are shown in red, those pre-incubated in the presence 
of Vps45p are shown in blue.  The control reactions of each assay are presented as dotted lines.  The raw 
fluorescence measurements for this experiment are presented in Appendix II. 
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Figure 5.20 Addition of Vps45p and Munc18c to fusion assay 
Fusion assay reactions were prepared consisting of 45 µl t-SNARE liposomes containing Tlg2p37-397, Vti1p, 
Sx8 / Tlg1p, a control reaction containing 5 µl cytosolic Snc2p1-88 was incubated with 45 µl t-SNARE 
liposomes for 1 hour at 4oC.  80 µl of either A200 buffer, Vps45p (25 µM) or Munc18c (25 µM) was added to 
each reaction (75 µl A200 buffer was added to the cytosolic control reaction, so all volumes were equal), and 
incubated for 24 hours at 4oC.  Fusion reactions were heated to 37oC before 5 µl of v-SNARE liposomes was 
added to each reaction.  Fusion reactions were then incubated at 37oC and NBD fluorescence at 535 nm was 
measured every 2 minutes.  Graph shows fluorescence data normalised to a maximum determined by 
addition of detergent.  The reaction lacking SM protein (solid line), and its control pre-incubated with 
cytosolic Snc2p1-88 (dotted line) are shown in red.  The reactions pre-incubated with Vps45p and Munc18c 
are shown in blue and green respectively.  The raw fluorescence measurements for this experiment are 
presented in Appendix II. 
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5.4 Chapter summary 
This Chapter has discussed the development of an in vitro fusion assay, which has been 
successfully used to demonstrate that versions of the SNARE proteins localised to the 
TGN / endosomal system of S. cerevisiae (Tlg2p37-397, Vti1p, Sx8 / Tlg1p chimera) are 
capable of fusing synthetic liposomes.  In addition to this, we have confirmed the finding 
that t-SNARE complexes containing full length Tlg1p are incapable of facilitating fusion 
of synthetic membranes (Paumet et al., 2005).  Our preliminary attempts to incorporate 
Vps45p into the fusion assay have not revealed any functional role the SM protein may 
have.  Addition of Vps45p to the t-SNARE liposomes overnight was seen to have no effect 
on fusion.  A stimulatory effect was observed when Vps45p was added to liposomes that 
had already been pre-incubated to allow complex formation, but this result was 
inconclusive as the standard reaction did not result in fusion.  It is possibly that we need to 
optimise the conditions of Vps45p addition to the liposome fusion assay.  Also, it is 
important to note that the version of Tlg2p we were using did not contain the first 36 N 
terminal residues, so it is unable to bind to Vps45p via mode-2 binding.  An obvious next 
step would be to reconstitute Vps45p pre-bound to Tlg2p, or indeed to Snc2p, into 
liposomes. 
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The work presented in this thesis was aimed at understanding the regulation of SNARE 
dependent membrane fusion, using the yeast endosomal system as a model.  To this end, I 
have demonstrated several key features of the syntaxin homologue Tlg2p, and the SM 
protein Vps45p, which are important for fusion. 
 
6.1 Discussion of results 
In Chapter III, I presented data in support of our hypothesis that Tlg2p forms a closed 
conformation which is inhibitory to complex formation.  This is contentious, as it disagrees 
with NMR data demonstrating that no intramolcular interactions were observed in Tlg2p, 
suggesting that it can not adopt a closed conformation (Dulubova et al., 2002).  One 
restriction of the recombinantly produced fragments used in the NMR analysis is that due 
to the insolubility of the full length protein, truncated versions of Tlg2p were used 
(Dulubova et al., 2002).  NMR analysis of Tlg2p fragments containing residues 60 - 283 
(representing the entire cytosolic domain) and residues 65 - 192 (representing the Habc 
domain) were compared to see if any difference in structure could imply an intramolecular 
interaction (Dulubova et al., 2002).  Unfortunately, these fragments lack more than half the 
SNARE motif and the carboxy-terminal residues preceding the transmembrane domain, 
which may be important for the stabilisation of a closed conformation.  Existing evidence 
for the N terminal domain of Tlg2p playing an inhibitory role include the finding that 
removal of the Habc domain alleviates the requirement for SM protein Vps45p to allow 
complex formation (Bryant and James, 2001).  My data are in agreement with this, as 
versions of Tlg2p lacking the Habc domain form complexes more readily than the full 
length version in vitro (Figure 3.3), suggesting these in vivo observations (Bryant and 
James, 2001) are directly due to the lack of the Habc domain.   
The most obvious explanation for a conformation of Tlg2p that has an inhibitory effect on 
complex formation, is that Tlg2p forms a closed conformation, akin to that of its 
homologues Sx1a (Dulubova et al., 1999, Misura et al., 2000) and Sso1p (Carr et al., 1999, 
Munson et al., 2000), as outlined in our hypothesis.  Our attempts to identify a direct 
interaction between the Habc domain and the SNARE domain of Tlg2p using a yeast-2-
hybrid assay proved unsuccessful; this could be explained by the fragments used not being 
sufficient to stabilise a closed conformation.  Also, the concentrations of each domain 
produced in the yeast-2-hybrid assay may be too low to detect an interaction, as the 
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effective concentration of the two domains situated on the same polypeptide (as it occurs in 
vivo), is much greater than can be achieved when they are produced individually.  
The closed conformation of Sx1a is intrinsically linked to the SM protein, Munc18a, which 
interacts directly with Sx1a in this conformation that is incompatible with SNARE 
complex assembly (Dulubova et al., 1999, Misura et al., 2000).  Studies investigating the 
inhibitory domain of Tlg2p must therefore also examine its interaction with the SM 
protein, Vps45p.  A study looking at the interaction of Sx16, a mammalian homologue of 
Tlg2p, with mammalian Vps45 concluded that Sx16 can adopt a closed conformation 
which interacts with Vps45 (Burkhardt et al., 2008).  This study used ITC to demonstrate 
that the apparent affinity of the entire cytosolic domain of Sx16 is greater than that of the 
N terminal peptide alone (the portion that facilitates mode-2 binding) (Burkhardt et al., 
2008).  A similar effect was observed in quantitative analysis of yeast-2-hybrid results 
testing the affinity of Vps45p for various truncations of Tlg2p, where a stronger reporter 
signal is detected for the full length cytosolic domain than that of the N terminal peptide 
alone; this observation was not commented on by the authors (Dulubova et al., 2002). 
More direct evidence for a Tlg2p closed conformation was produced using size exclusion 
chromatography, demonstrating that Vps45p can interact with a Tlg2p fragment lacking 
the N terminal peptide, through an interaction distinct from mode-2 binding (Furgason et 
al., 2009).  This study went on to further characterise the affinity of this other binding 
mode with Vps45p, using a quantitative competition EMSA technique.  These experiments 
estimated the affinity of the N terminal domain of Tlg2p (residues 1 - 33) for Vps45p to be 
35 ± 3 nM and that of the C terminal binding site to be 280 ± 4 nM (Furgason et al., 2009).  
Mutant versions of Tlg2p, predicted to either disrupt mode-1 binding (I285A) or to 
produce a version of Tlg2p that cannot adopt a closed conformation 
(K134A/K137A/K163A), were created based on homology to other known mutants, 
(Burkhardt et al., 2008, Wu et al., 1999) and (Munson et al., 2000, Munson and Hughson, 
2002), respectively (Furgason et al., 2009).  When these mutants were combined with the 
N terminal truncation (Tlg2p∆1-33), no apparent affinity was observed, suggesting that the 
second C terminal binding site of Tlg2p corresponds to a closed conformation (Furgason et 
al., 2009).  Interestingly, the N terminal binding mode of Tlg2p competes with the closed 
conformation for Vps45p binding (Furgason et al., 2009), the exact functional relevance of 
this remains to be understood. 
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Understanding the significance of Vps45p binding to Tlg2p by these two distinct 
mechanisms may be advantageous to understand SM protein function in general.  
Abrogation of Vps45p binding through either a mode-1 interaction with the closed 
conformation, or a mode-2 interaction with the N terminal peptide had no effect on the 
cell’s ability to correctly sort the vacuolar hydrolase CPY (Figure 3.10).  However, an 
essential role of Vps45p was shown when both binding modes were abolished, which 
resulted in defects in the trafficking pathway of CPY (Figure 3.10).  The finding that 
Vps45p relieves the kinetic delay on complex assembly experienced by full length Tlg2p 
in vitro (Figure 3.4), suggests that Vps45p has a direct role in SNARE complex assembly 
preceding fusion: priming SNAREs for assembly by activating Tlg2p.  This supports our 
hypothesis that Vps45p facilitates a conformational switch in Tlg2p, whereupon the Habc 
domain disengages with the SNARE domain, rendering it accessible to the cognate 
SNARE partners. 
Chapter IV details my analysis of Vps45p’s interaction with the v-SNARE Snc2p (Carpp 
et al., 2006).  I used a yeast-2-hybrid system to confirm the interaction, shown in Figure 
4.3, and further developed this assay to serve as a tool for mapping the binding sites of 
Vps45p to the Snc2p SNARE motif (discussed in section 6.2).  It is noteworthy that 
addition of the C terminal GFP tag to Vps45p reduced the levels of reporter gene activation 
in the assay, suggesting a weaker interaction than untagged Vps45p (Figure 4.3).  This may 
be due to the proximity of the GFP tag to the Snc2p binding site of Vps45p.  Introducing 
mutation in this area first may be the fastest course of action to determine the essential 
residues for the interaction. 
The interaction between Vps45p and Snc2p was also confirmed using an EMSA assay 
(Figures 4.10 & 4.11).  The EMSA assay was prepared with the aim of accurately 
determining the affinity of the interaction between Snc2p and Vps45p, as demonstrated for 
Tlg2p binding to Vps45p (Furgason et al., 2009).  This was not possible, as we were 
unable to obtain the high concentrations of recombinant protein required to accurately 
measure this low affinity interaction.  We can however estimate the Kd of the interaction to 
be approximately 10 µM.  This is a weaker interaction than either of the two binding 
modes between Tlg2p and Vps45p (Furgason et al., 2009).  This is consistent with our 
model: Vps45p travels to the site of membrane fusion on the transport vesicle through its 
interaction with Snc2p and is then transferred to Tlg2p in a closed conformation (discussed 
in section 6.3).  This model predicts that Vps45p would have a greater affinity for Tlg2p 
than Snc2p. 
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In conjunction with the EMSA assay, I attempted a fluorescence polarisation (FP) assay 
(Park and Raines, 2004), using similar binding conditions as described in the preparation 
of the EMSA (Chapter IV).  The FP assay is more sensitive than the EMSA, and has the 
advantage of being able to record measurements in solution.  This would eliminate any 
factor the gel matrix has on protein-protein interactions or protein mobility.  The principle 
of the assay is to distinguish unbound labelled protein from that which is in complex with 
another protein (Heyduk et al., 1996).  This can be achieved by measuring the fluorescence 
anisotropy of the samples in solution; the Vps45p-Snc2p complex will have a detectably 
slower rotational motion value than uncoupled Snc2p.  The size difference between the two 
proteins is favourable for these measurements.  Unfortunately, these results were 
inconclusive, but the method could potentially be used in the future to accurately measure 
the Kd of the Vps45p-Snc2p interaction.  Other possibly avenues of investigation to 
achieve this goal are discussed in section 6.2. 
As competition experiments could not be used in the EMSA assay, we used in vitro 
competition binding studies to investigate the relative affinities of Vps45p for Tlg2p and 
Snc2p.  In agreement with a previous report, Tlg2p can displace binding of Snc2p to 
Vps45p (Carpp et al., 2006).  Further to this, I demonstrated that the displacement of 
Snc2p occurs in a concentration dependent manner, and that the mode-2 interaction is 
dispensable for this displacement (Figure 4.13).  This is also in agreement with a model 
whereby Vps45p is transferred from Snc2p to the higher affinity binding of the closed 
conformation of Tlg2p (mode-1). 
My final results Chapter deals with developing an in vitro fusion assay.  I have 
successfully incorporated the SNARE proteins of the yeast endosomal system into 
synthetic liposomes, and demonstrated that they are capable of fusing the liposomes 
(Figure 5.15).  Further to this, in agreement with a previous report (Paumet et al., 2005), I 
have shown that the N terminal portion of the Tlg1p SNARE domain imposes a level of 
negative regulation on fusion (Figure 5.16).  Using a chimeric protein, that replaces the N 
terminus of the Tlg1p SNARE domain with that of the mammalian homologue, Sx8, 
relieves this inhibition (Figure 5.16). 
I spent considerable time and effort trying to optimise the in vitro assay, so that it can be 
used to investigate the role of Vps45p in membrane fusion.  I have extensively 
characterised the proteoliposomes produced in the process, so that we can assess their lipid 
and protein content, and what orientation the proteins are in (discussed in section 5.3.3).   
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In addition to this we have estimated the size of the liposomes; ensuring populations are of 
similar size distribution to each other.  This will also aide any “rounds of fusion” 
calculations, a physical parameter used to demonstrate the extent of fusion in donor 
vesicles (Parlati et al., 1999), which can now be calculated more accurately.  I also had 
some trouble maximising the inhibition of the cytosolic control, but my observation that 
liposomes lacking SNARE proteins results in a small increase in fluorescence that can not 
be reduced any further in the control fusion reaction, suggests this is unavoidable (Figure 
5.18). 
My attempts to incorporate Vps45p into the assay have as yet been unsuccessful in 
yielding any functional data on its SNARE interactions.  Addition of Vps45p to liposomes 
incorporated with SNARE proteins that had previously been allowed to form complexes at 
4oC was unsuccessful, but this may be have been due to the fluorescence equilibration I 
detect as the temperature is increased.  There is a high fluorescence at the start of the 
assays, as the temperature is changed from 4oC to 37oC (Vicogne and Pessin, 2008).  The 
neuronal Sx1a binds Munc18a via mode-2 during this stage, and enhances the rate of 
fusion (Shen et al., 2007).  If Vps45p is having an effect on fusion at this stage, it will only 
do so for the first round of liposome fusion from the pre-docked samples.  The first round 
of pre-docked liposomes containing the neuronal SNARE proteins occurs most 
significantly in the first 20 minutes (Shen et al., 2007).  If this is the also the case in our 
system, the effect will be drowned out by the high fluorescence background experienced at 
the start of the assay.  This is unavoidable, as the liposomes cannot be left to dock through 
SNARE interaction at 37oC, as fusion will also occur. 
Alternatively, as we are using a version of Tlg2p that cannot interact with Vps45p via a 
mode-2 interaction, maybe it cannot exert influence on the process.  Or, possibly, our 
system differs from the exocytotic systems thus far characterised using the in vitro fusion 
assay (Scott et al., 2004, Shen et al., 2007).  It has been shown previously that Vps45p 
dissociates from trans-SNARE complexes and then re-associates with the cis-SNARE 
complex after fusion (Bryant and James, 2003), so possibly the interaction between 
Vps45p and the SNARE complex by a mode distinct from mode-2 observed in vitro 
(Carpp et al., 2006) represents the cis complex, and Vps45p has no direct role on fusion 
per se.  Functional analysis of the full length Tlg2p protein is required to differentiate 
between these possibilities. 
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Interestingly, the reaction that was prepared in presence of Vps45p resulted in fusion 
(Figure 5.19).  We cannot say that this is an enhanced effect, as the standard reaction did 
not work; it may be standard fusion observed in the reaction containing Vps45p, and the 
basal fusion reaction did not work for some unknown reason.   
I also attempted to incorporate Vps45p into the assay before complex formation.  This did 
not result in any observable difference in the rate of fusion (Figure 5.20), but it is worth 
noting that addition of yeast Sec1p had a very marginal effect on increasing the rate of 
fusion, and it was only when the SM protein was reconstituted with the t-SNARE complex 
(Sso1p and Sec9p), that a 3 fold increase in the rate of liposome fusion was observed 
(Scott et al., 2004).  My initial attempts to reconstitute Vps45p with the t-SNARE 
complex, or that of the v-SNARE Snc2p, resulted in vast amounts of precipitation and no 
detectable protein reconstitution.  Also, it is again possible that the full length Tlg2p 
protein will have to be used in this manner to test the effect of Vps45p.  These difficulties 
may require considerable work to overcome. 
The physiological relevance of this in vitro fusion assay has been questioned, primarily due 
to its inability to replicate fusion at rates anywhere near those which must occur in the 
neuronal synapse (Chernomordik and Melikov, 2006, Rizo and Sudhof, 2002).  Also, it has 
been suggested that the number of reconstituted SNARE proteins per liposome may not 
represent physiological conditions (Chernomordik and Melikov, 2006), however estimates 
of this number for the neuronal system are not agreed upon (Brunger, 2005, Dennison et 
al., 2006).  Characterisation of proteoliposomes, such as those described in section 5.3.3, 
allows this information to be known prior to any fusion assays, so the results can be 
directly correlated, for example, to the amount of externally facing v-SNAREs in a donor 
liposome.  Also, the protein to lipid content can be adjusted at the preparation stage, to 
increase or decrease the number of SNAREs per liposome.  It has also been assumed that 
additional regulatory factors are required to allow fusion to occur at a faster rate (Weber et 
al., 1998), as there are many in vivo factors, such as the Rab and tethering protein families 
(discussed in sections 1.5.5 & 1.5.6) that are not represented in this system.  This has been 
supported by one study that successfully incorporated the Rab-SNARE machinery 
necessary for mammalian endosomal traffic into liposomes, and demonstrated that fusion 
is more efficient with the entire complement of Rab-SNARE machinery than SNAREs 
alone (Ohya et al., 2009).  Although the in vitro fusion assay is a simplified system, it does 
mimic both proteins and lipids involved with membrane fusion.  This reductionist 
approach remains a useful tool to reveal data related to function of the factors involved.   
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6.2 Future work 
In the light of a confirmed Tlg2p closed conformation (Furgason et al., 2009), it might be 
useful to repeat the competition binding experiments (Figure 4.13) with the mutants 
abrogated for mode-1 binding used in this study (Tlg2pI285A and Tlg2pK134A/K137A/K163A), 
both alone and in combination with the mutants used to abrogate mode-2 binding 
(Vps45pL117R and Tlg2pF9A/L10A).  This would allow us to test if the mode-1 interaction of 
Tlg2p is necessary to displace Snc2p, as we know mode-2 is not important (Figure 4.13).  
These studies could reveal more about the importance of each binding mode, and would 
confirm our hypothesis that the Vps45p binding to Snc2p precedes its interaction with the 
closed conformation of Tlg2p. 
We would also like to further characterise the Snc2p binding mode.  As the EMSA proved 
an inappropriate technique to estimate the affinity of the interaction, the more sensitive 
Biacore SPR may be a better technique.  One requirement of this method is to bind protein 
of interest to a chip, which is subsequently flushed with the interacting protein partner 
(Fivash et al., 1998).  The native cysteine in Snc2p, at residue 94, would be ideal to 
immobilise the protein on a chip (O'Shannessy et al., 1992) via a thiol reaction similar to 
the Alexa 488 labelling reaction we carried out for the EMSA technique (Section 4.3.2.3).  
Competition binding experiments could also be done through the Biacore technique.  We 
hope to carry out these experiments in collaboration with Dr. Sharon Kelly, University of 
Glasgow, UK.   My initial attempts to purify Vps45p either without GroEL, or to separate 
the GroEL by more extensive purification, proved unsuccessful.  Optimisation of the ion 
exchange chromatography could result in relatively rapid production of the necessary 
proteins for these Biacore experiments.  ITC is another more sensitive technique that has 
been recently used to estimate the affinity of SM protein binding (Burkhardt et al., 2008), 
which could be used to investigate the relative affinity of the Vps45p-Snc2p interaction. 
The yeast-2-hybrid assay discussed in Chapter IV is now ready to be moved into a 
different host strain that will allow a reverse selection to identify binding partners that do 
not interact.  Several reverse-2-hybrid techniques have been developed, the most common 
of which uses URA3 as a positive selection forward assay, then uses the toxic 5-fluororotic 
acid (5-FOA) drug to positively select for mutants that no longer interact (Vidal et al., 
1996b).  We attempted to do this with the yeast strains MaV103 and Mav203 (Vidal et al., 
1996a), and use the reconstitution of the transcriptional machinery to activate the URA3 
gene in these strains.  5-FOA is toxic to cells in the presence of uracil, as it converts uracil 
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to 5-fluro-deoxyuracil, which is toxic to yeast cells (Boeke et al., 1987).  Therefore, 5-FOA 
can be used to counter select yeast harbouring versions of Vps45p unable to interact with 
Snc2p.  Truncation mutants can be avoided by prior screening for the C terminal GFP tag 
that ensures the entire VPS45 gene has been translated.  Unfortunately the URA3 selection 
in the forward assay did not work consistently, so we are in search of a new reverse screen.  
Other systems involve using different agents that allow counter selection, such as 3-
aminotriazole (3-AT): a drug which competitively interacts with a critical enzyme in the 
biosynthetic pathway of histidine (Walhout and Vidal, 2001).  The best course of action for 
us is to use a yeast strain that allows selective incorporation of our constructs based on 
parent vectors pACT2 and pGBKT7.  This would be prudent as the forward assay has been 
shown to work well and consistently (Figure 4.3), also, the full length mutants will be 
easily identifiable by the C terminal GFPS65T tag, that has been successfully incorporated 
into both AD and BD versions of Vps45p and shown to express well (Figure 4.4).  
Alterations of selective markers or genetic modifications to a yeast strain genome are both 
difficult and time consuming tasks which could be avoided by choice of strain.  We have 
recently identified a model which could work with our system, the strain CY770 that 
contains a mutant cyh2 gene (which is resistant to cyclohexamide), could be used in 
conjunction with a plasmid that confers sensitivity to the drug through a GAL activated 
promoter (GALUAS-CYH2) (Young et al., 1998).  Resistance to this drug would allow us 
to isolate hybrid combinations that no longer interact.  Sequence analysis of a library of 
mutants that can no longer interact should indicate areas of the Vps45p molecule that are 
important for this interaction.  Further, site specific, mutations would then allow us to 
produce recombinant protein that was abrogated for this mode of binding.  We could then 
use this mutant, in conjunction with other mutant proteins abrogated for other binding 
modes, in various assays (including the in vitro fusion assay; discussed in Chapter V) to 
help us appreciate the significance of Vps45p binding SNAREs by multiple, distinct 
binding modes. 
We would like to do several things with the in vitro fusion assay, primarily to incorporate 
Vps45p in some way that will reveal its functional significance.  Our attempts thus far to 
do so have been unsuccessful, but sufficient time has not been spent to optimise conditions 
to a satisfactorily degree; further investigation could still prove fruitful.  Addition of 
Vps45p that has been more extensively purified (as is necessary for Biacore SPR analysis) 
could also be beneficial to these studies.  Also, optimisation of the purification and 
reconstitution of full length version of Tlg2p (containing the first 36 residues), allowing its 
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incorporation into liposomes, would allow us to directly test if Vps45p binding via mode-2 
has any effect on membrane fusion. 
Taking the arguments against the physiological relevance of the in vitro fusion assay into 
account (section 6.1), we still consider it a valuable tool to reveal the functional relevance 
of certain aspects of our model system.  The use of our existing mutant proteins versions 
could still reveal the importance of the various Vps45p binding modes.  Testing the ability 
of versions of Tlg2p both with the Habc domain truncated and a constitutively open protein 
could show us if the N terminal Habc domain / closed conformation has a reduced rate of 
fusion.  Also, versions of Vps45p abrogated for mode-1, mode-2 and the ill-defined Snc2p 
binding modes would allow us to test the role of each mode in the actual fusion event.  If 
experiments are correctly controlled internally, we see no reason why this type of data 
would not contribute to our overall understanding of membrane fusion. 
 
6.3 Proposed model 
A model for the proposed series of events resulting in fusion of trafficked vesicles at the 
yeast TGN / early endosome is outlined in Figure 6.1.  The novel interaction between 
Vps45p and Snc2p (Carpp et al., 2006; Chapter IV) allows the transportation of the SM 
protein to the target membrane harbouring the t-SNARE proteins.  To ensure non-
functional SNARE complexes are not formed, the Tlg2p molecule is in its closed 
conformation, with the Habc domain folded back and interacting with the SNARE motif 
(Chapter III; Furgason et al., 2009).  As Vps45p has a greater affinity for the closed 
conformation of Tlg2p (Kd = ~ 280 nM; Furgason et al., 2009) than Snc2p (Kd = ~1,000 
nM; Chapter IV), the SM protein is transferred to the Tlg2p molecule.  Mode-2 binding of 
Tlg2p is not required for it to displace Snc2p (Chapter IV), so presumably Vps45p 
interacts with Tlg2p through a mode-1 interaction.  As Vps45p cannot bind to Tlg2p and 
Snc2p at the same time (Carpp et al., 2006), as would be predicted for the simplest 
bridging hypothesis (Peng and Gallwitz, 2004), we speculate additional in vivo factors may 
work in concert with the proteins to allow the transfer.  It seems likely other proteins 
would be involved at this step, the GARP complex for example (Oka and Krieger, 2005), 
due to the temporal and spatial regulatory requirements of these distinct binding modes.  
Upon binding, Vps45p then facilitates a conformational change in Tlg2p, relieving the 
inhibitory effect of the Habc domain on that of the SNARE domain and allowing it to form 
Chris MacDonald, 2009  Chapter VI, 189 
a ternary complex with Vti1p and Tlg1p (Bryant and James, 2001).  We are unsure of the 
fate of Vps45p at this juncture, but based on the Sx1a-Munc18a model, we propose that 
Vps45p interacts with the SNARE partners at this point (through a mode-2 interaction; Kd 
= ~35 nM), possibly enhancing the rate of fusion.  As the N terminal binding site and the 
binding site of the closed conformation compete for interaction (Furgason et al., 2009), we 
must assume there are additional factors that allow the binding to the closed conformation 
to be favourable in the first instance.  Tlg2p differs from Sx1a in that its SM protein 
competes for these two binding modes (Furgason et al., 2009); we plan to use the in vitro 
fusion assay to test if Vps45p has an effect on the fusion rate, which would be suggestive 
of an interaction at this stage.  Mutant versions could then be used to test if, like Sx1a 
(Shen et al., 2007), Tlg2p binds via mode-2 at this point.  As the vesicle containing Snc2p, 
that delivered Vps45p to the inactive Tlg2p molecule, is in close proximity, a trans-
SNARE complex is then favourable; this allows the vesicle to dock at the target membrane 
site.  At this point Vps45p dissociates from the complex (Bryant and James, 2003).  After 
this, the trans-complex facilitates fusion of the opposing membranes.  Vps45p re-
associates with the membrane through an interaction (possible mode-3 binding) with the 
cis-complex (Bryant and James, 2003); which may have been the in vivo scenario 
replicated by the in vitro binding experiments demonstrating that Vps45p associates to 
SNARE complexes via a mode distinct from mode-2 (Carpp et al., 2006).  This interaction 
may be associated with a distinct role from the earlier events in the fusion process, possibly 
associated with the disassembly process, which the other yeast SM protein, Sly1p, has been 
implicated in (Kosodo et al., 2003).  
The production of Vps45p mutants abrogated in Snc2p binding (as discussed for the yeast-
2-hybrid reverse screen) would allow us to check if this binding in vivo functions to 
correctly traffic vesicles to the endosomal membranes.  Also, I have not discussed the role 
Vps45p plays in stabilising endogenous levels of Tlg2p, by protecting it from proteasomal 
degradation (Bryant and James, 2001, Carpp et al., 2007).  I have hinted at additional 
regulatory factors having roles in this model, one such example could be phosphorylation.  
It has been shown in vitro that Tlg2p can be phosphorylated, which prohibits its entry into 
SNARE complexes (Gurunathan et al., 2002).  It might be that this is a sublevel of 
regulation, which works in concert with Vps45p to regulate both Tlg2p levels and its 
proclivity to form SNARE complexes. 
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Figure 6.1 Proposed model 
(A) The weak affinity interaction between Vps45p (purple) and Snc2p (blue) anchored to a transport vesicle, 
localises the SM protein to target membrane.  Tlg2p (red) is in a closed conformation at the target membrane, 
with the Habc domain interacting with the SNARE motif (black); and not interacting with cognate t-SNAREs 
Vti1p and Tlg1p (both in green). (B) Upon its arrival at the target destination, Vps45p detaches from Snc2p 
and interacts with Tlg2p via a mode-1 interaction.  This binding results in a conformational switch in Tlg2p, 
releasing the Habc domain from the SNARE domain. (C) The Tlg2p SNARE domain is free to form a ternary 
complex with Vti1p and Tlg1p; Vps45p binds Tlg2p via mode-2 interaction. (D) trans-SNARE complex 
formation, docking the vesicle at then target membrane; Vps45p dissociates at this point. (E) SNARE 
complex facilitates fusion of opposing membranes, releasing cargo (turquoise).  (F) Vps45p interacts with 
the cis-SNARE complex through a mode distinct from mode-2 (possibly mode-3).  Complex is disassembled; 
SNAREs are recycled and ready for another round of fusion (A).   
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7.1 Appendix I: Dynamic light scattering raw data  
Data readout from the DynaPro 801 Dynamic light scattering instrument was analysed 
using dynamics V2 software (Wyatt Technology Corp.).  Readout from hydrodynamic 
radii estimations made on t-SNARE acceptor liposomes and v-SNARE donor liposomes. 
 
 
Figure 7.1 DLS raw data for t-SNARE liposome size estimations 
Data print out from the dynamic light scattering measurements made to calculate the hydrodynamic radii of t-
SNARE acceptor liposomes. 
Chris MacDonald, 2009  Chapter VII, 193 
 
Figure 7.2 DLS raw data for v-SNARE liposome size estimations 
Data print out from the dynamic light scattering measurements made to calculate the hydrodynamic radii of 
v- SNARE donor liposomes. 
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7.2 Appendix II: Fusion assay raw fluorescence data 
NBD fluorescence measured from fusion assays indicated, both tables of data and a graph 
depicting the fluorescence from the dequenching assay before and after the addition of 
detergent to achieve a maximal signal, which is subsequently used to normalize data. 
 
Figure 7.3 Raw fluorescence data from Figure 5.15 
Fluorescence measurements (arbitrary units) taken from standard reaction (T+V) and control reaction where 
t-SNARE liposomes are pre-incubated with cytosolic Snc2p1-88, every 2 minutes for 160 minutes.  After the 2 
hour time point, 10 µl n-dodecylmaltoside was added before final 40 minutes of measurements were 
recorded.  The maximal fluorescence measured after addition of detergent was used to normalise data as a 
percentage of this maximum. 
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Figure 7.4 Normalisation of data from Figure 5.15 
Data from Figure 7.3 presented as a graph after normalisation to the maximal fluorescence determined by 
addition of detergent.   
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Figure 7.5 Raw fluorescence data from Figure 5.16 
Fluorescence measurements (arbitrary units) at 520 nm were measured for 2 hours for all reactions: reactions 
of Tlg1p or Sx8 / Tlg1p containing t-SNARE complexes with v-SNAREs, alongside a negative control for 
each where samples were pre-incubated in the presence of cytosolic Snc2p1-88.  After this, 10 µl of detergent 
n-dodecylmaltoside was added to each reaction and measurements were taken for a further 40 minutes.  The 
maximal fluorescence measured after addition of detergent was used to normalise data as a percentage of this 
maximum.   
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Figure 7.6 Normalisation of data from Figure 5.16 
Data from figure 7.5 presented as a graph after normalisation to the maximal fluorescence determined by 
addition of detergent. 
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Figure 7.7  Raw fluorescence data from Figure 5.17 
Fluorescence measurements (arbitrary units) from various control reactions were taken every 2 minutes for 
160 minutes.   The first two reactions incubated t-SNARE liposomes with either 1 µl or 10 µl cytosolic 
Snc2p1-88, before addition of v-SNARE liposomes.  The final control reaction contained only donor v-
SNARE liposomes.  After the 2 hour time point, 10 µl n-dodecylmaltoside was added before final 40 minutes 
of measurements were recorded.  The maximal fluorescence measured after addition of detergent was used to 
normalise data as a percentage of this maximum. 
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Figure 7.8 Normalisation of data from Figure 5.17 
Data from Figure 7.7 presented as a graph after normalisation to the maximal fluorescence determined by 
addition of detergent.   
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Figure 7.9 Raw fluorescence data from Figure 5.18 
Fluorescence measurements (arbitrary units) from control reactions were taken every 2 minutes for 160 
minutes.   The first reaction is the standard control where 10 µl cytosolic Snc2p1-88 is added to t-SNAREs 
prior to incubation with v-SNARE liposomes.  The next two control reactions contained either t- or v-
SNARE liposomes incubated with empty donor (V*) and acceptor liposomes (T*) respectively.  The final 
control reaction contained only donor v-SNARE liposomes.  After the 2 hour time point, 10 µl n-
dodecylmaltoside was added before final 40 minutes of measurements were recorded.  The maximal 
fluorescence measured after addition of detergent was used to normalise data as a percentage of this 
maximum. 
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Figure 7.10  Normalisation of data from Figure 5.18 
Data from Figure 7.9 presented as a graph after normalisation to the maximal fluorescence determined by 
addition of detergent.   
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Figure 7.11 Raw fluorescence data from Figure 5.19 
Fluorescence measurements (arbitrary units) from all fusion reactions were taken every 2 minutes for 160 
minutes.   Reactions containing t- and v-SNARE liposomes alone or incubated in the presence of Vps45p 
were carried out; each with a negative control previously incubated with cytosolic Snc2p1-88 to inhibit fusion.  
After the 2 hour time point, 10 µl n-dodecylmaltoside was added before final 40 minutes of measurements 
were recorded.  The maximal fluorescence measured after addition of detergent was used to normalise data as 
a percentage of this maximum. 
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Figure 7.12 Normalisation of data from Figure 5.19 
Data from Figure 7.11 presented as a graph after normalisation to the maximal fluorescence determined by 
addition of detergent.   
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Figure 7.13 Raw fluorescence data from Figure 5.20 
Fluorescence measurements (arbitrary units) from all fusion reactions were taken every 2 minutes for 160 
minutes.   Reactions containing t- and v-SNARE liposomes alone or incubated with either Vps45p or 
Munc18c were carried out.  A control reaction where t-SNARE liposomes were previously incubated with 
cytosolic Snc2p1-88 was included.  After the 2 hour time point, 10 µl n-dodecylmaltoside was added before 
final 40 minutes of measurements were recorded.  The maximal fluorescence measured after addition of 
detergent was used to normalise data as a percentage of this maximum 
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Figure 7.14 Normalisation of data from Figure 5.20 
Data from Figure 7.13 presented as a graph after normalisation to the maximal fluorescence determined by 
addition of detergent.   
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7.3 Appendix III: Publications related to this work 
Struthers M, Shanks SG, MacDonald C, Carpp LN, Drozdowska A, Kioumourtzoglou D, 
Furgason ML, Munson M and Bryant NJ. (2009)  Functional homology of mammalian 
syntaxin16 and yeast Tlg2p reveals a conserved regulatory mechanism.  J. Cell Sci. 
122:2292-9. 
Furgason ML, MacDonald C, Shanks SG, Ryder SP, Bryant NJ, Munson M. (2009)  The 
N-terminal peptide of the syntaxin Tlg2p modulates binding of its closed conformation to 
Vps45p. Proc. Natl. Acad. Sci. 103: 14303-8. 
MacDonald C, Munson M and Bryant NJ. (2010) Auto-inhibition of SNARE complex 
assembly by a conformational switch represents a conserved feature of syntaxins. Biochem. 
Soc. Trans. (in press; due to be published February 2010) 
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